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Abstract 
Abstract 
Ageing is an inevitable process characterised by a progressive deterioration in the 
function of a number of organs and systems, ultimately reducing the individual's quality 
of life of. Despite its obvious importance, our understanding of the basic age-related 
changes in cardiac function remains poor. In part because past studies, describing the 
changes in cardiac function with age, have not always adequately controlled for 
different lifestyles or superimposed diseases, while using less than complete measures 
of overall cardiac function and appropriate scaling models. The aim of this thesis was to 
determine the changes in overall cardiac function associated with healthy ageing, using 
the comprehensive, non-invasive method of cardiac power output (CPO). 
After identifying that CPO was not affected by circadian rhythms, 149 sedentary men 
and women (19-75 years) and 60 active men were investigated. All were free from 
cardiovascular diseases and medications. The findings indicated that healthy ageing, in 
all subject populations, was associated with an -17% decline in CPO.,,, t, -15% in 
CPOmax, and -14% in CR. Age for age, sedentary men had greater CPO values than 
women, both at rest (-19%) and at maximal exercise (-25%). In addition, cardiac 
function was greater in the active men, compared with age-matched, sedentary controls, 
with values ranging from 11 -30% greater. 
It was also found that body composition had a significant impact on the interpretation of 
CPO data. For example, when scaled allometrically for fat free mass (FFMb ), absolute 
sex-related differences in CPO disappeared, as did the age-related decline in CPO. a. 
Also, in women no age-related changes in CPO.. were found once normalised to FFNIb 
even though in men, CPO.. and CR still declined with age. 
Clearly, how these data are normalised relative to body composition is crucial to the 
interpretation of the effects of ageing or an active lifestyle. These are novel findings and 
indicate that healthy ageing is associated with reductions in overall cardiac function, as 
represented by significant declines in CPO,,,. and CR in men, but not women. In 
addition, endurance training improved aerobic capacity while attenuating the changes in 
cardiac ftinction. 
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Introduction 
Ageing is characterised by an impaired ability to maintain homeostasis (Lakatta, 1993). 
This comes about because of a progressive deterioration in the functional capacity of 
various organs and systems. Superimposed on the ageing process is an increase in the 
prevalence of diseases, such as atherosclerosis, obesity, diabetes, and ischaernic heart 
disease. The severity of these conditions usually increases with age. Such diseases may 
affect the process of ageing, highlighting the importance of demarcating the 
pathological condition from healthy ageing. In practice, it is difficult to differentiate 
between healthy ageing and the presence of specific diseases (Olivetti et aL, 1995), 
especially with advancing years. 'Mis issue is further complicated by the fact that age- 
related changes are not uniform in nature. Some physiological functions may fail to 
show impairment with ageing, whereas other functions may be paradoxically enhanced, 
which makes this line of research a demanding one. 
As the average life expectancy increases, the importance of understanding the 
physiological changes and associated mechanisms that occur with ageing, have become 
a higher priority than ever before. Improving the health and quality of life is relevant to 
all age groups, but in particular to the increasing number of older people. This increased 
longevity places extra demands on any country's financial resources. Increased 
demands on health care resources have lead to the realisation that maintaining 
physiological function through increased physical activity can be a positive intervention 
from which the NHS may reap financial benefits. As well as these financial rewards, 
older people should have the opportunity to improve their quality of life by remaining 
fitter, and therefore more able to perform daily activities and retain their independence 
for longer. The improvement in physiological function may be brought about by 
changes in the function of the heart, through increased physical activity. Ageing is 
inevitable. However, understanding the physiological changes brought about by the 
process of healthy ageing, particularly in defining how the performance of the heart 
changes and precisely when the heart begins to deteriorate, can help to formulate 
appropriate regimens or interventions to delay, and in some cases reverse, the 
consequences of ageing. 
Past research has tended to cloud the issue of ageing per se because of a failure to 
acknowledge, or control for interactions among age, disease and lifestyle, thus 
I 
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complicating the interpretation of the process of ageing. It is important to determine the 
changes in cardiac function that occur during the process of healthy ageing, only then 
will we be able to distinguish the underlying process of disease. 
1.1. Ageing 
Ageing is a non-specific term that has been applied to a spectrum of life periods, e. g. 
stages surrounding perinatal, neonatal, maturational, adulthood, and old age. Thus 
development or ageing can be defined as that which happens over a period of time, thus 
encapsulating changes that can be beneficial, detrimental, or no change in function. In 
this thesis, ageing relates to the physiological changes that occur to an organism 
throughout the process of post pubertal, adult lifespan. 
1.1.1. Definitions of Ageing 
For scientific clarity it is important to provide the correct terminology that describes the 
process of ageing. A number of terms have been used which refer to the process of 
ageing in the presence or absence of disease. For example, normal ageing refers to 
senescence in the absence of disease (Masoro, 2001). This term has been criticised 
because it is thought that ageing in the absence of disease is a rare occurrence. It is 
therefore atypical (Masoro, 2001). In addition, normal ageing goes against the evolution 
theory of ageing, which predicts the occurrence of age-related disease is an almost 
inevitable and intrinsic component of senescence (Weinert and Timiras, 2003). Other 
terms used to describe the process of ageing include, 'Primary' and 'Secondary' ageing. 
Primary ageing relates to changes that occur in a population, but are not caused by 
disease or by environmental influences, whereas Secondary ageing refers to changes 
involving interactions of Primary ageing with environmental influences and disease 
processes (Busse, 1969). The validity of these terms has also been questioned. The 
process of senescence can be viewed as the result of the long-term accumulation of 
unrepaired cellular damage, the nature and site of this damage relating to genetic 
characteristics of the individual. Masoro (2001) concluded that it is immaterial whether 
the damage is caused by intrinsic (genetics) or extrinsic processes (environment and 
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lifestyle). Masoro (2001) went on to say that it is often the interaction between the 
biological system and environmental and/or lifestyle factors that result in damage, 
therefore all damage can be thought of as intrinsic. Two more widely used concepts are 
'Usual' and 'Successful' ageing (Rowe and Kahn, 1987). Those individuals who 
exhibited a substantial deterioration in physiological functions with increasing age were 
categorised as Usual ageing and therefore are associated with a significant risk of 
disease and premature death. Whereas, those who exhibited minimal change in 
physiological function with advancing age were categorised as undergoing Successful 
ageing. The concept of Successful ageing implies that advancing age, ending in death, 
can be achieved without major deteriorations in physiological function. More often that 
not, individuals in the later stages of life suffer a marked deterioration in physiological 
function prior to death. Masoro (2001) suggested that it would simply be more 
appropriate to say that the process of ageing occurs more slowly in these individuals. 
Within the context of this thesis the term 'healthy ageing' will be used to represent the 
process of ageing in individuals in the absence of overt clinical diseases, and in 
particular cardiovascular abnormalities or disease. This term allows us to measure the 
deterioration of cardiac function with increasing age, without the complication of 
superimposed disease 
1.1.2. Theories of ageing 
There are a number of theories, which attempt to explain how and why ageing occurs. A 
problem with ageing is that it is often synonymous with disease (Lakatta, 2000). One 
possible explanation for the aged-related increased prevalence of certain diseases is that 
there is an increased exposure time to risk factors, with increased severity and extent of 
pathophysiological manifestations in older individuals. A somewhat different view is 
that cardiovascular structures and functions change with time because of an "ageing 
process", and that over time specific pathophysiological disease mechanisms become 
superimposed on this process (Lakatta, 2002). This view suggests age-disease 
interactions which escalate as the organism becomes older. 
3 
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The original search for a single gene or the functional deterioration of one major system 
in the body that is responsible for ageing has been replaced with the concept that ageing 
is the consequence of several complex and multi-factorial processes (Weinert and 
Timiras, 2003). Rather the theories that attempt to explain how organisms age have 
been grouped into several categories, with the 'programmed' and 'error' theories of 
ageing being the most widely used. According to the 'programmed' theory, ageing 
depends on biological clocks regulating life span through stages of growth, 
development maturity, and old age. This regulation depends on genes sequentially 
switching 'on' and 'off' signals to the nervous, endocrine, and immune systems 
responsible for maintenance of homeostasis (Weinert and Timiras, 2003). The 'error' 
theory, relate to environment influences that induce progressive damage at various 
cellular or intracellular levels, e. g. mitochondria DNA damage, oxygen radicals 
accumulation, cross-linking etc (Medawar, 1952). 
1.1.3. Age-related changes In cardiac structure 
The average weight of the heart in men and women is considered to be approximately 
320 and 280 grams, respectively (Olivetti et aL, 1995). It has been suggested that the 
human heart increases in weight by approximately 1 gram per year in men and 1.5 gram 
per year in women (Linzbach and Akuamoa-Boateng, 1973). However, these figures 
paid little attention to the pathophysiological states of the heart and major blood vessels 
upon analysis. More recent observations in the absence of disease, have reported that 
ageing, in men is associated with a consistent loss of myocardial mass, while the female 
heart remains essentially constant (Olivetti et aL, 1991,1995). Hence, weight or mass 
alone is not very informative. 
It is however generally believed that there is an increase in left ventricular wall 
thickness with age in both men and women (Gerstenblith et aL, 1977). However, in old 
age (80-100 years) the left ventricular mass (LVM) may decrease (Waller and Roberts, 
1983), perhaps because of an extreme sedentary lifestyle. Most of the studies measure 
LVM through echocardiography, which samples only a single small area of the left 
ventricle posterior wall or ventricular septum and extrapolates this to represent the 
global left ventricle thickness; LVM is then estimated assuming a constant ventricular 
4 
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geometry at all ages. So while providing useful non-invasive information on internal 
cardiac structures, there are technical limitations. Using magnetic resonance imaging 
Hees et aL (2002) identified that healthy ageing was associated with left ventricular 
remodelling, with a decrease in long axis length of the heart in both men and women. 
These changes resulted in a decrease in LVM in men. However an increase in wall 
thickness prevented any such loss in LVM in women. 
Although the data on age-related changes in LVM are generally conflicting, it has been 
suggested that a major adaptation of the human heart in response to ageing is a 
progressive loss of cardiomyocytes (Olivetti et aL, 1991). In men between the ages of 
18 and 70 years, up to 30-35% of the cardiomyocytes have been lost through apoptotic 
and necrotic cell death (Figure 1.1 A). Interestingly, in women between 20 and 95 years- 
of-age, loss of cardiomyocytes is very much less (Figure LIC). In men, but not in 
women, some of the remaining viable cardiomyocytes undergo hypertrophy (Figures 
1.113 and LID). However, this adaptive response in the male heart does not fully 
compensate for the progressive decline in cardiomyocyte numbers (Olivetti et aL, 
1991). The consequence of this natural attrition of contractile cells is a decrease in 
cardiac mass. Such data at the cellular level may explain why women live longer than 
men. However, there is mounting evidence that cardiac stem cells and some smaller 
cardiomyocytes may re-enter the cell cycle and develop into differential 
cardiomyocytes. This suggests that a potential for cardiomyocyte regeneration does 
indeed exist with the heart (Nadel-Ginard et aL, 2003; Sussman and Anversa, 2003). As 
it stands the work of Olivetti et aL (1991,1995) suggests that myocyte death exceeds 
regeneration with a net loss of these contractile cells, at least in men. Whether this 
newly discovered regenerative capacity in the mammalian heart declines with healthy 
ageing is an important research question. 
1.1.4. Age-related changes in resting Indices of cardiovascular function 
Resting cardiac output (CO,,, t), the product of stroke volume (SV) and heart rate (HR), 
is an important component of cardiac function. Resting CO has been shown to either 
decline (Brandfonbrener et aL, 1955; Conway et aL, 1971; Julius et aL, 1967; Messerli 
et aL, 1981) or remain unchanged (Fleg et aL, 1990,1995; Higginbotham et aL, 1984; 
Rodeheffer et aL, 1984,1986) with increasing age. Differences have also been reported 
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between men and women, with women expressing a gradual decline in Meg, whereas 
no change was reported in men (Fleg et aL, 1990,1995). In contrast, Rodeheffer et aL 
(1984) reported that men and women behave similarly with increasing age, with no 
change in CO. Some of this contradictory data can be attributed to the differences in the 
selection of subjects, protocols and techniques used, and body position when CO was 
measured. 
Some of the conflicting evidence in resting CO may reside in the measurements of SV 
and HR, with age. Many studies have found no age-related change in SV, whereas 
resting HR declined, resulting in a corresponding decline in CO (Brandfonbrener et al., 
1955). A longitudinal study over 30 years by Arora et al. (1987) found that in men and 
women, HR .. t decreased from approximately 81 to 60 beats/min. This was subsequently 
confirmed in cross-sectional studies by Fleg et al. (1990 and 1995). In contrast, other 
studies found that SV increased with age to compensate for the decline in resting HF. 
For example, stroke volume relative to body surface area (i. e. stroke volume index; 
SVI) was shown to be augmented in men (Fleg et al., 1990,1995). This age-related 
increase in SVI was mainly due to an increase in end diastole volume index (EDVI), 
with no change in end systolic volume index (ESVI). In contrast in healthy women 
EDVI and SVI have not been found to increase with age, and ESVI tends to decrease 
slightly (Fleg et al., 1990,1995). Conversely, no changes in either HR or SV have also 
been reported, with increasing age (Rodeheffer et al., 1984). 
Such conflicting findings may relate to the difficulty in attaining a truly basal resting 
state. However, it is generally believed that, in a sitting position, HRes, declines, 
whereas SVI does not decrease with advancing age in both males and females (Fleg et 
A, 1990,1995; Rodeheffer et aL, 1984; Schwartz et aL, 1991; Simpson and Wicks, 
1988). These results have been interpreted as indicating either a decline or no change in 
resting CO, and hence cardiac function with age. 
Ageing is also associated with a progressive increase in blood pressure (BP), beginning 
in childhood and continuing into late adulthood (Kannel and Gordon, 1978). This trend 
during middle age is associated with a greater increase in systolic (SBP) than diastolic 
(DBP) blood pressure. Whereas SBP continues to rise, it is thought that DBP either 
remains constant or declines after the fifth or sixth decade (Franklin et aL, 1997). Such 
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changes increase pulse pressure (PP) and have been attributed to increased arterial 
stiffness (Lakatta, 1993). Women tend to follow a similar trend to the men. However BP 
starts off lower in women compared to men, but then catches up by the sixth decade and 
frequently becomes even higher thereafter (Franklin et aL, 1997). Mean arterial pressure 
(MAP), the steady component of pressure by which the variations in PP fluctuate, has 
been shown to increase gradually up to the fifth decade after which MAP,,,, t levels off 
(Franklin et A, 1997). 
Because the cardiovascular system at rest functions at only a fraction of its total 
capacity, age-related studies at rest do not adequately characterise changes in this 
system or its regulatory mechanisms (Lakatta, 1993). While subtle changes in 
cardiovascular function may be evident during acute stress, the major signs of 
adaptation in cardiovascular function between younger and older individuals will 
become evident at maximal exercise. 
1.1.5. Cardiovascular function at maximal stress 
Exercise provides a powerful research tool that permits the study of the regulation of the 
cardiovascular system, and its functional capacity under rigorously controlled and 
highly reproducible conditions (Rowell, 1974). Prior to reviewing some of the age- 
associated changes in the cardiovascular system some of the normal physiological 
responses to dynamic exercise will be described. 
Normal responses to maximal exercise 
The transition from rest to maximal exercise is mainly facilitated by an increase in 
oxygen uptake (Iýo2) to support the increased metabolic demands of exercising skeletal 
muscles and to maintain cellular homeostasis. Oxygen uptake can be expressed using 
the following equation, which is based on the Fick principle, 
ý102 
= HR x SV x a-v 02 difference, 
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where ý702 is oxygen uptake, HR is heart rate, SV is stroke volume, and a-v 02 
difference is the arterial-mixed venous oxygen difference. 
The degree to which each of these variables can increase determines the upper limit for 
whole-body consumption. This limit is called maximal oxygen uptake (Vo2 .. a,, ). The a-v 
02 difference is dependent on the efficiency of muscles to extract oxygen from the 
blood. This in turn is influenced by the muscle's metabolic rate and oxidative capacity, 
regional and peripheral distributions of blood flow, muscle capillary density and 
perfusion, changes in the oxyhaemoglobin dissociation curve etc (Jones et al., 1985). In 
healthy individuals, at rest, a-v 02 difference is normally 4.5 MI 02 /100 ml of blood 
(-23% extraction) and at V02inax this difference is closer to 16 MI 02 /100 M, of blood, 
which represents approximately 80-85% extraction (Rowell, 1974). 
To match this increased demand CO increases four-to five-fold from rest to maximal 
exercise in a near linear manner to increasing 'ý02 (Astrand et aL, 1964; Clausen, 1976; 
Epstein et al., 1967). It is generally believed that a linear rise in HR with increasing 
exercise intensity has a greater contribution than SV to the increase in CO. Numerous 
studies have shown that after the initial increase in SV a plateau is reached at -40% of 
'ý02m., and that subsequent increases in workload do not further affect SV (Astrand et 
aL, 1964; Epstein et aL, 1967; Higginbotham et aL, 1986; Plotnick et aL, 1986). In 
contrast, to the above non-trained individuals, it has been reported that SV increases 
progressively throughout the incremental work rates in achieving maximal exercise in 
endurance trained men and women (Glendhill et aL, 1994; Wiebe et A, 1998). In these 
trained individuals, this adaptation was attributed to a greater filling of the ventricles 
(i. e. venous return), thereby using the Frank-Starling mechanism more effectively up to 
1ý02m. (Glendhill et aL, 1994; Krip et aL, 1997). 
During exercise, SBP usually rises to around 200 mm. Hg at peak exercise. In contrast, 
DBP remains essentially constant (Jones et aL, 1985). The rise in SBP is thought to be 
linearly related to the exercise workload (Rowell, 1991). Ile control of BP with 
exercise involves complex interactions between the peripheral vasculature and the heart. 
These are carefully modulated through the baroreceptors and the central nervous system 
via the sympathetic nervous system (SNS), as well as locally by factors that are 
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responsible for autoregulation at an arteriolar level (Schrager and Ellestad, 1983). Two 
major haemodynamic changes occur almost simultaneously with the onset of exercise. 
The resistance to blood flow through contracting muscles decreases and results in a fall 
in systemic vascular resistance (SVR). Various other perfusion beds in non-exercising 
areas vasoconstrict, thereby redirecting more blood to the exercising muscles. The SNS 
also constricts capacitance vessels aiding the return of blood to the heart, thereby 
increasing SV and CO by increasing preload. This action is of prime importance in 
enabling CO to rise in the face of reduced SVR (Guyton, 1981) and consequently the 
rise in MAP is comparatively small (Jones et aL, 1985). 
Changes in maximal cardiovascularfunction in relation to ageing. 
It has been well documented that V02ma,, declines with increasing age (Figure 1.2) in 
both men and women (Ehsani et aL, 1991; Hagberg et aL, 1985; Heath et aL, 1981; 
Ogawa et aL, 1992), with many studies reporting a 10% decline per decade (Drinkwater 
et aL, 1975; Inbar et aL, 1994; Jackson et aL, 1995; Toth et aL, 1994). In addition, 
V02m. has been shown to decline in individuals who maintain endurance training 
throughout life (Figure 1.2). These deteriorations in V02,,,. have been attributed to an 
age-associated decline in COm. and a progressive decline in maximal a-v 02 difference 
(Fleg et aL, 1990,1995; Ogawa et aL, 1992). 
Despite this, controversy exists regarding the age-related changes in maximal SV and 
CO. The vast amount of evidence suggest that CO.. declines with age (Ehsani et aL, 
1991; Fleg et aL, 1990,1995; Gerstenblith et aL, 1976; Hagberg et aL, 1985; Owaga et 
aL, 1992). However, some studies have reported that CO. ax is maintained with 
increasing age (McGuire et A, 2001; Rodelieffer et A, 1984). These latter investigators 
identified that maximal SVI was increased at maximal exercise in older, compared to 
younger individuals, and that this was sufficient to compensate for the well recognised 
decline in HR,,. (Fleg et aL, 1990,1995; Lakatta, 1993; Owaga et aL, 1992). It is here 
were the controversy arises. An age-related decline in HRax is unquestioned by all 
investigators. However, changes in SVna., remain equivocal. Numerous studies have 
found a decline in maximal SVI with increasing age (Julius et aL, 1967; Kuikka and 
Lansimies, 1982), whilst in other studies SVI remains essentially constant (Fleg et al., 
10 
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Figure 1.2. Maximal oxygen consumption (V02max) in males of varying ages, 
fitness, and body composition (From Lakatta, 1993). 
Data presented are for champion young athletes [0] (Health et al., 1981) and [0] 
(Dill el al., 1967); ex-champion athletes [, L] (Dill et al., 1967 and Robinson Ct al., 
1976); cross-country runners [A] (Grimby and Saltin, 1966); runners Is] (Pollock 
et al., 1974). Groups of untrained men from 9 studies 10 and X] and master 
athletes [0 and *] are from Heath et al. (1981) and Fleg et al. (1988), 
respectively. 
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1990,1995, Higginbotham et aL, 1984,1986; Younis et aL, 1990). The lack of clarity 
may result from differences in the extent to which coronary artery disease is present 
among subjects, or from differences in fitness status, heart size, and body composition. 
When such variables have been controlled, it is generally believed that CO declines with 
increasing age, as a prime result of a decline in HR.., with SVInia,, remaining constant 
(Fleg et aL, 1990,1995; Owaga et aL, 1992). 
Unlike the wealth of data concerning CO,, a.,, very little is know about the age-related 
changes in maximal BP. Limited data suggests that both SBP and DBP and thus MAP, 
rises with increasing age in both men and women (Ogawa et aL, 1992). In addition, it 
has been reported that SBPm.,, is lower in young women when compared to age-matched 
men (Martin et aL, 1991; Ogawa et aL, 1992; Wiebe et aL, 1998). However no such 
sex-related differences have been found in older subjects (Ogawa et aL, 1992). A study 
by Fleg et aL (1995) identified an age-related increase in DBP and MAP at maximal 
exercise in both sexes while only SBPm. increased with age in women. 
Information regarding the age-related changes in maximal systemic vascular resistance 
(SVRn,,,., ) in normotensive subjects is conflicting. In some studies the reduction in SVR 
that occurs during exercise was noted to be less in older than in younger individuals 
(Julius et d, 1967; Ogawa et d, 1992). In others studies this effect of age was minimal 
in men, but substantial in women (Fleg et aL, 1990; Rodeheffer et aL, 1984). 
Such conflicting evidence on the age-related changes in blood flow and pressure has 
lead to confusion concerning how ageing effects maximal overall cardiac function. This 
is especially likely to be true when combing flow and pressure generating capacities of 
the heart as in the studies described here. 
1.2. Cardiac function 
Cardiac function is a complex integration of electrical, biochemical and mechanical 
processes, which is also dependent on the preload and afterload imposed on it by the 
vascular system (Braunwald, 1971). Whilst there have been a number of methods 
developed to measure cardiac function, many are either invasive or tend to examine 
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only specific aspects of cardiac function, rather than overall cardiac function. For 
example, CO and ejection fraction has been used as markers of cardiac function. 
Cardiac output has been claimed to be an accurate measure of the heart's ability to 
perform its function (Braunwald, 1971) and therefore has been shown to be 
prognostically important in relation to the survival of patient (Chomsky et aL, 1996). 
Therefore, CO plays a vital role in the measurement of cardiac function. However, it 
must be remembered that the heart generates pressure as well as blood flow. Myocardial 
contractility (maximum left ventricular rate of pressure rise at end systolic resistance 
etc) has been used as a marker of cardiac function, as it is considered that only 
myocardial contractility originates from 'central' factors (i. e. the heart itselo, whereas 
other determinants, HR, preload, and afterload are considered 'peripheral' factors 
(Braunwald, 197 1). Although, contractility is a major contribution to cardiac function, it 
is by no means equal to the overall cardiac pump function. That is, contractile force is 
closely linked to the 'peripheral factors'. Alterations in the vasculature invariably affect 
cardiac performance. To date the ability to separate the central from the peripheral 
factors have been untenable. Therefore, a measure of overall cardiac function, which is 
sensitive to the way the heart is coupled with the vasculature, must be considered. In 
addition, the heart should not be represented by the performance of any one of its 
component parts alone (Tan, 199 1). 
Another important aspect in the measurement of overall cardiac function is whether 
cardiac function is evaluated at basal resting states or at maximal stimulation e. g. 
maximal exercise. Although, basal resting measures are easy to perform, no information 
is gained on the pumping reserve of the heart and critically how the heart responds to 
stress. That is, the heart, like the cardiovascular system, at rest functions at only a 
fraction of its total capacity. As such these basal measurements are very poor at 
discriminating between subject populations. However, once the heart is maximally 
stimulated such differences between populations can be readily identified. This was 
appreciated by Lakatta (1993) who indicated that differences in cardiovascular function 
between young and older individuals manifest themselves during situations of stress, 
such as exercise. 
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1.2.1. Cardiac power output and Cardiac functional reserve 
Cardiac power output (CPO) has been used as a marker of overall cardiac function (Tan 
et aL, 1989). Measuring CPO is a relatively novel technique that measures both the 
pressure and flow generating capacities of the heart, and has been independently judged 
to be the best overall indicator of heart function (Nicholls and Reilly, 2001). The 
product of flow output and systemic arterial pressure is the rate of the useful work done, 
or power output. The relationship between flow and pressure in the circulation has long 
been known to involve the concept of hydraulic power. By converting ATP into 
mechanical energy, the function of the heart is to supply adequate hydraulic energy to 
maintain the circulation (Tan, 1991). Without this energy the circulation would come to 
a standstill. Cardiac power output is therefore the rate at which the heart imparts 
hydraulic energy into the arterial system to maintain the circulation of blood and can be 
defined as the work of the heart per cardiac cycle multiplied by its frequency (Tan, 
1991). Thus the ability of the heart to generate energy and perform external work 
encompasses not only its ability to generate flow, but also its ability to generate 
pressure. In addition to the prognostic value of CO, a number of groups have also 
shown the importance of the pressure generating capacity of the heart and have 
concluded that the measurement of maximal BP to be independently predictive of 
prognosis (Ghali et aL, 1992; Osada et aL, 1998; Pousset et aL, 2000). Thus, the 
incorporation of pressure into exercise haemodynamic assessment is crucial. Cardiac 
power output does this and is therefore a true measure of overall cardiac function. 
Furthermore, because the measurement of CPO is not derived from studies that isolate 
the heart from the rest of the circulation (i. e. in vitro). It is sensitive to all aspects of 
cardiac function, including central factors such as contractility, but as well as peripheral 
effects such as loading and HR (reviewed by Tan, 199 1). 
The measurement of the mechanical energy of the heart is by now means new (Bergel et 
aL, 1969) and indeed, left ventricular minute work presents similar information 
combining flow and pressure. However, CPO is viewed as providing information on the 
overall function of the heart rather than simply an index of contractility, and, is based on 
fluid dynamics rather than muscle mechanics (Tan, 1991). Furthermore, CPO is viewed 
as a better indicator of overall cardiac function than CO and left ventricular minute 
work (Tan, 1987). At rest a mean CPO of approximately I Watt is required to generate a 
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flow rate of 5 Ymin and a MAP of 90 mm Hg in an average healthy adult male (Tan, 
1995). Both components increase during exercise, with CPOmax increasing up to 4 Watts 
in healthy young but untrained subjects, and 8 Watts in elite athletes (Tan, 1991). These 
differences in CPOIax mainly result from cardiornyocyte hypertrophy, highlighting the 
beneficial effects of physical training. 
It is strongly believed that the heart is a flow generating organ with arterial pressure 
presumed to be a by-product of CO and SVR (Braunwald, 1997). However, recent data 
have suggested otherwise (Schlosshan et aL, 2004). If arterial pressure is a by-product 
of CO and SVR, then any improvement in cardiac function should manifest itself as 
primarily a greater cardiac flow generating capacity leading secondary to higher BP. 
However, recently Schlosshan and colleagues (2004) challenged this theory in severe 
heart failure patients who had undergone cardiac resynchronisation therapy (CRT). The 
authors were able to measure cardiac functional reserve without directly affecting SVR. 
In a randomly controlled cross-over study, CPO was measured at rest and at peak 
exercise when either the CRT device was switched on or off. It was found that at 
maximal exercise, when the CRT device was switched on, there was an improvement in 
CPO.,,.. This improvement was due entirely to a significant increase in MAPa,,, as no 
change in maximal CO or SVR was evident. The authors therefore concluded that 
cardiac pressure-generating capacity was a primary manifestation of improved cardiac 
function. This highlights the importance of including the pressure generating capacity of 
the heart to provide meaningful measurements of overall cardiac function. 
There are two aspects to the overall assessment of cardiac performance, first the 
maximal pumping capacity which is the performance of the heart when maximally 
stressed (CPOna,, ). Second, the cardiac pumping reserve (CR) represents the difference 
between maximal stimulation and resting cardiac performance (CPOet) i. e. CR = 
CPO. u - CPO,,, t. Each heart has its own upper limit for maximal pumping 
performance (CPOma., ); a ceiling point that is physically impossible to exceed. This 
value will change if the heart's intrinsic conditions are changed, for example with 
myocardial hypertrophy, contractility and a reduction in afterload or after damage by a 
myocardial infarction. 'Me theoretical maximum value for CPO is obtained when all the 
cardiac settings (including loading conditions, inotrophy, rhythm, and rate) are 
optimised. When comparing these maximal measures i. e. CPO.,,, cardiac function is a 
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direct indicator of how functionally effective or impaired the heart is as a hydraulic 
pump (Figure 1.3). How good the heart is in fulfilling its function as a representative 
and flexible pump depends on the maximal value in relation to the baseline resting 
value i. e. its functional reserve capacity. For the same ceiling value, a subject with a 
high baseline resting CPO (high output state, due to metabolic disorders, hypertension 
etc), will have less CR to call upon. 
The measurement of CPO has originated from a clinical setting, mainly through the 
work of Dr Tan (1987). Initially, this involved an invasive technique used to examine 
the prognosis of patients with heart failure (Tan and William, 1990). However, 
measurements of CPO have since been conducted non-invasively (Cooke et aL, 1998), 
after being successfully validated against the former invasive technique (Cooke et aL, 
1998). The measurement of CPO..,, has been identified as the most powerful predictor 
of prognosis in cohorts of patients with heart failure (Roul et aL, 1995; Tan, 1986; Tan 
and Littler, 1990; Williams et aL, 2001b). Furthen-nore, in a recent review, CPO was 
shown to give further prognostic power over ý702max in the assessment of cardiac 
function (Nicholls and Riley, 2001). Heart failure patients who are unable to generate 1 
Watt of power, i. e. those patients in cardiogenic shock, and have little or no pumping 
reserve (Figure 1.3), have a very poor prognosis. Cardiac functional reserve has been 
shown to be a useful method of determining exercise capacity in heart failure as well as 
healthy populations, from sedentary individuals to elite athletes (Cooke et aL, 1998). 
However, to date the emphasis on using CPO has mainly been directed as a diagnostic 
and prognostic tool for heart failure patients. 
Various studies have identified the deleterious effects ageing has on physiological 
variables such as CO, early left ventricular filling (Fleg et aL, 1995), arterial systolic 
and diastolic pressure (Lakatta, 1989), and maximal aerobic capacity (Lakatta, 1990). 
However, the affects of ageing on the overall pumping performance of the heart have 
not previously been investigated. The beneficial effects of an active lifestyle and 
exercise training on endurance capacity (Hagberg et al., 1998) and skeletal muscle force 
(Lemmer et al., 2000) have been documented in populations of elderly people. While 
endurance training does little to counteract the age-related decline in skeletal muscle 
mass and force generation, it should be a useful intervention in inducing cardiomyocyte 
hypertrophy etc. It is therefore essential that the age-related changes in overall cardiac 
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Figure 1.3. Schematic representation of the changes in cardiac reserve as a consequent 
of age, and ischaemic damage (Courtesy of Dr L-B Tan). 
The lower dashed blue line represents resting CPO and the solid blue line maximal CPO. 
The hatched area between represents the reserve capacity of the heart. This can be 
affected by age or a myocardial infarction (MI). When the maximal performance of the 
heart is close to the resting CPO the prognosis is poor. 
17 
Introduction 
function (CPO) are examined and compare to studies looking purely at the flow or 
pressure generating capacities of the heart. In addition to what affect endurance training 
in older subjects has on CPO is unknown and therefore requires investigating. 
1.3. Pump-load interactions 
The performance of the cardiac pump, as indicated above, is influenced by its 
interaction with the load imposed on it. The afterload on the left ventricle is identified 
physiologically as the impedance by which the ventricle has to overcome. This is 
determined by the physical properties of the systemic vasculature and the blood, and is 
independent of myocardial performance. Aortic input impedance is the best 
representation of systemic afterload on the cardiac pump (Milnor, 1975), and is the ratio 
of aortic pressure to flow measured at the aortic root. The ratio of mean pressure to flow 
gives the resistive terms, and is often referred to as the SVR. An increase in afterload 
would lead to a decrease in ventricular emptying and myocardial shortening, and vice 
versa. At either extreme of the spectrum of vascular impedance, there is little or no 
hydraulic energy output from the heart (Figure 1.4). Given an extreme of total 
vasoconstriction with infinite vascular resistance (e. g. aortic valve occlusion), the 
pressure generating capacity will be maximal, but flow will be zero. Thus CPO is zero 
(Tan, 1986,1987). Conversely, at the extreme of total vasodilatation (zero vascular 
impedance), flow is maximal, but the pressure generating capacity is zero and CPO is 
again zero. In between these two extremes is an optimal point, in which CPO is 
maximal (Figure 1.4). The cardiovascular system usually functions at the point where 
the pump and load are matched (Wilcken et aL, 1964; van der Horn et aL, 1985) to 
ensure the production of optimal power output. Optimal coupling of the cardiac pump 
and the arterial system at this point is presumably the most conductive to yield normal 
physiological cardiac reserve and exercise capacity (Williams et aL, 2001 a). At rest in a 
healthy heart, the left ventricle normally functions at this optimal point (Wilcken et aL, 
1964). However, in a diseased heart this operational point is shifted towards higher 
resistances, due to compensatory mechanisms causing vasoconstriction (Cotter et aL, 
2003). Consequently, the cardiac pump is functioning at a mechanical disadvantage and 
therefore is less efficient. 
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Figure 1.4. A schematic diagram depicting a family of ventriculo-arterial function 
curves (From Tan et aL, 2003). 
The optimal operating points of normal ventriculo-arterial function curves (VAFCs) 
are at the zenith of the curves. However in pathophysiological states i. e. patients 
with mild heart failure and cardiogenic shock, the operating point may be shifted to 
higher resistance levels in different extents of heart failure, or to lower resistance 
states in vasodilative conductions. Additionally exercise can affect the operating 
point i. e. mild aerobic exercise. 
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When examining overall cardiac function, the influence of pump afterload must be 
taken into account to fully comprehend the changes associated with cardiac function. 
1.4. Circadian rhythms and physiological function 
Biomedical sciences depend heavily upon good measurements of physiological 
functions. These need to be highly reproducible. Factors which affect the reproducibility 
can have significant consequences to the reliability of data and their interpretations. 
Chronobiological investigations have shown that numerous cardiovascular variables 
have a periodic dependency with time (Smolensky et aL, 1976). Circadian rhythms are 
thought to be a direct result of changes in the environment (exogenous), such as the 
changes from day to night (Reilly and Brooks, 1990). However, biological rhythms may 
also occur when the environmental conditions are held constant, i. e. endogenous 
sources (Reilly and Brooks, 1990). Research has identified that the human body clock is 
regulated endogenously by the suprachiasmatic nuclei in the hypothalamus (Waterhouse 
et aL, 1997). In addition, to this master clock there are local timekeepers which have 
been found within skeletal and cardiac muscles (Waterhouse et aL, 1997). 
Many of the biological variables that change over a 24-hour period are thought to 
change in a circadian pattern as a consequence of variations in body temperature. Core 
temperature has been shown to impact on muscle performance (Saltin and Hermansen, 
1966). Furthermore, temperature is considered to act as a secondary pacemaker for the 
periodicity of numerous other physiological variables, e. g. resting ýIo2, ventilation rate, 
etc (Refinetti and Menaker, 1992). The normal circadian curve for body temperature in 
men aged 21-27 years, reaches a nadir around 04: 00 to 06: 00 hours, and a peak at 
approximately 16: 00 to 18: 00 hours (Reilly et aL, 1997). 
Circadian variations have been documented in relation to resting CO and MAP, and 
their component parts, HR and SV, and DBP (Cohen and Muehl, 1977; Cugini et al., 
1991; Deschenes et al., 1998a; Wang et al., 1991), all which could have confounding 
influences when it comes to measurements of resting CPO. However, the current 
scientific literature contains a great deal of conflicting evidence. Significant circadian 
variations in resting CO and SV have been documented, with both reaching a peak 
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around 17: 00 hours and a nadir around 06: 00 hours (Cugini et al., 1991). Conversely, 
Wang et al. (1992) identified the acrophase for resting CO at 15: 00 hours and at 16: 00 
hours for SV. 
Once again the evidence is conflicting for HR, another vital component that determines 
CO. Reilly and Brooks (1990) identified a peak in resting HR at 14: 00 hours, whereas 
De Scalzi et aL (1984) found the peak to be between 10: 00 to 12: 00 hours. 
Blood pressure is another cardiovascular parameter that has been extensively 
investigated at rest (Atkinson et al., 1994; Furlan et al., 1990; Reilly et al., 1984). 
Systolic and diastolic pressures have been shown to exhibit circadian variations (Millar- 
Craig et al., 1978; Rodahl et al., 1976). Furlan et al, (1990) have shown that in healthy 
subjects, resting BP peaks between 22: 00 and 24: 00 hours, with a nadir between 03: 00 
to 06: 00 hours or I to 3 hours before awaking. Whereas, Zulch and Hossman (1967) 
identified that BP in some subjects rose in the morning, transiently declined in the 
afternoon and peaked again in the early evening. However, no changes in resting BP 
have also been identified (Deschenes et al., 1998a). It has been reported that a circadian 
rhythm for resting BP was only observed when intra-arterial measurements were made 
and were not apparent with sphygmomanorntery (Reilly et aL, 1984). Additionally, the 
BP rhythm can be easily disrupted by the timing and termination of sleep (Reilly et al., 
1984). 
When examining maximal values with respect to an influence of a circadian rhythm, it 
is imperative that measurements are made at the ceiling point of the physiological 
variable, otherwise erroneous conclusions can be made. Therefore, recognized criteria 
must be applied when measuring maximal capacities, otherwise data collected may 
merely reflect the reluctance of subjects to work at their maximum at night time or early 
morning. This may explain why there is a lot of conflicting evidence identifying 
whether a circadian rhythm is evident at maximal exercise, or not. For example, 
maximal oxygen uptake has been reported to vary by some investigations (Hill et aL, 
1989; Wojtczak-Jaroszowa, 1974), while others (Reilly and Brooks, 1990; Torii et A, 
1992) failed to confirm such variations in 1ý02m.. Reilly and Brooks (1990) stated that 
ý102m. is a stable function, independent of the time of day. 
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Past research examining whether a circadian rhythm influences maximal exercise for 
CO are few and far between. To my knowledge Davis and Sergeant, (1975) are the only 
investigators to examine CO. a,,, and they identified no such rhythm. Maximal HR has 
been more extensively reviewed than CO. However, the evidence in the literature is 
once again conflicting. Reilly et aL (1984) observing a positive time of day effect in 
HRma,,, which contradicted the earlier work of Cohen (1980). Deschenes et aL (2002) 
also found that HRn. failed to differentiate across the time of day. One possible 
explanation for the lack of agreement for fluctuations in HRm,,,, is that the rhythmicity of 
HR appears to be confirmed only when exercise is performed in the early hours of the 
morning (i. e. 02: 00-06: 00 hours) when HR values are at their nadir (Reilly and Brooks, 
1990). 
Similar data concerning changes in maximal BP are limited. Deschenes et al. (1998a, 
1998b) established significant variations in MAP when measured at maximal exercise. 
On both occasions the changes in MAP were mainly related to significant variations in 
SBP, with no changes in DBP (Deschenes et al., 1998a, 1998b). These changes were 
linked to similar variations in plasma adrenaline concentrations. Catecholamines are 
known to increase the contractility of the myocardium (Hedge et al., 1987), with 
circulating adrenaline and MAP ebbing around 08: 00 hours. 
However it may be that the stimulus of exercise doesn't simply enhance any time of day 
effects even if past research has identified such effects at rest. This may explain the lack 
of convincing evidence to suggest that circadian rhythms have any impact at maximal 
exercise. Indeed, circadian rhythms are highly influenced by other exogenous factors 
such as sleep, posture, ingestion of food and activity patterns (Pickering, 1988). Such 
influencing factors question whether an endogenous component exists at all. 
However, if such rhythms do impact on CPO, then the timing of such measurements 
will need to be standardised according to the optimal time. In practical terms this will 
prove difficult. 'Me temporal optima could vary between individuals which would 
severely limit the number of subjects that can be tested each day and have a significant 
impact on the accuracy of cross-sectional studies. 
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The current discrepancies highlighted here and the lack of precise knowledge of how 
circadian rhythms may affect cardiovascular function and their potential implications, 
warrant further study. 
1.5. The effects of body size on physiological function 
A number of physiological variables (e. g. 1ý02.., CO etc) are influenced by body size, 
e. g. height, body mass, muscle mass etc. In these relationships an increase in body size 
is often associated with a general increase in a relevant physiological variable. 
Comparisons between group means, or between an individual's performance relative to 
that of their peers, are often confounded by differences in body dimensions. To obtain 
meaningful inter-or intra-group comparisons, the effects of body size need to be 
accounted for (Batterharn et aL, 1999). This process is often referred to as scaling or 
normalisation of the data, i. e. the physiological variable (y) is normalised for differences 
in a variable of body size (x). However, normalisation of such biological variables 
needs to take into account the fact that the relationships between body size and 
structures or physiological functions are complex and often non-linear (Nevill et aL, 
1992). If non-linear, simple ratio scaling (ylx) will either under-or over-correct for the 
impact of body size and lead to erroneous interpretations and conclusions. 
Previous investigators have scaled certain structures of the heart to a variety of body 
dimensions, e. g. LVM to body size has helped in the detection of LV hypertrophy in 
both obese normotensive or hypertensive subjects (de Simone et aL, 1992,1994; 
Malcom et aL, 1993) and increased the prediction of cardiovascular events in clinically 
hypertensive patients (de Simone et al., 1995). The effect of scaling heart size to body 
size can be further extended to parameters of cardiac function. Inevitably, CO or the 
amount of work performed by the heart in a 120 kg man would be greater than that 
performed in a 60 kg woman. Since CO is an integral component of CPO, dimensional 
effects on CO could have implications on the interpretation of CPO. Strong positive 
correlations have been reported between CO and body size (de Simone et aL, 1997), due 
to the larger oxygen demand imposed by a larger body mass (Lakatta, 1993). In addition 
to CO, SV and certain cardiac structures are usually normalised for body surface area 
(BSA), to effectively assess their effects when independent of body size. For example, 
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de Simone et aL (1997) concluded that normalisation of CO and SV to BSA, raised to 
the power of 0.7 1,, was pertinent when the effects of obesity needed to be accounted for, 
as a lack of normalisation obscured any impact of obesity. 
The other important component of CPO is MAP, which has been reported to be 
physiologically independent of body size (Dobeln, 1956). Therefore, it is more likely 
that CPO would be affected by different body dimensions in a similar way to that 
reported for CO. If such a relationship is identified then it is important that the potential 
confounding influences of body size on CPO are accounted for, especially when intra- 
and inter-group comparisons are to be made. 
1.5.1. Scalingmodels 
Numerous scaling approaches have been used to correct for the influence of body size 
(x) from physiological functions (y). Traditionally, the per-ratio standard (RS) approach 
was used. This method assumes a proportional linear relationship between the 
physiological dependent variable (y) and the body dimension variable (x) with the line 
of best fit passing through the origin (Batterham et A, 1999). That is, 
y=bx . 
where b is a constant derived from the mean values of the physiological (Y) and the 
body size (x) variables for the series of data it describes. 
The construction of a simple RS model is assumed to "normalise" the data, i. e. remove 
the influence of body dimensions from subsequent analyses. However, theoretical and 
mathematical flaws in this approach were recognised by Tanner (1949) over 50 years 
ago. Tanner (1949), indicated that the use of the RS method was "theoretically 
fallacious and in practice misleading! '. Because, smaller individuals received an 
arithmetic advantage while larger individuals were penalised. Tanner also stated that 
only in special circumstances is the RS method valid, i. e. when the coefficient of 
variation (CV) for body dimensions (M) divided by the CV for the physiological 
dependent variable (CVy) is equal to the Pearson's product moment correlation (r, X Y) 
between the two variables (i. e. CVx/CVy = r, X, 1). If the two values are not similar, 
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then either a linear relationship does not exist or the linear relationship has either a 
positive or negative intercept on the y-axis. Indeed, this special circumstance is rarely 
satisfied (Welsman et aL, 1996). 
As an extension to the RS model we have the linear regression standards (RES) 
approach. The general form is, 
a+bx+c, 
where b represents the gradient of the line of best fit a the intercept on the y-axis, and E 
the additive residual error term. The difference between this and the RS model concerns 
the assumption of a y-axis intercept term (a). As a consequence the RES approach does 
not require that the least-squares regression line pass through the origin (Batterham et 
aL, 1999). Although, this model has been shown to provide a better statistical fit in 
terms of a reduction in the residual error associated with this analysis compared with the 
RS model, positive intercepts are common. The latter would indicate that someone with 
zero body mass (BM) would still exhibit a physiological response. Since extrapolation 
of the regression line beyond the actual data points must be avoided, the values at y- 
intercepts are at best approximates. More importantly, the RES model assumes a 
constant (additive) error term, i. e. that the spread of scores around the regression line is 
constant throughout the range of x and y variables, a property known as 
homoscedasticity. This assumption is unlikely to be achieved in subjects who vary 
greatly in body size (Nevill et aL, 1992). Rather the measurement error tends to be 
greater as the independent variable (x) increases, and therefore the error is said to be 
heteroscedastic. Therefore, the use of the RES model for the normalisation of 
physiological data may not be appropriate even when the least squares regression line 
provides a better fit to the data. 
Because the assumptions of the RS and RES models are not always justified, the 
allometric model has also been used for scaling purposes. It has been reported that a 
number of physiological variables relate to body size according to the general allometric 
equation below (Bergh, 1987; Bergh et aL, 1991; Nevill and Holder, 1994), 
axc, 
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where y is the physiological variable, x is the variable of body dimension, a is the 
proportionality coefficient (constant multiplier), b the scaling component (i. e. the power 
ratio for scaling body size), and c the multiplicative error term (which takes into account 
the error around the regression line). Using this simple allometric equation, 
physiological dependent variables may be scaled for differences in body dimensions by 
constructing a power function ratio (see below), that is supposedly size-independent 
(Nevill et aL, 1992). 
Y/. tl 
Although the allometric model may produce only a modest improvement in statistical fit 
to the data (i. e. with less residual error) compared with the RES model, its use is 
justified for two reasons. First, the allometric model assumes a multiplicative error term, 
which allows the model to control for spread in the data (heteroscedasticity) providing 
that the variables diverge at a constant rate (Nevill et A, 1992). Second, the relationship 
is plausible as the line of best fit passes through the origin, thus providing a more valid 
method of producing a dimensionless physiological variable (Nevill et aL, 1992). A 
simple regression analysis then can be performed on the log-transformed y and x 
components, from which the slope of the log-linear plot of data determines the exact 
values of the allometric power function exponent b. 
1.5.2. Scaling variables 
The next important aspect of scaling is to determine which variables of body size should 
be used. The choice of the most appropriate variable should be based on the accuracy of 
its measurement and its biological relevance. In the cardiology literature, a variety of 
different variables of body dimensions have been proposed for the scaling physiological 
variables. For the scaling of heart size (e. g. LVM, chamber volume etc), BSA has been 
widely used as it incorporates both height (HT) and BM and therefore some element of 
body composition. In this way a single scaling variable can be used that would 
theoretically incorporate changes in HT and BM. Despite BSA seemingly being 
advantageous, this type of 'cardiac normalisation' has been criticised both on theoretical 
(Gutsegell, 1990) and mathematical grounds (Tanner, 1949). Body surface area is 
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actually never measured, but simply estimated via an equation (e. g. DuBois and 
DuBois, 1916), which introduces a degree of measurement error. Furthermore, BSA 
does not differentiate between the modifications in body composition, e. g. a large 
proportion of metabolically active muscle versus metabolically inert adipose tissue 
(Forbes and Welle, 1983). Due to the relative ease and accuracy by which they can be 
measured, other widely used scaling variables include HT, and BM. 
Daniels et aL (1995) and Roman et aL (1997) suggested that fat free mass (FFM) might 
represent the optimal parameter for allometric normalisation of cardiac structures and 
functions. Fat free mass has been defined by Jensen et aL (1993) as the non-adipose 
tissue of body mass (i. e. skeletal muscle, brain, heart, liver, kidneys and gastrointestinal 
tract) and the non-fat component of adipose tissue (e. g. proteins in cellular and 
extracellular structures). Therefore, as the metabolic rate of adipose tissue is relatively 
inert, compared to FFM (Weinsier et aL, 1993), scaling for FFM will allow the 
independent isolation of body dimensions that relate to metabolically active tissues and 
hence, physiologically dependent variables. Given that CO (and therefore CPO) is 
known to response to the tissues' demands for oxygen (Lakatta, 1993), it would seem to 
be theoretically plausible to scale CPO to FFM. However, whether FFM will be the 
optimal parameter, will depend on the accuracy with which it is measured. The 
emergence of dual energy x-ray absorptiometry (DEXA) provides a definitive method 
of accurately determining FFM and adipose mass, allowing the investigation of their 
independent effects on CPO (Jensen et aL, 1993). 
1.6. Dietary creatine supplementation and cardiac 
performance 
Older people and patients with failing hearts are less able to respond to exercise and 
various daily stresses. Hence a nutritional or ergogenic aid, leading to a metabolic 
improvement in cardiac function, may be better suited to the elderly than exercise-based 
interventions. Creatine is a substance found in fish and meat. In addition to this 
exogenous source, de novo synthesis of creatine occurs in the liver from the amino 
acids, arginine, glycine and methionine (Persky and Brazeau, 2001). The skeletal 
muscles and the heart activity take up approximately 95% of newly synthesised 
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creatine. Once inside the myocytes, approximately 70% of creatine is phosphorylated 
(PCr) by creatine kinase, the remaining 30% existing as free creatine (Wyss and 
Kaddurah-Daouk, 2000). In all muscles PCr represents an immediate source of energy 
to replenish the immediate but limited concentrations of ATP. 
It has been well documented that when creatine is supplemented in the diet, skeletal 
muscles increase their creatine and PCr contents (Harris et aL, 1992; Greenhaff et aL, 
1994). Although not always universal accepted (Snow et aL, 1998; Smith et aL, 1999). 
This results in improved exercise performance (Balsom et aL, 1995; Vandenberghe et 
aL, 1997,1999) and muscle force or power (Vandenberghe et aL, 1997), These 
performance-enhancing effects, when seen, would be especially useful to an elderly 
population, who are reported to have depleted creatine concentrations in their skeletal 
muscles (Balsom et aL, 1994; Moller et aL, 1980; Smith et aL, 1998). In addition, 
creatine concentrations in the human heart have been found to be depleted during 
ageing (Nascimben et aL, 1996), and also in the diseased heart (Smith et aL, 1998). As 
such reversing an age-related decline in creatine concentrations in the heart could 
represent a simple and inexpensive way of improving cardiovascular function. 
Furthermore, creatine supplementation, combined with exercise, may even produce 
additive benefits. 
Studies examining changes in skeletal muscle force in older individuals have been 
inconclusive. Rawson et A (1999) and Rawson and Clarkson (2000) examined healthy 
older men (60-82 years) and showed no significant changes in exercise performance or 
body mass. A further study by Bermon et aL (1998) examined 8 weeks of resistance 
training and creatine supplementation in older subjects (67-80 years), but found that the 
training regimen alone was sufficient to explain the increase in muscle force, with no 
additional effects of creatine. This was further confirmed by Eijnde et aL (2003) who 
found no added improvement in physical fit 55 to 75 year-old men, who took creatine 
supplementation in conjunction with exercise training. Therefore, these negative sets of 
data may suggest that older subjects may respond differently to creatine 
supplementation than young subjects. 
In contrast to skeletal muscle, very little is known about the effects of creatine 
supplementation on cardiac performance. Indeed, Juhn and Tamopolosky (1998) noted 
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that "to truly determine whether oral creatine supplementation has any effect on cardiac 
muscle concentration and function, long-term human studies are needed". A number of 
animal studies have examined the role of creatine in cardiac performance. It has been 
postulated that the creatine kinase /phosphocreatine system acts as an energy reservoir 
and may, in addition function as an energy shuttle between intracellular sites of ATP 
production and consumption, for the maintenance of normal cardiac performance 
(Neubauer et aL, 1999). A number of studies have examined this hypothesis, by 
depleting intramuscular PCr and free creatine concentrations, by chronic feeding with 
the creatine analogue P-guanidinopropionate. Most reports have found an impaired 
cardiac performance (measured via cardiac contractility) under severe creatine depletion 
by P-guanidinopropionate (Kapelko et aL, 1989; Mekhfi et aL, 1990; Zweier et A, 
1991). However, the above studies were performed on in vitro-perfused hearts. 
Neubauer et aL (1999) examined the role of chronic myocardial creatine depletion in 
both vitro and vivo rat hearts. The vivo analysis showed that at rest or during acute 
volume loading no alterations in cardiac haemodynamics occurred after P- 
guanidinopropionate, despite a 90% reduction in creatine kinase reaction velocity. 
These workers suggested that in the intact rat cardiac and/or humoral compensatory 
mechanisms are sufficient to maintain normal haemodynamics. However, these 
compensatory mechanisms may not be sufficient when the heart is maximally stressed, 
i. e. at maximal exercise. Then the depletion of creatine may limit the heart's ability to 
perform external work. As mentioned earlier, the heart under resting situations operates 
at a fraction of its total capacity and therefore measurement of cardiac function at rest 
does not provided important information about the reserve capacity of the heart 
(Neubauer et aL, 1999). 
A study by Brzezinska et aL (1998) examined 7 days of creatine loading in the rat and 
found that this dietary loading did increase cardiac muscle high energy phosphate 
reserves and its oxidative potential. Theses results conflict with those of Horn et aL 
(1998), who found no change in the high-energy phosphate content in myocardium of 
rats fed with a variety of creatine doses for 40 days. 
Therefore, when added as a supplement to normal diets, creatine may improve the 
functional reserve of both ageing normal and failing heart. If so, this simple approach 
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may improve the power output of the heart, as well as that of skeletal muscles, and 
hence help frail elderly and heart failure patients too enjoy a more active life-style and 
improve their quality of life. 
1.7. Aims of the following research 
The major aim of this thesis was to examine the age-related changes in cardiac power 
output and cardiac reserve. However, there were a number of potential confounding 
factors which could affect the interpretation of the results. Such factors, therefore, 
needed to be addressed prior to meaningfully analysing the effects of ageing on CPO. 
This overall aim was approached by examining the following objectives: 
1. To investigate whether measurements of CPO were affected by the time of 
day at which they were measured. 
2. To determine the relationships between variables of body size and CPO, and 
where such relationships exist identify the best scaling model and variables 
to provide valid inter-and intra-group data set comparisons. 
3. To establish a temporal baseline of overall cardiac function, with respect to 
healthy ageing. 
4. To determine the effects of an active lifestyle and long-term endurance 
training on these age-related changes in CPO and CR. 
5. To investigate the potentially beneficial effects, if any, of orally ingested 
creatine on CPO in older men. 
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Method 
2.1. Ethics and medical screening 
Ethical approval was obtained from Liverpool John Moores University ethics 
committee. All subjects received verbal and written explanation of the procedures 
involved and filled in consent forms. 
Prior screening for the suitability of the subjects was accomplished by completing a 
medical health questionnaire, which ascertained any past history of cardiovascular 
conditions and any other contradictions to testing (Appendix 1). Medical exclusion 
criteria for entry into the studies included a history of coronary artery disease (CAD), 
hypertension (blood pressure >140/90 mm Hg), diabetes mellitus, and use of any 
medications known to affect cardio-respiratory function. Subjects with evidence of 
CAD during screening on the exercise treadmill test were also excluded. To eliminate 
the confounding influence of severe obesity, only subjects with a body mass index less 
than 35 k g/m 2 were included in the studies. 
Subjects were categorised based on their self-reported physical activity levels, which 
were obtained via a fitness questionnaire (Appendix 1). The questionnaire ascertained 
the frequency, duration and intensity of the physical activity performed. The validity of 
the answers to questions set in the questionnaire were ascertained through an interview 
with the subject. Furthermore, confirmation of the fitness of the subjects were 
ascertained through examination of their V02max (MI/Min/kg) score (see below) 
compared to guidelines of physical fitness set by the American college of sports 
medicine (ACSM; 2000). Therefore, individuals were classified as sedentary if they 
performed no regular aerobic physical exercise on a weekly basis and if their V02ma,, 
score was below average i. e. <500' percentile for their age according to the ACSM 
guidelines (Appendix 2). Conversely, individuals were categorised as physically active 
if they performed regular aerobic physical exercise three times per week, at an intensity 
that causes sweating. In addition, they achieved above average i. e. >6& percentile or 
their V02max for their age, according to the ACSM guidelines. 
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2.2. Measurements of body composition using Dual Energy 
X-ray Absorptiometry 
Height (HT) was measured using a Harpenden stadiometer and body mass (BM), in 
light clothing, was measured to the nearest 0.1 kg using Avery balance beam scales. 
Height and BM measurements were then used to calculate body surface area (BSA), 
according to the formula of DuBois and DuBois (1916). 
Whole-body and regional body composition were measured using Dual Energy X-Ray 
Absorptiometry (Hologic Inc, Horizon Park, Levensesteenweg, Belgium). The software 
(Delphi A SIN 70719) provided the mass of fat free tissue, fat tissue and bone. 
Appendages were isolated from the trunk and head by using DEXA regional computer- 
generated default lines, with possibility of manual adjustment. With the use of specific 
anatomical landmarks, the specific regions of the body (head, left and right arms and 
legs, trunk, and pelvis) were determined. 
For this analysis all subjects wore light clothing, having previously removed any metal 
objects Oewellery, coins, under wire bra etc). The DEYCA unit consists of a bed on 
which the subject lies supine, while a collimated dual energy x-ray fan beam, 
originating from a source under the bed, passes through the subject (Figure 2.1). The 
beam's attenuation is measured by the detectors above the subject. Both the source and 
detector move so that whether the whole body, or selected regions, of the subject are 
scanned. The dual energy of the beam allows quantification of two components in each 
pixel; i. e. fat and lean tissue components in boneless regions. 
For this thesis, the body components were defined, as follows: 
" Body mass (BM) equals the sum of the body fat mass, fat free mass and bone. 
" Body fat mass (FM) equals the quantity of triglyceride fat in the body. 
" Adipose tissue mass equals the storage form of body fat and its supporting 
cellular and extracellular structures. 
" Lean body mass (LBM) equals the non-adipose tissue of body mass and bone 
mineral-free constituents. 
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Figure 2.1. Dual Energy X-ray Absorptiometry (DEXA). 
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Fat free mass (FFM) equals the lean body mass (e. g. skeletal muscle, brain, 
heart, liver, kidneys and gastrointestinal tract) and the non-fat component of 
adipose tissue (e. g. proteins in cellular and extracellular structures). This 
definition also excludes the bone mineral-free constituents and the head. 
The calibration of the DEYCA was performed on a daily basis using a spine phantom to 
test the system's calibration and its precision of imaging. In addition, a step phantom 
was used. That has known concentrations of soft and lean tissue. In order to obtain a 
subject's body composition, the dual energy attenuation values of the subject were 
compared to those produced by the step phantom. 
2.3. The measurement of cardiac power output 
To determine cardiac power output (CPO) the pressure and flow generating capacities 
of the heart need to be measured. This process can be achieved non-invasively by 
measuring mean arterial pressure (MAP) and cardiac output (CO), both at rest and at 
maximal exercise (Cooke et aL, 1998). This involves a three-stage procedure: 
An incremental exercise test to exhaustion to measure maximal oxygen 
consumption (ý702.. ), carbon dioxide production, and maximal heart rate. 
Measurement of CPO at rest (CPOest) 
Measurement of maximal CPO (CPO.. ), i. e. when subjects are exercising at 
their previously established V021nax (determined in stage i). 
Breath- by-breath gas sampling and analysis 
Continuous breath-by-breath sampling of the respiratory gases were obtained during the 
incremental exercise testý and during the measurement of resting and maximal CPO, 
using the Medgraphics cardiopulmonary exercise testing system (CPX-D system; 
Medgraphics Corporation, St Paul, Minnesota, USA). This is an integrated module 
system incorporating a flow/waveform module, a gas analyser, 12-lead 
electrocardiograph and a dedicated host computer with the appropriate software to 
calibrate and to analyse the respiratory gases. 
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A pink sample line connected to the pneumotachograph draws the respiratory gases and 
passes them through a drying sample line (to remove moisture), via a vacuum system 
before entering the gas analyser. The drying sample line helps to increase the accuracy 
of the measurement of these gases. 
The measurement of respiratory gas flow was obtained through a disposable (pre Vent 
Tm) pneumotachograph (Medgraphics Corporation), which was attached to the flow 
analyser via an umbilical tube (double lumen). Flow was measured indirectly as a 
pressure differential by the patented tube-style pneurnotachograph. 
Oxygen (02) concentrations were measured by a patented zirconium fuel cell, which 
was divided into an inner chamber containing the sample gas and an outer chamber 
containing a reference gas. With a reference gas on one side of the cell and sample gas 
on the other, a voltage is created by the movement Of 02 molecules and this is measured 
by the cell. 
The carbon dioxide (C02) concentrations in the same samples were measured by an 
infrared analyser. Carbon dioxide absorbs more infrared light at the 4.3 gm wavelength 
than any other gas. 'Me amount of light absorbed in the sample chamber was compared 
to the amount absorbed in the reference cell and the relative amount of C02 in sample 
gas quantified. 
Prior to each test both the pneurnotachograph and gas analyser were calibrated. 
Initially, environmental factors such as ambient temperature, barometric pressure and 
relative humidity were measured and entered into the system as such factors can affect 
the results. Then the pneurnotachograph was calibrated using a3 litre syringe, having 
established a baseline "zero" without any flow. Five injections and withdrawals of the 
syringe were performed at varying speeds, in order to represent fluctuations in 
respiration. The gas analyser was calibrated using precise concentrations of reference 
gases (21% 02 and balanced N2) and calibration gases (12% 029 5% C02, and balanced 
N2). 
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2.3.2. Measurement of maximal oxygen uptake(ýo2,,,,,, ) 
All exercise tests were conducted in specialised cardiopulmonary exercise laboratories. 
The environmental conditions within the laboratory were controlled; temperature and 
humidity were maintained around 20"C and 40-60%, respectively. All subjects attended 
the laboratory after a minimum 3-hour postprandial period, having abstained from 
caffeine in the preceding 3 hours. On arrival, a 12-lead electrocardiogram (ECG) 
(Cardio-perfect, Atlanta) was attached with the electrodes positioned on to the chest of 
the subject. 
Irrespective of the subject population, a single exercise protocol was used to determine 
their All subjects were tested on a programmable treadmill (Cosmos, Nussdorf- 
Traunstein, Germany) using a modified version of the Bruce (1971) protocol (Table 
2.1). Ile protocol contained two preliminary 1-minute stages of 2.2 kph at 0% incline. 
The protocol then increased in both speed and gradient every minute, until exhaustion 
was reached. From stage 4 onwards of the protocol, every alterative stage corresponded 
to a stage in the Bruce (1971) protocol (Table 2.1). The reason for adopting the I- 
minute incremental protocol was to obtain a more linear rise in the ý702 and HR relative 
to the workload and to avoid the fluctuations apparent with the Bruce (1971) protocol. 
Additionally, maximal exercise would be achieved within approximately 10 minutes, in 
keeping with the recommendations of Buchfuhrer et aL (1983). Figure 2.2 illustrates a 
symptom limited exercise test performed by a sedentary 50 year-old male. 
Throughout the exercise test a 12-lead ECG was monitored and the HR was derived 
from it. Blood pressure (BP) was measured by an experienced investigator using a 
manual sphygmomanometer before starting the test, at two-minute stages during the 
exercise test, at maximal exercise and immediately at the end of the exercise test (refer 
to section 2.33 for further detail). Oxygen consumption (ýIo2), carbon dioxide 
production (ýrCO2), end tidal partial pressure of carbon dioxide (PETC02), tidal 
ventilation ('ýE) and respiratory rate were measured breath-by-breath using the 
Medgraphics CPX-D system (Medgraphics Corporation, St Paul, Minnesota, USA). 
Breath-by-breath data (Vo2 and VC02) were averaged from 5 breaths. 
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Table 2.1. Exercise protocol. 
One minute incremental programme for treadmill, adapted from Bruce (197 1) 
Protocol 
Bruce, 1971 1 -minute incremental programme 
Stage Duration 
(min) 
Speed 
(km/h) 
Gradient 
M) 
Stage Duration 
(min) 
Speed 
(km/h) 
Gradient 
M) 
1 0-1 2.2 0 
2 1-2 2.2 0 
3 2-3 2.7 5 
1 3 2.7 10 4 3-4 2.7 10 
5 4-5 3.3 11 
2 3 4.0 12 6 5-6 4 12 
7 6-7 4.8 13 
3 3 5.5 14 8 7-8 5.5 14 
9 8-9 6.2 15 
4 3 6.8 16 10 9-10 6.8 16 
11 10-11 7.4 17 
5 3 8.0 18 12 11-12 8 18 
13 12-13 8.4 19 
14 13-14 8.8 20 
15 14-15 9.2 21 
16 15-16 9.6 22 
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Figure 2.2. Graphical representation of the changes that occurred during an incremental 
exercise test. 
Changes in oxygen consumption [V02 (1/min); pink line], carbon dioxide production 
['ýC02 (1/min); blue line], heart rate [HR (b/m); red line] and the volume of expired gas 
VE (ml BTPS); green line] during the I -minute incremental exercise test. The subject 
began to exercise at approximately 2 minutes and reached exhaustion around 13 
minutes, with V02,,,,, achieved at 12 minutes. 
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Maximal oxygen consumption was considered to be reached when two out of the 
following three criteria were satisfied; 'ý02 levelling off despite further increase in 
workload, heart rate greater than 95% of their age-predicted maximal value (220-age), 
and a respiratory exchange ratio greater than 1.10. All subjects were given verbal 
encouragement to achieve the criteria outlined above. 
Any premature termination of the incremental exercise test consisted of any evidence of 
ECG ischaernia or arrhythmia, and a rise in systolic blood pressure (SBP; >230 mm. Hg) 
and/or a rise in diastolic blood pressure (DBP; >1 15 mm Hg). 
The main purpose of the exercise test was to obtain the subject's maximal HR, ýIo2, 
lko2, and Vt values. These values were then used as benchmarks to ensure that subjects 
re-attain their maximal levels during the measurement of maximal CPO (i. e. stage iii). 
Therefore, the ýro2max test acted as a familiarisation session for the subjects, while to 
excluding any silent ischaernia or latent exercise induced hypertension, and determining 
their exercise capability prior to the crucial measurement of maximal CPO. 
2.3.3. Measurements of arterial bloodpressure at rest and during dynamic 
exercise 
The measurements of resting and maximal blood pressure (BP) were performed 
manually, using a mercury sphygmomamater and a stethoscope. The measurement of 
BP conformed to the recommendations of American Heart Association (Frohlich et aL 
1988). The correct size of BP cuff (i. e. bladder width and length = 40-50% and 80% of 
upper arm circumference, respectively) was fitted to the subject's left arm, positioned 
over the brachial artery (Figure 2.3). The drum of the stethoscope was positioned over 
the brachial artery, and the cuff was inflated 40 mm Hg beyond the disappearance of the 
Korotkoff sound, this phase represented the point at which the blood flow in the 
brachial artery was occluded. The cuff was then deflated by approximately 3 mm Hg 
per second. During the deflation of the BP cuff, systolic blood pressure (SBP) was taken 
as the appearance of the first Korotkoff sound (faint, clear tapping sound) and diastolic 
blood pressure (DBP) was taken as the 5th Korotkoff sound (the pressure level when the 
last sound is heard, and after which all sounds disappear). 
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Figure 2.3. Determination of blood pressure using the auscultation method during an 
incremental exercise test. 
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2.3.4. Measurement of cardiac output using the carbon dioxide (CO2) 
rebreathing technique 
The measurement of CO was determined using the C02 rebreathing methods of Collier 
(1956) and Defares (1958), and calculated using the indirect Fick equation. The indirect 
Fick equation requires measurements of respiratory gases to obtain lko2, arterial 
(CaC02), and venous (CVC02) concentration Of C02, Ibis was achieved using the 
Medgraphics CPX-D system. The Fick equation (see below) was programmed into the 
software, which accompanied the gas analyser and was used to calculate CO, 
CO- "ý 
ý7C02 / (CVC02 
- Cac02), 
where CVC02 is the venous and CaC02 the arterial concentrations Of C02 (mm Hg). 
The ýC02 component of the Fick equation was obtained from the inspiratory and 
expiratory gas volumes. The content Of C02 in arterial blood (Caco2) was derived from 
the logarithmic version of the C02 dissociation curve (Jones, 1988) of the partial 
pressure Of C02 in the arterial blood (Pac02; mm Hg). Partial pressure Of C02 in the 
arterial blood was estimated from the end-tidal PC02 (PETC02), assuming normal lung 
function, using the following equation (Jones, 1988), 
Pac02 = 5.5 + 0-9 PETC02 - 0.0021 x Vt (BTPS), 
where Vt - tidal volume (ml BTPS) and PETC02 is the average taken over the 30 
seconds preceding the commencement of the rebreathing manoeuvre. 
The CVC02 component of the Fick equation was measured by obtaining the partial 
pressure Of C02 in the venous blood (PVC02; mm Hg). The PVC02 can be determined 
using one of two rebreathing methods, the equilibrium (Collier) or the exponential 
(Defares) rebreathe techniques. 
However, when converting partial pressures to content, two assumptions are made. 
First, the haernoglobin concentration is at 15 g/100 ml, and second, the mixed venous 
oxygen saturation was > 95% during rebreathing (Jones, 1988). 
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(A) The Equilibrium (Collier) C02 rebreathing technique 
To determine PVC02 the Collier (1956) method and hence CO, was used at rest, as past 
research has shown that this method was more accurate and reproducible than the 
Dcfares (1958) method (Auchincloss et aL, 1980; Franciosa et aL, 1976; Zeidifard et 
aL, 1972). For this procedure the subjects breathed through a low resistance three-way 
rebreathe valve (Hans Rudolph, Model 2870 Series). This valve allowed rapid switching 
from breathing room air to breathing a known concentration of gases from a5 litre- 
rebreathe bag. Attached to the outflow of the valve, was a pre-vent pneurnotachograph 
to measure the flow of breathing. Also a gas sampling line was fitted near to the 
mouthpiece, and connected to the gas analyser (Figure 2.4). 
At rest, the rebreathe bag was filled with 10% C02 (35% 02 and balanced N2) in a 
known volume, which corresponded to approximately twice the subject's resting tidal 
volume (VT). A table relating flow rate to bag volume was constructed by the author to 
facilitate easy of flow. Under or overfilling of the bag can lead to falsely high or low 
CO, respectively. At the end of a normal tidal breathe the three-way valve was closed 
manually by the investigator. This switched the subject's breathing from room air to 
that of the rebreathe bag. The subject was then instructed to take a deep inspiration, 
inhaling the full volume of the bag. The subject continued to rebreathe from the bag at a 
rate of approximately 30 breaths/min, ensuring the bag was completely emptied each 
time. This procedure lasted approximately II seconds, until a plateau in the percentage 
Of C02 concentrations were achieved and maintained for at least two breaths. The valve 
was then switched back to room air. Figure 2.5, illustrates such an equilibrium breathing 
pattern. 
A satisfactory capnograph plot met the following criteria: 
" The C02 equilibrium was reached after 2 to 3 breaths. 
" The equilibrium was maintained for at least 2 breaths. 
" This equilibrium was reached within 12-15 seconds, to avoid problems with 
recirculation. 
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Figure 2.5. Capnograph plot taken 
from a healthy sedentary 50 year-old 
subject. 
The graph shows the change in tidal 
C02 concentration, which occur% 
during the rebreathe manoeuvre. 
Normal tidal breathing can be seen 
initially. Then at the end of the second 
expiration (arrow) the subject began it) 
rebreathe From the bag. A plateau 
(arrow) in %CO., had occurred after 
the third breath and was maintained 
for two breaths. 
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As recommended by Jones (1988), the empirically derived 'downstream correction' 
equation was applied to the equilibrium method to correct for the alveolar to arterial 
Pco2 difference observed during this method. This equation is present in the software 
and it follows, 
PVC02 (mm Hg) ý PeqC02 - (0.24 x Pqco2- 11) (Jones et A, 1972), 
where PeqC02 -"ý the equilibrium PC02 before correction. 
(B) Exponential (Defares) C02 rebreathing technique 
At maximal exercise the Defares method was employed to measure CO.,,., as past 
research has established that this method provides the most accurate and reliable 
measurement of CO (Ferguson et aL, 1968). Once again the subjects breathed through a 
three-way rebreathe valve (Hans Rudolph) as described for the equilibrium method. 
Attached to the rebreathe valve with a specialised accessory to connect a facemask 
(Hans Rudolph). Connected to the mask was a seal gel, which moulded to the shape of 
each subject's face. Once the valve was closed this seal gel ensured that the subject was 
breathing into a closed system. The weight of the rebreathe valve was balanced by 
attaching the value to a specialised head support device (Hans Rudolph, Model 2785 
Series), which allowed the subjects to walk/run with little hindrance (Figure 2.6). 
Once the subjects reached 100% of their predetermined V02", ax values, the valve was 
manually closed and the subject began to breathe the gas mixture (4% C02,35% 02 and 
balanced N2) in the rebreathe bag, the volume of which equalled each subject's maximal 
Vt (as determined during the V02.. test). The subject rebreathed from this bag at a rate 
of approximately 40 breaths/min, for approximately 8-10 seconds. Ile valve was then 
opened to allow the subject to breathe room air. Figure 2.7 shows the exponential 
rebreathe pattern, taken from a healthy male subject. As described by Da Silva el aL 
(1985), the first breath was rejected because of incomplete mixing of the gases in the 
lung. All PETC02 points were then analysed, using an iterative technique that was 
solved for t= 20 seconds. Only PETC02 values up to 8 seconds were analysed, i. e. only 
- I- 
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Figure 2.6. Measurement of maximal 
cardiac output using the Defares carbon 
dioxide rebreathe technique. 
The figure illustrates the 3-way rebreathe 
valve attached to Hans Rudolph face 
mask and support device. The face mask 
and seal gel produces a comfortable seal 
around the contours of the face allowing 
complete gas collection. The device helps 
to balance the weight of the valve, while 
the subject is walking or running. 
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Figure 2.7. Capnograph plot taken 
from a healthy sedentary 50 year-old 
subject. 
The graph shows the exponential 
change, in tidal C02 concentration, 
which occurs during the C02 
rebreathe at maximal exercise. It can 
be seen from the graph that with 
each breath the concentration of tidal 
C02 increases. 
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3 to 6 breaths were used. This was to ensure that no PETC02 were taken after 
recirculation of blood through the lungs had occurred. 
For both the Collier (at rest) and Defares (at maximal exercise) methods a 3-minute 
wash out period was left between successive (duplicate or triplicate) measurements, 
during which time the preceding respiratory values were re-established. 
2.3.5. Measurement ofresting cardiac power output 
Resting CPO (CPO,,,, t) was performed after the subjects had rested (seated position) for 
approximately 20 minutes. During that time ventilatory gases were measured and 
standardised. Blood pressure was measured on three occasions, with each measurement 
separated by 2 minutes. Cardiac output was measured using the C02 rebreathing 
technique of Collier (1956), with at least three resting measurements separated by 4 
minutes to allow for a complete wash out of C02 from the circulating blood. The 
average of three CPO.,, t values were calculated. The day to day reproducibility of the 
average measurement of CPO,,, t had a coefficient of variation of 7.7% (equating to 
approximately 0.1 W), which is below the acceptable level of 10% (Atkinson and 
Nevill, 1998). 
2.3.6. Measurement ofmaximal cardiac power output 
The protocol to measure the subject's maximal CPO was as follows; 
The speed and gradient of the treadmill (based on the values obtained during the 
'ý02. ax) were adjusted manually by the investigator to obtain maximal respiratory and 
haemodynamic values within 6-9 minutes. By this time all subjects were exercising at 
100% of the values that they attained during theý102max test. Once maximal ý'02, ýC02 
and HR were reached BP and CO (Defares method) were measured. Duplicate or 
triplicate COn,.., were made, each separated by 2 to 3 minutes of recovery at a low 
intensity of exercise. An average value was then calculated. 
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The day to day measurements of CPO.. corresponded to a coefflicient of variation of 
7.3%. Again this was below the acceptable level of 10%. 
2.3.7. Calculations 
Mean arterial pressure (MAP) was calculated from the following equation 
(Meaney et aL, 2000), 
MAP = DBP + 0.412 x (SBP - DBP), 
where SBP is systolic and DBP is diastolic blood pressure, measured in mm Hg. 
Cardiac power output (expressed in Watts) was calculated from the equation 
(Cooke et aL, 1998), 
CPO = (CO x MAP) x K, 
where CO is cardiac output (1/min) and K the conversion factor (2.22 x 10'3) into 
Watts. 
* Cardiac reserve (CR; expressed in Watts) was calculated from the equation 
CR = CPO.. - CPO,,, t 
2.4. Measurements of cardiac dimensions using 
echocardiography 
Echocardiographic measurements were performed in the supine position, using an 
Acuson Cypress Echocardiography System (Siemens Ltd, Hertfordshire) with 
simultaneous ECG recordings. Ultrasound images of the left ventricle were obtained 
with the subject lying in the left lateral decubitus position. Placement of a 2.5-MHz 
transducer at the parasternal window allowed the production of a two-dimensional 
image of the left ventricle in the long axis (Figure 2.8A). M-mode recordings were 
taken at the tip of the mitral valve leaflets (Figure 2.8B). All measurements were taken 
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B 
Figure 2.8. Cardiac dimensions using echocardiography 
(A) 2-D image of the heart, with the transducer positioned on the parasternal long- 
axis. (B) M-mode image of the left ventricle at the level of the mitral valve, from 
which septal wall thickness (SWT). posterior wall thickness (PWT), left ventricular 
internal diameter in diastole (LVIDd) and systole (LVIDs) can be measured. 
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in accordance with the guidelines set by the American Society of Echocardiography 
(Sahn et aL, 1978). Three to five consecutive measures were made and the average was 
taken. From the concomitant ECG trace septal wall thickness (SWT), posterior wall 
thickness (PWT) and left ventricular end-diastolic dimension (LVIDd) were digitised at 
the peak of the R-wave, according to Penn convention guidelines (Devereux and 
Reichek, 1977). Left ventricular end-systolic dimensions (LVIDs) were measured as the 
minimum separation of the septal and posterior walls. Left ventricular mass (LVM) was 
determined via a regression-corrected "cube-formula" (Devereux and Reichek, 1977). 
2.5. The Process of Scaling 
In order to establish the best scaling procedure and to identify the most appropriate 
scaling variable, the following processes were implemented. All data from males and 
females subjects were grouped together into one large population. The relationship 
between various variables representing body size (e. g. body mass, height, body surface 
area, and fat free mass) and CPO were checked using Pearson's correlation. If a 
relationship was identified, then by using Tanner's (1949) calculation for 'special 
circumstances' their relationships were analysed for linearity with a zero intercept. In 
this procedure the correlation coefficient (r, X, Y) for each variable representing body 
size and CPO were compared with the ratio of the coefficient of variation (CV) for body 
dimensions (CVx) divided by the CV for the physiological dependent variable (CVy) 
i. e. CVx/CVy. Where rX, Y is either equal to or roughly equivalent (arbitrarily chosen 
as ± 0.05 in this study) to CVx/CVy, a linear relationship with an intercept at zero is 
likely to be true. Conversely, if these two terms are not similar (the difference between 
CVx/CVy and r is >0.05), then either a linear relationship does not exist or the linear 
relationship has a non-zero intercept on the y-axis. 
Subsequently, the allometric modelling technique was investigated to describe the 
relationship between each combination of body size and the physiological variables. 
Allometric relationships were derived from natural log transformations (base c) of the 
absolute data. The general curvilinear allometric equation can be log-transformed into 
linear relations (Nevill et aL, 1992), 
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logy =log a+ blogx+ log c, 
where the exponent b, is the slope of the regression line when comparing the log 
transformed variables of body size and CPO on the log linear plot, and a is derived from 
the antilog of the intercept on the y-axis. All exponents were calculated as means, with 
95% confidence intervals (CI). Statistical significances of the coefficients were tested at 
an cc-level of 0.05. 
First, it was important to determine the viability of a common power function ratio 
) for both male and females, across the age range studied. Only in this way can 
CPO, when normalised for body size throughout different populations, be compared 
directly. For this, the slopes of the regression lines for male and female data were tested 
to see if they were parallel, as equality of slopes across all age groups must be satisfied 
for ANCOVA to proceed. This was achieved by including a gender (males coded 0, 
females coded 1) times log BM (or log HT, BSA and FFM) interaction term in a 
multiple log-linear regression model (Nevill et aL, 1992). 
log CPO,,. t = log a+ d(sex - log BM) +c. sex + blog BM + log f 
Clearly, the above equation can be changed to include the remaining variables of body 
size and CPO, to examine a sex-related interaction. If the interactive term is not 
significant (P>0.05), commonality of slopes in the disparate groups is then confirmed. 
An inclusive 'best compromise' exponent b can then be derived by removing the 
interaction term, but including sex as a predictor variable alongside the body size 
variable in a multiple allometric regression model (see below) (Nevill et aL, 1992). 
log CPO .. t= log a+c- Sex + blog BM + log f 
This model provides a solution for a single exponent b, isolating the "sex independent" 
influence of body size on CPOst. Furthermore, the above equation allows for the 
derivation of adjusted values of the proportionality coefficient a, isolating the effects of 
sex on CPO,, st. With a common exponent b, the a value can be statistically analysed to 
test for size-independent sex differences in CPO. Alternatively, using the best 
compromise exponent b, the power function ratios CP0, g/BMý, CPO,,, g/HTb, 
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CPO,,, t/BSAýb or CPO,,, t/FFMb can be compared statistically. Similarly, CPO .. t can be 
replaced with CPO,,,. or CR and the exponent b statistically analysed. 
After the generation of the exponent b, it was possible to check whether this allometric 
approach produced a size-independent physiological parameter by correlating the power 
function ratio with the variables of body size. If the influence of body size were 
corrected for, then this correlation would not be significantly different from zero 
(Batterham et aL, 1999). 
(CPO/BM b)/ BM =zero 
Information regarding the optimal body dimension was obtained by comparing the 
model Rý (i. e. the ratio of the variance due to treatment and the total variance) and root- 
mean-squares-error from separate regression models, together with the relative width 
and stability of the confidence intervals surrounding the mean size exponents. The root- 
mean-squares-error indicates the variation not explained by the regression line, so it is a 
measure of the 'goodness-of-fit' of the line in the units of the measurements made. 
2.6. Creatine supplementation prior to measurements of 
cardiac power output. 
To examine the possible effects of dietary creatine supplementation on CPO in older 
sedentary and active male subjects, a double blind cross over experiment was 
performed, with all tests randomised to ensure that no bias was involved. All subjects 
ingested either placebo (control) or creatine drinks. The placebo drink contained l5g of 
maltodextrin with no creatine, whilst in the creatine trial 5g of creatine and lOg of 
maltodextrin (SIS, Blackburn) were dissolved and ingested. Both the placebo and 
creatine drinks contained flavouring to make them more palatable and to disguise the 
presence of creatine from the subjects. 
The contents of each sachet, was dissolved in warm water before ingestion and the 
equivalent of four full sachets (i. e. 20 g of creatine) were ingested each day, for 5 days. 
The ýIo2, ax exercise test was performed in the morning on the sixth day after the 
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contents of a sachet had been taken prior to attending the laboratory. The resting and 
maximal CPO was performed on the seventh day, this time after the contents of the last 
sachet had been taken. At least four weeks were allowed between the I't and 2nd trial, to 
allow for an adequate wash out period and to ensure that a complete restoration of the 
initial concentrations of creatine were obtained. 
1 
2.7. Statistical analysis 
All data are presented as Means ± SEM. Data from each experiment were first tested for 
normality (Kolmogorov-Smimov test). Normally distributed data were analysed for 
statistically significant differences using parametric tests. Simple comparisons between 
two independent cases were analysed using Student's two-tailed independent Mest. 
Comparisons between the same data sets were analysed using Paired Sample t-test. 
More complex comparisons were conducted using one-way analysis of variance 
followed by Tukey's HSD post-hoc analysis.. 
Linear regression analyses were performed to determine the association among 
variables. In all cases, age was used as the predictor variable. Pearson product-moment 
correlation coefficients were used to indicate the magnitude and direction of relations 
among variables. The slopes of the regression lines (comparing men and women or 
sedentary and active men) were compared using analysis of covariance which included 
an interaction term. Significant differences were expressed as P _--ý 0.05. 
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3.1. The effects of time of day on the measurement of cardiac 
power output 
Previous research has established a circadian rhythm in cardiac output (CO), a principal 
component of cardiac power output (CPO), and also diastolic blood pressure (DBP), 
which is a component of mean arterial pressure (MAP) (Cugini et aL, 1991; Deschenes 
et aL, 1998a). However, this circadian rhythm in CO and MAP has only been observed 
at rest. It is therefore conceivable that CPO may be influenced by the time of day at 
which it is measured. If such a pattern does exist, the implications on the measurement 
of CPO would be considerable. For example, in cross-sectional studies measurements of 
CPO would need to be standardised according to the optimal time of day. In practical 
terms this would be limiting, with fewer subjects tested each day. Therefore, before 
investigating how ageing effects CPO, it was necessary to ascertain whether a circadian 
pattern exists for CPO. 
For this purpose nine male subjects, with a mean age of 22 ± 1.1 years, performed the 
CPO protocol on two separate occasions, at 04: 30 (morning) and 16: 30 (afternoon) 
hours. These times reflected the points at which resting core temperature reaches its 
nadir and peak (Refinetti and Menaker, 1992; Reilly el aL, 1997). The only change from 
the protocol was that the ý102, ax test was performed a week prior to the start of the 
experiment, to obtain the subjects maximal exercising limits. 
Past research has identified that many biological functions follow a circadian pattern, 
similar to that of the fluctuations in resting core temperature (Reilly et al., 1997). In the 
present study, although not significantly different, core temperature, measured via rectal 
temperature, was lower (37.2'C) in the morning than in the afternoon (37.511C), under 
resting conditions. In addition, no significant differences were measured in core 
temperature attained at maximal exercise between the morning and afternoon. In 
contrast, significant (P<0.001) increases in core temperature were measured when 
comparing resting to maximal exercise, whether undertaken in the morning (37.60C) or 
afternoon (37.9*C) trial. 
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When examining the resting haemodynamic data for CPO, CO and MAP, no significant 
differences were measured in relation to morning or afternoon sessions (Table 3.1). 
Similarly, no differences were established for the same variables when measured at 
maximal exercise (Table 3.1). As expected from these findings, the component parts of 
CO and MAP, i. e. SV, HR, SBP and DBP, were also unaffected by the time of day 
whether they were measured at rest or at maximal exercise (Table 3.1). 
To be absolutely sure that trends relating to the time of day were not obscured by 
averaging these data from the nine subjects, measurements for CPO (Figure 3.1), CO 
(Figure 3.2) and MAP (Figure 3.3) were examined within each individual subject. No 
consistent trends were evident when comparing the data obtained in the morning or 
afternoon trials. 
The lack of significant changes determined between morning and afternoon trials for 
CPO.. were also evident in the measurement of maximal oxygen consumption (ýF02 
,, a,, ). The values attained in the morning 
(46.1 ± 1.8 ml/min/kg) and afternoon (45.0 ± 
1.7 ml/min/kg) trials were not significantly different from each other. Furthermore, 
these values were not different from the initial ýrObnu (45.1 ± 1.2 ml/min/kg) test 
performed a week prior to the start of the investigation. This also confirmed that all 
subjects exercised at their maximum when CPOn. was measured. 
Collectively, these results indicate that CPO is not affected by the time of day at which 
it was measured. Therefore, CPO can be measured accurately and the results collected, 
at different times of day, from various subjects in cross-sectional studies averaged with 
confidence. 
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Table 3.1. The measurement of resting and maximal cardiac power and its component 
parts, during morning and afternoon trials. 
Time of Day 
Moming Aftemoon e 
Heart Rate (b/m) 
At Rest 65 ± 3.3 66 ± 3.1 0.65 
At Maximal Exercise 187 2.5 188 2.9 0.57 
Stroke Volume (ml) 
At Rest 79.6 4.8 84.8 3.0 0.16 
At Maximal Exercise 121.0 ± 6.9 120.1 5.6 0.72 
Cardiac Output (1/min) 
At Rest 5.1 ± 0.3 5.6 ± 0.3 0.26 
At Maximal Exercise 22.6 ± 1.1 0.9 0.83 
Systolic Pressure (mm Hg) 
At Rest 117.2 ± 3.0 118.7 ± 2.3 0.58 
At Maximal Exercise 191.0 ±4.4 192.1 ± 5.2 0.70 
Diastolic Pressure (mm Hg) 
At Rest 74.6 ± 2.1 69.8 ± 2.3 0.06 
At Maximal Exercise 58.6 ± 2.5 56.8 ±2.1 0.51 
Mean Arterial Pressure (mm Hg) 
At Rest 92.1 ± 2.0 89.9 ± 1.4 0.49 
At Maximal Exercise 111.2 ± 2.5 118.2 ± 3.0 0.21 
Cardiac Power Output (Watts) 
At Rest 1.0 ± 0.1 1.1 ± 0.1 0.42 
At Maximal Exercise 5.6 ± 0.3 5.7 ± 0.3 0.74 
Cardiac Reserve (Watts) 4.6 ± 0.3 4.6 ± 0.3 0.93 
Data presented as mean ± SEM, for n=9. Morning measures were taken between 
04: 15 and 05: 30, with afternoon measurements taken between 16: 15 and 17: 30. The 
morning and afternoon sessions were separated by at least two days to prevent any 
fatigue and tiredness. 
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Figure 3.1. Cardiac power output (CPO) of individual subjects. 
Measurements were taken at rest (A) and at maximal exercise (B), during the morning 
(N) and afternoon (E) trials. 
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Figure 3.2. Cardiac output (CO) for individual subjects. 
Measurements were made at rest (A) and at maximal exercise (B), during the 
morning (N) and afternoon (0) trials. 
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Measurements were taken at rest (A) and at maximal exercise (B), during the 
morning (0) and afternoon (E) trials. 
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3.2. The influence of body size on the measurement of cardiac 
power output 
Past research has reported significant sex-related differences in a number of 
physiological variables. For example, when expressed in absolute terms maximal 
oxygen consumption (ý702,1,.; Figure 3.4A), cardiac output (COnax), and stroke volume 
(SV, na,, ), are generally higher 
in men compared to women (Lakatta, 1993; Ogawa et aL, 
1992). Consequently, such data are often expressed relative to a variable of body size. 
Normalising V02ma,, data relative to body mass is a common procedure using the linear 
regression standards (RES) approach. However, scaling to fat free mass (FFM) can 
further improve the precision of the measurement because of its ability to take into 
account the metabolically active tissue (Toth et aL, 1994). As can be seen in Figure 
3.4B, once V02max values were expressed relative to FFM the sex differences were 
reduced. Although, such normalisation reduces the differences between the sexes, 
significant (P<0.001) differences often still remain (Figure 3.4B). However, when such 
data were expressed relative to FFM using the allometric scaling approach (Figure 
3.4C), the differences between the sexes were further reduced compared to the RES 
model. Nevertheless a significant (P<0.01) difference still remained. 
In addition to significant sex-related differences for ý702. ax, resting and maximal 
measures of CPO, CO and SV (Table 3.2) were also found to be significantly (P<0.05) 
different. However, on average men had a larger body mass (BM), fat free mass (FFM), 
body surface area (BSA) and were taller, compared to the women by 24%, 28%, 15% 
and 7%, respectively. Therefore, the relationships between CPO and body dimensions 
were examined. 
Initially, the relationships between body size and variables of CPO, for male and female 
data combined, were investigated. The results revealed highly significant (P<0.01) 
positive Pearson's correlations (r) with all variables of CPO and body dimensions 
(Table 3.3). However, FFM presented the strongest correlations, with CPOCt (r = 0.52), 
CPO,,,. (r = 0.75) and CR (r = 0.7 1), compared to the other body dimensions. 
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Table 3.2. Sex-related differences in resting and maximal haemodynamics and variables 
of body size. 
Variables Males 
(n = 88) 
Females 
(n = 103) 
% difference of 
women relative 
to men 
Age (years) 45.4 ± 1.8 44.3 ± 1.4 -2 
BM (kg) 81.5 ± 1.1 66.9 ± 1.0 -18* 
Height (cm) 175.9 +-0.7 164.0 :h0.6 -7* 
BSA (m 2) 2.0 ± 0.02 1.7 ± 0.01 -15* 
FFM (kg) 59.6 ± 0.7 43.0 ± 0.5 -28* 
CO,,, t (1/min) 4.8 ± 0.1 3.8 ± 0.1 -21** 
COrnax (1/min) 19.6 d: 0.3 15.1 ± 0.2 -23** 
sv. ýt (ml) 74.0 1.9 57.5 ± 1.4 -22** 
SVynax (MI) 114.2 1.6 88.9 ± 1.3 -22** 
CPO,, t (W) 1.0 ± 0.02 0.8 ± 0.02 -20* 
CPOmax 5.3 +-0.09 4.0 ± 0.06 -25* 
CR (W) 4.3 ± 0.08 3.2 10.06 -26* 
Data are expressed as mean ± SEM for n= 191. Significant difference between the two 
sexes, at *P< 0.05 and **P< 0.001. 
Table 3.3. Direct comparisons of the correlation coefficients for all relationships 
between cardiac power and body size. 
cpo'ýt CPO,,, CR 
Body Mass 0.43* 0.59* 0.55* 
Height 0.41 0.61* 0.58* 
Body surface area 0.46* 0.65* 0.61 
Fat free mass 0.52* 0.75* 0.71 
Significant Pearson's correlations at *P<0.01. Male and female data are pooled 
together; n= 191. 
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These sex-related differences in body size and the associated highly significant 
correlations with CPO highlight the importance of scaling to provide meaningful 
comparisons independent of body-size. 
3.2.1. Scaling models 
The correct scaling model needs to be identified prior to determining which variable of 
body size should be used for scaling. This is to avoid the wrong scaling model being 
adopted thus leading to potential errors. This is highlighted below. 
To determine if the ratio standard (RS) model correctly partitions out the influence of 
body size, linearity checks were performed. The special circumstance for RS 
normalisation of linearity and zero intercept was not satisfied for variables of CPO 
relative to body mass (BM), height (HT), body surface area (BSA) or fat free mass 
(FFM), as the ratio of the coefficient of variation (CVx/CVy) did not equal the 
correlation coefficient (rX, 1) (Table 3.4). In some circumstances the differences 
between CVx/CVy and rXY were as great as 0.37. However, a close similarity 
between the ratio of CV and r was noted between BSA and CPO,,, t as the difference 
between the values were equal to 0.05 (i. e. 0.46-0.41; Table 3.4). Therefore, except for 
CPO,,, t correlated to BSA, the use of the RS method for scaling CPO would distort the 
data in this study. This would probably lead to erroneous interpretations of these data. 
Compared to the ratio standards (RS) approach, the linear regression standards (RES) 
scaling model improved the fit to these data and resulted in reductions in the residual 
error around the regression lines (Figures 3.5-3.7). However, positive intercepts were 
common in the RES model, as illustrated in Figure 3.5A. This suggests that for zero BM 
a resting CPO value of 0.36 W exists. Clearly, this is physiologically impossible. in 
contrast, Figures 3.5B-3.5C presented negative intercepts. Therefore extension of these 
regression lines should be avoided. The discrepancy between the RES line of best fit 
and the RS line of fit are highlighted in Figures 3.5-3.7. The occurrence of positive and 
negative intercepts further illustrates that the assumption of the RS model, with a zero 
intercept on the y-axis, has been violated. In addition, significant (P<0.05) correlations 
were calculated between the absolute residuals and the independent variables for all of 
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Table 3.4. Direct comparisons of the correlation coefficient (r) and the ratio of 
coefficient of variation (CV) data (rX, Y: CVx/CVy). 
CPo"t CPO,,, CR 
Cv r Cv r Cv r 
Body Mass 0.71 0.43 0.80 0.59 0.72 0.55 
Height 0.21 0.41 0.24 0.61 0.21 0.58 
Body surface area 0.41 0.46 0.46 0.65 0.42 0.61 
Fat free mass 1 0.84 1 0.52 1 0.94 1 0.75 0.64 0.71 
Ratios are shown in bold if the difference between the values are : 5D. 05. Based on 
same data (n = 19 1) as Table 3.3. 
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Figure 3.5. The relationship of resting cardiac power output to variables of body 
dimensions. 
The variables of body dimensions are (A) body mass (BM), (B) height (I-IT), (C) body 
surface area (BSA) and (D) fat free mass (FFM) for all male and female data combined 
(n = 191). Superimposed on the figures are the dashed line (y = bx) with zero intercept 
and the solid lines of best fit (y =a+ bx + c), representing the ratio standard (RS) and 
linear regression standards (RES) scaling models, respectively. 
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the RES model relationship analysed. This indicated that the error around the regression 
line was not constant, and therefore the assumption of homoscedasticity had not been 
satisfied. Rather the error around the regression line increased as the independent 
variable increased (i. e. heteroscedasticity). This is an important assumption of the RES 
model, and consequently this model should not be used for the scaling of CPO. 
Due to the general inadequacies of the RS and RES approaches to scaling, the log-linear 
allometric scaling approach was examined. Kolmogorov-Smimov one-sample tests 
revealed that the log-transformed dependent and independent variables, together with 
the allometric model residuals, were normally distributed. In addition, no significant 
correlations were identified between the absolute residuals and the predictor variable 
(logs FFM, log BM and log BSA). The absence of correlations between residuals from 
the log-linear ANCOVA confirmed the appropriate fit provided by the allometric 
model. 
ANCOVA analysis to determine commonality of slopes produced non-significant sex. 
interaction terms for all body-size-CPO relationships, except those involving HT. That 
is the slopes of the regression lines for male and female data were similar (apart for HT) 
and therefore quantitatively the same, thereby allowing common exponents to be 
calculated for both sexes. However, the exponents will change depending on the 
variables used (Table 3.5). This would allow direct group comparisons to be made. 
However, because the ANCOVA results indicated that the relationship of CPO and HT 
were quantitatively different when comparing male and female data (i. e. a significant 
sex interaction term was established), different male and female exponents would be 
required. These individual exponents would preclude intergroup comparisons to be 
made; therefore HT was excluded from further data analysis. 
By using the following equation [(CPO/BMb) / BM = zero], it was possible to check 
whether the allometric models produced dimensionless physiological variables. The 
scaling of cardiac power to FFMb resulted in non-significant Pearson's correlations 
(Figure 3.8). Conversely, significant (P<0.01) correlations remained when CPO was 
scaled to either BMb or BSAb. However, when men and women were analysed 
separately (but with the same exponent b) non-significant correlations were calculated 
for all variables of CPO relative to body dimensions (Table 3.6). In addition, 
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Table 3.5. Common group allometric exponents b, for describing the relationships 
between variables of cardiac power and body dimensions. 
CPO'e't CPO. "", CR 
0.33 ± 0.11 0.41 ± 0.08 0.44 ± 0.10 
Body mass 
(0.11-0.54) (0.25-0.57) (0.25-0.62) 
0.60 ± 0.21 0.81 ± 0.15 0.87 ± 0.18 
Body surface area 
(0.20-1.01) (0.52-1.10) (0.53-1.22) 
0.47 ± 0.13 0.71 ± 0.09 0.79 ± 0.11 
Fat free mass 
(0.22-0.73) (0.53-0.89) (0.57-1.00) 
Data are presented as mean exponents b± SEM, with 95% confidence intervals in 
parenthesis for combined male and female data. 
Table 3.6. Pearson's correlation check for the normalisation of cardiac power to 
variables of body dimensions for men and women. 
CPO scaled to the appropriate b exponent for body size 
CPOI't CPO,,, CR 
Male Female Male Female Male Female 
Body mass 
-0.13 0.09 -0.08 0.03 -0.05 0.02 
Body surface area 
-0.09 0. -0.07 0.05 -0.06 0.03 
Fat free mass 
-0: 05 -0.01 -0.01 -0.02 1 -0.01 -0.02 
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examination of the model residuals revealed no size related distributional pattern, 
indicating that the log-linear model was correctly specified, with the residuals randomly 
scattered about zero. Therefore, scaling of CPO to BMb, BSAb or FFMb produced size 
independent values. 
The lines of best fit obtained using the allometric equation can now be re-examined and 
compared to the RES model. Using the allometric model the lines of best fit pass 
through the origin (Figure 3.9), whereas negative intercepts on the y-axis were obtained 
for the RES model (Figure 3.5-3.7). 
In summary, the use of the RS and RES models of scaling, failed to provide 
dimensionless physiological variables and therefore were dismissed. Conversely, the 
allometric scaling model provided completely dimensionless physiological variables. 
Therefore, this model will be used to examine intcr-and intra-group differences for CPO 
and other haemodynamic variables. However, the optimal scaling variable (i. e. BM, 
BSA or FFM) to be used in the allometric model must be established prior to 
examination of these data. 
3.2.2. Scaling variables 
As mentioned above, all allometric models were successful in providing dimensionless 
size exponents. Therefore, BMý, BSAý, and FFMb may now be used to scale CPO. The 
common b exponents for the variables of CPO and body size are presented in Table 3.7. 
This process allowed the comparisons of data from intra-or inter-groups to be made. 
When examining the strength of the b exponents, scaling to FFMb gave the highest Rý, 
lowest root-mean-squares error and the width of the confidence intervals (CI) were 
relatively narrow for all variables of CPO. By comparison the use of either BMb or 
BSAb was less precise (Table 3.7). 
The sex-related differences for CPO (Table 3.2) were re-analysed by scaling CPO to 
either BM5, BSAb or FFMb to provide data that were body size-independent (Table 3.8). 
For all values of CPO, highly significant (P<0.001) sex-related differences remained 
once scaled for BW or BSAb (Table 3.8). Furthermore, significant (P<0.05) differences 
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Table 3.7. Body dimension exponents derived from log-linear allometric models. 
Size variable 
W 
b exponent 
(95% CD 
log a 
(Female) 
log a 
_jMale) 
Model 
Rý 
Model 
RMSE 
P-value of 
size exponew 
CPOI. t 
BM 0.33 (0.11-0.54) 0.201 0.239 0.278 0.043 0.001 
BSA 0.60 (0.20-1.01) 0.566 0.664 0.277 0.043 0.001 
FFM 0.47 (0.22-0.73) 0.143 0.134 0.275 0.040 0.001 
CPO,,,, 
BM 0.41 (0.25-0.57) 0.714 0.872 0.504 0.023 0.001 
BSA 0.81 (0.52 1.10) 2.532 3.013 0.513 0.022 0.001 
FFM 0.71 (0.53-0.89) 0.272 0.285 0.567 0.020 0.001 
CR 
BM 0.44 (0.25-0.62) 0.505 0.620 0.435 0.032 0.001 
BSA 0.87 (0.53-1.22) 1.946 2.319 0.445 0.032 0.001 
FFM 0.79 (0.57-1.00) , 0.164 1 0.170 1 0.501 . 
0.030 0.001 
95% confidence intervals shown in parenthesis. 
72 
Results 
Table 3.8. Sex-related comparisons of cardiac power output once normalised. 
Males Females 
% difference of 
women relative 
To men 
Age (years) 45.4 ± 1.8 44.3 ± 1.4 -2 
Absolute data 
CPOrest (W) 1.0 ± 0.02 8.0 ± 0.02 -20* 
Cp0m. (W) 5.3 ± 0.09 4.0 ± 0.06 -25* 
CR (W) 4.3 ± 0.08 3.2 d: 0.06 -26* 
CPO scaled to BMb 
CPOrest (W/kg BM 0.33) 0.24 ± 0.01 0.21 ± 0.01 -13** 
CPOm. (W/kg BM 0.41) 0.88 ± 0.01 0.72 ± 0.01 -18** 
CR (W/kg BM 0'44) 0.63 ± 0.01 0.51 ± 0.01 -19** 
CPO scaled to BSAb 
CPO,, t(WW BSA 
0.60) 0.7 d: 0.01 0.6 :h0.0 1 -14** 
CPOmax (W/m' BSA 0.8 1) 3.1 ± 0.05 2.6+-0.04 -16** 
CR (W/m 2 BSA 0,87) 2.4 ± 0.04 2.0: b 0.03 -17** 
CPO scaled to FFMb 
CPO, ý, t (W/kg FFM 
0.47) 0.15 ± 0.003 0.14 d: 0.003 -7* 
CPOm. (W/kg FFM 0*71) 0.29: h O. OL4 0.27 ± 0.004 0* -7* 
CR (W/kg FFM 0,79) 0.17: LO. 003 0.17±0.003 0 
71 
Data are expressed as means ± SEM for n= 191. Significant difference between the two 
sexes, at *P< 0.05 and **P< 0.001 
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remained once CPO .. t (7%) and CPOinax (7%) were scaled to FFMb, with males 
presenting with higher values compared to females. Nevertheless, the percentage 
differences for CPO,. e, t and CPOinax between sexes were considerably reduced (i. e. 
previously 22% and 25%, respectively). Non-significant differences were obtained 
between the sexes for values of CR when scaled to FFMb. 
These results highlight the importance of scaling CPO while using the appropriate 
scaling model and body dimension. Therefore, the evaluation of the age, sex and 
fitness-related changes in CPO (section 3.3) will be examined relative to FFMb . 
Similarly, other haemodynamic variables, i. e. CO and SV, will also be examined in this 
way. 
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3.3. Age-related changes in overall cardiac function 
Past research examining the relationship between ageing and cardiac function has 
tended to either neglect the measurement of the overall functional capacity of the heart 
or have failed to take into account the confounding influences of body size, 
cardiovascular disease and/or fitness levels of the subjects. The following studies 
examine the age-related changes in overall cardiac function by measuring both the 
pressure and flow generating capacities of the heart, both at rest and at maximal 
exercise. In an attempt to remove the confounding influence of cardiovascular diseases, 
only healthy men and women were selected for these studies. In addition, subjects were 
separated into specific fitness groups (sedentary, active and endurance trained athletes). 
Furthermore, the influences of body size on measures of cardiac function were also 
accounted for. 
3.3.1. The changes in body composition and cardiacfunction due to age in 
sedentary men and women 
To examine the age-and sex-related effects on CPO, sixty men and eighty-nine women, 
who were healthy and sedentary were investigated. The female subjects consisted of 
fifty-two pre-menopausal, thirty-two post-menopausal, and five peri-menopausal 
women. 'Me pre-menopausal women consisted of a variety of pill and non-pill users. 
Furthermore, the post-menopausal women consisted of a variety of women who were 
taking hormone replacement therapy and those who were not. 
Body Composition 
Between 20 and 75 years of age, the sedentary men had significantly (P<0.001) 23% 
greater body mass (BM) and 37% greater fat ftee mass (FFM) values compared to 
sedentary women (Figures 3.10A and 3.10B). Fat mass (FM) was found to be similar 
between men and women (Figure 3.10C). However, the percentage of body fat was 
found to be significantly (P<0.001) greater (32%) in the sedentary women compared to 
their male equivalents (Figure 3.1 OD), this being attributed to a greater BM in the men. 
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Figure 3.10. Changes in body composition in relation to age and sex. 
(A) Body mass (BM), (B) fat free mass (FFM), (C) fat mass (FM) and (D) the percentage of body 
fat (fat) are shown for 60 sedentary men (0) and 89 women (0). The lines of best fit for men 
(-) and women (-) are shown. The same subjects were used for all subsequent figures. 
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Examination of the body compositional changes in association with increasing age 
indicated that BM (Figure 3.1 OA) did not change in both men and women. Furthermore, 
a non-significant decline of 6 to 7% in FFM was found with increasing age (Figure 
3.10B). Due to the scatter of these data, FM was not found to be significantly different 
(Figure 3.10C) with age in either sex, despite a 21% increase. However, significant 
(P<0.05) increases in the percentage of fat were found in both men (20%) and women 
(22%), with age (Figure 3.1 OD). 
(B) Resting cardiac power output and Its component parts 
Male subjects consistently had a significantly (P<0.001) greater (19%) resting cardiac 
function (CPO ... t) than the sedentary women. In addition, a gradual decrease (P<0.05) in 
CPO,,, t with increasing age was experienced in both male (r = -0.32) and female (r -- 
0.24) subjects (Figure 3.1 IA). By testing for parallelism of the regression lines, it was 
found that the slope of the age-related changes in CPO,,, t were slightly greater in the 
sedentary men (19%) than the women (17%). However, once CPO,,, t was normalised to 
FFMb (CPie, t) to provide dimensionless values, the differences between men and 
women were removed (Figure 3.11B). Furthermore, the age-relatcd decline in resting 
cardiac function was also removed once expressed as CPi,. t. 
The greater CPO,,., t in the sedentary men was due to a consistently 21% largcr 
(P<0.001) CO,, t than women (Figure 3.12A). Even when expressed rclativc to FFMb 
(Ci,, g) the significant sex-related difference remained (3.1213). The decline in CPO,,. I. 
with age, was attributed to significant (P<0.001) decreases in CO,,, t in both men (26%; r 
=-0.55) and women (27%; r= -0.45). Despite similar percentage decrcascs bctwccn 20 
to 75 years in men and women, analysis of the slopes of the regression lines indicatcd 
that the decline in COrst was greater in the sedentary men than women (Figure 3.12A). 
Furthermore this age-related decline in CO,. t was still evident once scaled for FFMb 
(Figure 3.1213). 
Upon attempting to explain the sex-and age-related differences in CO,. t, its component 
parts were examined i. e. SV and HR. The sex-related differences in CO,,, St were 
attributed to significantly (P<0.0 1) 23% greater resting stroke volumes (SV,,, t) 
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in men than women (Figure 3.13A). However, once scaled to FFMb this sex-difference 
was lost (Figure 3.13B). The age-related decline in CO,, st was due to a significant 
(P<0.001) decline in SVeq in both men (24%; r= -0.44) and women (22%; r= -0.28) 
(Figure 3.13A). This age-related decline was also evident when SV,,, t was scaled for 
FFMb (P<0.01) and therefore contributed to the decline in Ci.,,, t. Resting HR did not 
change significantly over the age-range and therefore did not contribute to the decline in 
CO, eg. Furthermore, no sex-related differences in HR,,, t were measured (Figure 3.13C). 
Despite the age-related decline in the heart's ability to generate blood flow, the heart 
also acts as a pressure generator. The observed age-related decline in CP0, eg occurred 
despite a significant (P<0.01) increase in MAP,,, t (Figure 3.14A) in both sedentary men 
(r = 0.39) and women (r = 0.51). Both sexes had similar increases (16%) in pressure 
with age (Figure 3.14A). Indeed, the changes in MAP,,, t were not significantly different 
between men and women. When analysed in more detail, the age-related increases in 
MAP,,, t in women resulted from significant (P<0.01) increases in resting SBP (22%; r= 
0.62) and DBP (10%; r=0.36) (Figures 3.14B and 3.14C). In contrast in men a 
significant (P<0.01) increase in SBP,,, t (13%; r=0.46) together with a smaller (7%) 
non-significant increase in DBP,,, t contributed to the increase in MAP"g. Despite these 
increases in resting blood pressure, no significant differences were measured between 
the sexes. 
in summary, the significant age-related decreases in resting cardiac function (CPO,,, t) in 
sedentary men and women were due to significant declines in CO,,, t. Ilis was despite 
significant increases in MAP., g. However, when CPO was adjusted to FFMb the age- 
and sex-related differences in resting cardiac function were removed. 
(C) Changes in resting systemic vascular resistance (SVR) with age and the 
differences between men and women. 
Systemic vascular resistance, a surrogate of pump afterload, has an important role in 
influencing the performance of the heart. Age for age, the sedentary men had 
significantly (P<0.001) lower (-18%) resting SVR values compared to the women 
(Figure 3.15A). Both sexes experienced significant (P<0.01) increases in SVR,,, with 
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age, however the sedentary women expressed a greater rate of change (65%) compared 
to men (57%). Once expressed relative to FFMb the differences between the sexes were 
still evident as were the age-related increases in SVRi,, st (Figure 3.15B). 
(D) Cardiac power output and its component parts when measured at maximal 
exercise 
Maximal CPO is a better measure of maximal functional capacity than 'ýo2..,,.,, as it 
defines the maximal pumping capacity of the heart. Also, CPO,,, t only represents a 
fraction (approximately 20%) of the total capacity of the heart. Any changes that occur 
in CPOmax can have pronounced affects on daily living. Age for age, the sedentary men 
had a significantly (P<0.001) -23% greater CPO.. compared to women (Figure 
3.16A). A significant decline in cardiac function was also evident during maximal 
exercise. That is, CPO,,, a,, declined by 18% and 12% between 20 to 75 years in men (r = 
-0.52) and women (r = -0.23), respectively. The age-related rate of decline was greater 
in men. 
In men, this age-related decline in CPOma,, resulted in a significant (P<0.001) 18% 
decline (r = -0.45) in cardiac reserve (CR). This was smaller in women, with a non- 
significant 10% decline (r = -0.17) measured in CR with age (Figure 3.17A). 
Consequently, age for age significant (P<0.001) sex-related differences were observed 
in CR. 
The importance of scaling for FFMb, as demonstrated in resting cardiac function, was 
also evident for the measurements made at maximal exercise. The significant (P<0.001) 
age-related decreases in CPOma., and CR were still evident once expressed relative to 
FFMb in the male subjects. That is, from 20 to 75 years of age the sedentary men 
demonstrated a 15% decline in both CPi.. (r = -0.44) and CRi (r = -0.35). In contrast, 
despite a decrease of 8% in CPi,,,. in the sedentary women with age, no significant 
differences were found. In addition, no age-related decline in CRi was found for 
women. Normalisation of CPO.. and CR for FFMb removed the significant sex-related 
differences (Figure 3.16B and 3.17B). 
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These changes in Mm, were explained by examining the age-related changes in CO 
and MAP. Age for age, sedentary men had a significantly (P<0.001) 22% greater 
CO, n., compared to women. Significant (P<0.001) age-related 
decrease (25%) in CO",.. ' 
contributed to the decline in CPOn. in men (r = -0.65) and women (r = -0.58; Figure 
3.18A). Analysis of the slopes of the regression lines identified that men had a steeper 
age-related decline in CO. ý, compared to the women. These sex-and age-related 
differences were still evident once normalised for FFMb (Figure 3.18B). But while still 
significant (P<0.05), the differences in COn. between the sexes were dramatically 
reduced once expressed as Ci.. 
The progressive decline in CO,,,. with age was attributed in part to significant 
(P<0.001) and substantial decreases in HR,,,., (Figure 3.19A) for both men (21%; r=- 
0.87) and women (19%; r= -0.64). Age for age, HR,,,. were very similar and not 
significantly different between men and women, and a similar rate of decline was 
evident with age (Figure 3.19A). In contrast, SV,,. was significantly (P<0.05) greater in 
men compared to women, but in both sexes, age-related changes in SV,,,. were only 
small and not significant (Figure 3.1913). No differences were found in SV,,.,, between 
men and women once normalised for FFMý, and no age-related changes in SVi.. were 
evident (Figure 3.19C). 
In terms of the heart's pressure generating capacity, no significant differences were 
measured in MAP at maximal exercise between men and women (Figure 3.20A). 
However, the sedentary men had significantly (P<0.05) greater SBPn.,, and lower 
DBI`n, ýý compared to the women (Figures 3.2013 and 3.20C). Unlike the fall in flow 
generation (COm. ), MAPmax significantly (P<0.001) increased with age in both men 
(19%; r=0.39) and women (18%; r=0.45). Analysis of the slopes of the regression 
lines indicated that both sexes increased their MAP,, a,, at similar rates with age (Figure 
3.20A). Significant (P<0.01) 36% and 56% increases in DBP,,. contributed to the 
increases in MAP.., in both men (r = 0.58) and women (r = 0.66) respectively, while 
SBPm,, remained relatively constant with age (Figure 3.20B). 
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In summary, healthy ageing in sedentary men and women were associated with 
significant decreases in CPO.. est and CPOm.. However, when normalised for FFMb the 
age-related decreases in CPOm, and CPOn,. disappeared in women. Also, once 
expressed relative to FFMb the previously significant differences in CPO ... and CR 
between men and women were abolished. 
(E) Changes In systemic vascular resistance during maximal exercise In relation 
to age and sex 
As was also evident at rest, age for age, men had significantly (P<0.001) 16 to 23% 
lower SVR values at maximal exercise, compared to the women (Figure 3.21A). 
However, these differences were no longer significant when expressed as SVRi,. 
(Figure 3.21B). Maximal SVR increased (P<0.001) with age in both sexes (Figure 
3.21A), with the rate of change greater in the women compared to men. These increases 
(P<0.01) in SVR.. with age were still evident when expressed as SVRi (Figure 3.21B). 
(F) The relationship between maximal cardiac power and systemic vascular 
resistance 
The relationship between systemic vascular resistance and CPO,,., in men and women 
have not been examined before. It is interesting to note that for any given Mmax, the 
sedentary men had a significantly (P<0.05) greater CPOn, ýx compared to women (Figure 
3.22A). 'Mis relationship was lost once both CPO,,,. and SVR,,,. were expressed 
relative to FFMb (Figure 3.22B). A strong inverse relationship was identified between 
SVRmax and CPO, ax. That is, an increase in SVRna,, resulted in a significant (P<0.001) 
decline in CPOn,. in both sexes (Figure 3.22A). This significant (P<0.05) inverse 
relationship remained even when scaled for FFMb (Figure 3.22B). 
In addition, a similar relationship was also identified of the pressure generating capacity 
of the heart. An increase in SVR.. resulted in significant (P<0.01) increases in MAP,,,. 
in both men (r = 0.73) and women (r = 0.75). However, for any given SVRm., the 
sedentary men had a significantly (P<0.01) greater MAPa, than women (Figure 
3.23A). Although reduced, this relationship was still evident even when SVR.,,, was 
expressed as SVRim, (Figure 3.2313). 
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3.3.2. The effects of training status on the measurement of cardiacfunction 
in men 
Endurance training has been shown to have beneficial responses on a number of 
cardiovascular variables, e. g. improved V02ma,, COm., SVma, etc, in both young and 
older individuals (Ogawa et aL, 1992). Furthermore, those who are physical active 
generally enjoy better health and quality of life, compared to inactive individuals. The 
following study compares the age-and fitness-related changes in CPO in healthy 
sedentary and active men. The sedentary men, who acted as control subjects for the 
active men (n = 60; range 19-72 years), were the same subjects as described in section 
3.3.1. 
(A) Body composition 
The more active individuals had significantly (P<0.001) lower BM (Figure 3.24A), FM 
(Figure 3.24C) and percentage of fat (Figure 3.24D), compared to their age-matched 
sedentary controls. Both groups did however have similar values of FFM (Figure 
3.24B). With increasing age, the active men demonstrated a significant (P<0.05) decline 
in BM (Figure 3.24A) and FFM (Figure 3.24B). In contrast no such decreases were 
found in their sedentary counterparts. For both active and sedentary men significant 
(P<0.01) age-related increases in the percentage of body fat were measured (Figure 
3.24D). 
(B) The changes in maximal oxygen consumption (ý702maz ) due to ritness and age 
Maximal oxygen consumption is often used as a marker of the functional capacity of the 
cardiovascular system and as such has been used as an indirect indicator of cardiac 
function (Tan et aL, 1997). Furthermore, values Of 'ý02=, are often used to identify 
how physically fit individuals are. It is clear to see that, age for age, the active men had 
significantly (P<0.001) greater 'ý02max values than their sedentary counterparts (Figures 
3.25A and 3.25B), both in absolute terms (19 to 26%) and relative to FFMý (12 to 36%). 
Therefore, it is conceivable that these fitter individuals would have a better cardiac 
function than their sedentary counterparts. 
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Irrespective of the levels of fitness, the sedentary and active men experienced similar 
rates of decline in Vo2ma., with age, with values of 38 and 41%, respectively. When 
V02max values were adjusted for FFMb, the age-related decreases in V02max values were 
still evident (Figure 3.2513). However the rate of decline was greater in the sedentary 
men after being expressed relative to FFMb. 
Maximal oxygen uptake is the product of maximal CO and maximal a-v 02 difference 
and can therefore be affected by changes in either central and/or peripheral adaptations 
to exercise training. In the active men, significantly (P<0.001) greater COn-ax values 
contributed to their greater ý102max values (Figure 3.26A). However, in the active group 
no significant differences were found, with age, for maximal a-v 02 difference. This can 
mainly be explained by the wide scatter of the data points (Figure 3.26B). Whether 
sedentary or active, the decline in 'ý02tnax with age was mainly attributed to a significant 
(P<0.001) -30% decline in CO.. (Figure 3.26A). However, a significant (P<0.001) 
age-related decline in maximal a-v 02 difference in the sedentary men (22%; r= -0.69) 
but not active men, also contributed to the decline in V02max. Therefore, in both groups 
the predominant changes in central adaptations were the main explanation for the age- 
related decline in maximal cardiovascular function. 
Of interest, the sedentary women had a similar decline in V02", ax to men. However 
women had lower absolute values for V02, a,, CO.., and maximal a-v 02 difference. 
Once again the age-related changes in the sedentary women were mainly due to central 
changes, with a 25% decrease in CO.. compared to only an 11% decrease in maximal 
a-v 02 difference. 
(C) Lifestyle effects on resting cardiac power output and its component parts 
No significant differences in resting cardiac function were found between the sedentary 
or active men, whether expressed in absolute terms (CPO,. t; Figure 3.27A) or relative 
to FFMb (CPi,,, t; Figure 3.27B). As already indicated CPO,. t decreased with age in both 
sedentary and active men (r = -0.40). By testing the regression lines for parallelism, it 
was found that while the slopes of the changes in CPOr,, t (± adjusted for FFM) with age 
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were slightly greater in the active men, no significant differences were obtained (Figure 
3.27B). 
During early adulthood, CO,. t was significantly (P<0.05) greater in the active men 
compared to their sedentary counterparts (Figure 3.28A). However, this difference was 
lost when expressed as Cierg (Figure 3.28B). Resting CO fell significantly (P<0.01) with 
age in both groups of men with a greater rate of decline in the active (37%) compared to 
the sedentary men (26%). Despite the lack of distinction in CPiest, significant (P<0.01) 
20% decreases in Ci,,, t were expressed, irrespective of fitness levels (Figure 3.2813). 
Although, no differences were measured in CO,,, t later in life, the benefits of an active 
lifestyle became apparent when viewed as changes in SV and HR. The active men had a 
significantly (P<0.001) -21% greater SV,,, st (Figure 3.29A) and 3 to 21% lower HP,,,, t 
(Figure 3.29C), compared to their sedentary counterparts. The differences in SV,,, t were 
still evident once normalised for FFMb (Figure 3.29B). The decline in CO. t was 
explained by significant (P<0.05) decreases in SVre, t in both sedentary (IS%; r= -0.44) 
and active (24%; r= -0.3 1) men, with the rate of decline significantly (P<0.00 1) greater 
in the active individuals. When expressed as SVi,,, t the age-related decline in SV was 
still evident for the sedentary men. However no change was found in their active 
counterparts (Figure 3.29B). An interesting area of difference was seen in the HR at 
rest. In the active men, a decrease in HReg (21%; r= -0.42) also contributed to the 
decline in COeg with age. In contrast, the HRrest of the sedentary men was not affected 
by age (Figure 3.29C). 
Considering the pressure generating capacity of the heart, near identical absolute values, 
and increases in MAP (Figure 3.30A), SBP (Figure 3.3013) and DBP (Figure 3.30C) 
were measured in both groups of men. 
In summary, similar age-related decreases in CP0, em were found in sedentary and active 
men. In both cases this was explained by age-related decreases in CO. 't, despite 
increases in MAP., t. After being normalised for FFMb these decreases in Ci,,, t remained 
similar with age. 
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Figure 3.28. The relationship between age and fitness in the measurement of 
resting blood flow. 
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Figure 3.29. The relationships between age and fitness in the measurements of 
resting stoke volume and heart rate. 
Stroke volume (A), stroke volume index (B), and heart rate (C) are plotted against 
age for sedentary (40) and active (A) men, with the lines of best fit for sedentary 
(-) and active (---) men. 
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Figure 3.30. The relationships between age and fitness on the measurements of 
resting blood pressure. 
Mean arterial pressure (A), systolic pressure (B) and diastolic pressure (C) for 
sedentary (0) and active (A) men, along with the lines of best fit Plotted against 
age for sedentary (-) and active (-) men are shown. 
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(D) Changes in resting systemic vascular resistance with age and fitness 
Resting SVR (or SVRi.,, t) was not significantly different between sedentary and active 
men (Figures 3.31). Similar age-related increases in SVRest were also evident in the 
sedentary and active men, even when expressed relative to FFMb (Figure 3.3 1 B). 
(E) Cardiac power output at maximal exercise 
Although changes in CPO were noted at rest, the most dramatic difference between an 
active and sedentary lifestyle might reasonably be expected when performing maximal 
exercise. Age for age, the greater 9021nax values attained in the active men suggests an 
improved cardiac function, compared to the sedentary men. Indeed, the active men had 
significantly (P<0.01) 11 to 30% greater CPOm. values compared to the sedentary men 
(Figure 3.32A). Even when expressed relative to FFMb, CPi, a,, was still greater in the 
more active men (Figure 3.31B). However, CPOmax (or CPi,,,. ) decreased significantly 
(P<0.0 1) in both groups (r = -0.60) as they aged (Figure 3.32). By testing for parallelism 
of the regression lines for CPOm. it was determined that the decline was significantly 
(P<0.0 1) greater in the active (3 0%) than in the sedentary (18%) men. 
As to be expected, age for age, the greater CPOmax in the active men resulted in an 18 to 
30% greater reserve capacity of the heart, compared to their sedentary controls (Figure 
3.33A). This was also true when expressed as CRi (Figure 3.33B). A consequence of 
the age-related decline in CPO.,,. was also reflected in a corresponding, significant 
(P<0.001) 18 to 30% decline in CR, in both groups (Figure 3.33A). 
As predicted, on an age for age basis, the active men had significantly (P<0.001) 10 to 
23% greater COm., values compared to their sedentary counterparts (Figure 3.34A). 
The changes that occurred in COm. (Figure 3.34A) with age essentially mimicked the 
changes that occurred in CPOmax, whereby significant (P<0.001) decreases in CO,,. 
occurred in both sedentary (25%; r= -0.65) and active (35%; r= -0.70) men. However, 
the active men had a greater rate of decline than their sedentary counterparts. Ile 
adjustment of COma, for FFMb did not change the interpretation of these data; maximal 
CO remained greater in the active men and the decreases in CO,,,,, with age were still 
evident for both groups when expressed as Cima,,. 
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In keeping with their larger CO,,,., (or Ci,,,. ) age for age, the active men possessed 
significantly (P<0.01) 12 to 24% greater SV,,, a., (or SVi,,,. ) values, compared to the 
sedentary men (Figures 3.35A and 3.3513). These reductions in COma,, with age were 
attributed to significant (P<0.05) decreases in HRnax (2 1 %; r= -0.79) and SV. a,, (18%; r 
= -0.39) in the active individuals. In contrast, for the sedentary men, significant 
(P<0.00 1) decreases in HR.,, ý, x (2 1 %; r= -0.87) were solely responsible for the decreases 
in CO. ax (Figure 3.35A). The age-related decline in SVna., in the active group was lost 
once scaled for FFMb (Figure 3.35B), as demonstrated by a non-significant 7% decline 
in SVi,,,. between 20 to 75 years of age. 
Clearly the hearts of the active men possessed better flow generating capacities. 
However what about their pressure generation? Increases in MAP,,,., as identified 
earlier in the sedentary men, were also evident in the active men. Maximal MAP 
increased (8%; r=0.29) significantly (P<0.05) with age. The increases in MAP,,. were 
almost identical in both groups (Figure 3.36A). In all men the increases in MAP ..... were 
attributed to very similar significant (P<0.001) increases in DBP,., while SBP", 
remained unchanged (Figure 3.36B). 
It can therefore be concluded that the more active men had greater absolute values for 
CR, CPO,., CO.,,., and SV.., compared to their age-matched sedentary counterparts 
even when expressed relative to FFNP. However, irrespective of fitness levels, Cjý, 
CpOm,,,, CO.., HR.., all decreased, while MAPm. increased with age. 
(F) Maximal changes in systemic vascular resistance with age and fitness 
Age for age, maximal pump afterload (SVR.. ) was significantly (P<0.01) 13 to 22% 
lower in the active men, compared to their sedentary counterparts (Figure 3.37A). As 
previously noted, the significant (P<0.001) increases in SVRn,,. with age in the 
sedentary men were also evident in the active men (Figure 3.37A). This age-related 
relationship remained evident even when expressed as SVRinax (Figure 3.37B), as did 
the differences (P<0.01) between sedentary and active men (Figure 3.37B). 
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(G) The relationship between maximal cardiac power and systemic vascular 
resistance 
When comparing the maximal pumping performance of the heart (CPOn) and the 
maximal pump afterload (SVRmax) between the sedentary and active men an interesting 
relationship was found. That is, for a given SVRna.,, CPOm. was significantly (P<0.05) 
greater in the active men (Figure 3.38A). However, both fitness groups expressed a 
significant (P<0.001) decline in CPO.. as SVR,,, x increased. Scaling of SVR,,. and 
CPO a,, for FFMb, did not change the interpretation of these data for active men (Figure 
3.38B). But now, no change in CPi.,,. was found in the sedentary men as Mi.., 
increased. 
A similar relationship was also identified between the pressure generating capacity of 
the heart and vascular resistance at maximal exercise. Both groups of men experienced 
increases in MAPmax as SVRm. increased. However active men possessed a 
significantly (P<0.01) greater MAPmax for any given SVRn., compared to the sedentary 
men (Figure 3.39A), indicating that the pressure generating capacity was at least in part 
independent of SVRma.. When scaled for FFM b, the positive relationships between 
SVRin,,, x and MAP.. remained significant (Figure 3.39B), but with the active men still 
presenting with greater pressure generating capacities. 
(H) Relationship between maximal pumping performance of the heart and 
oxygen consumption 
Research examining the relationship between COma,, and 'ý02ma,, has reported strong 
positive correlations between the two variables (Cooke et aL, 1998). This relationship 
was confirmed in the current study. That is, when the sedentary and active male data 
were pooled together a Pearson's correlation of 0.86 was obtained for relationship 
between CO.. (1/min) and ý102tnax (1/min; Figure 3.40A). This relationship was also 
evident in women (r = 0.80). Strong significantly (P<0.001) positive relationships 
between 902 max (1/min) and CPOmax were also evident (Figure 3.40C), in men (r = 0.80) 
and women (r = 0.58), despite significant (P<0.01) negative correlations between 
'ý02mn (1/min) and MAP.. in men (r = -0.3 1) and women (r = -0.25) (Figure 3.40B). 
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The variables presented are maximal systemic vascular resistance compared to 
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of best fit for the sedentary (-) and active men (-) are shown. 
115 
Results 
A 
0 
150 
A 0 
130 
AA 00 
CL 110 A -Ä"izww -- 
3 de 2A 
90 
200 
B 
130 
m All S 
150 
110 
A 
JLA A #OA 0 
.2 A 
60 
&A 
;- A- - 
n& AI! 
N 
0 
400 600 
SVRi .,,, (dyne. sec/cm 
6 
A 
800 
90 
700 5700 10700 15700 20700 25700 30700 
SVRi m,,, (dyne. sec/cm 
5/ kg b) 
Figure 3.39. Maximal systemic vascular resistance relative to maximal mean artcrial 
pressure in sedentary and active men. 
The variables plotted are for maximal systemic vascular resistance (A) and maximal 
systemic vascular resistance index (B), compared against maximal mean arterial 
pressure as measured in sedentary (0) and active (A) men. Lines of best fit flor the 
sedentary (-) and active men (--) are shown. 
0 
116 
Results 
40 
- 30 ' 
20 
10 
0 
180 
0 
00 
0 
00 
023456 
V02 M, x (1/rrin) 
B 
160 
x 
E 140 
E 
9 1120 
100 
80 
zim a Ibt t 
le 
am 0 
02345 
V02 
,, (1/min) 
C 
10 
8 
2 
2346 
V02 
max (1/rTin) 
Figure 3.40. Changes in maximal cardiac output, mean arterial pressure and cardiac 
power output relative to maximal oxygen uptake. 
The variables shown are (A) cardiac output, 
(B) mean arterial pressure, and (C) 
cardiac power output 
for active and sedentary men (0) and women A. The lines ot 
best fit are shown for men (- ) and women 
(-). Data corresponds to all fitness 
m 
0 
levels for men and women, n= 222.117 
Results 
3.3.3. Yhe influence oflong-term endurance training 
Because of the wide ranging and heterogeneous sample of ages and fitness levels of the 
subjects in the previous section (section 3.3.2), a more in-depth examination of the 
influence of long-term endurance training on CPO was undertaken. The purpose was to 
obtain more insight into the effects of high level of physical activity on ageing per se. 
Therefore, two groups of veteran endurance-trained, male subjects were examined 
strictly against age-matched sedentary controls. The veteran athletes consisted of 20 
long distance runners, and 1 long distance swimmer. On average the veteran athletes 
had been training for approximately 18 years with an average training distance of 32 
miles per week. 
(A) Body Composition 
Anthropometric data describing the effects of fitness on body composition are presented 
in Table 3.9. Veteran athletes (mean ages of 50 and 58 years) had significantly (P<0.05) 
lower BM, FM and percentage of body fat, compared to the age-matched sedentary 
men. No differences were found for FFM between the groups. 
(B) The effects of long-term endurance training on maximal oxygen 
consumption 
Maximal aerobic capacity has been shown to be significantly higher in endurance 
trained subjects, compared to their sedentary counterparts (Tanaka and Seals, 2003; 
Ogawa et A, 1992). This study confirms these reports. The 50 and 58 year-old veteran 
athletes had on average 34 to 44% greater (P<0.001) 9021nax values, whether expressed 
in either absolute terms or relative to FFMb, compared to the sedentary men (Table 
3.10). 
(C) Cardiac power output measured at rest 
No significant differences were found in any of the resting values, i. e. CPO"St, Core't, or 
MAP,, st between the veteran athletes and their age-matched controls (Table 3.11 and 
Figure 3.4 1 A). Although, SVRr, st was lower at 50 (10%) and 58 (16%) years, compared 
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Table 3.9. Anthropornetric characteristics of veteran endurance trained athletes and sedentary men. 
Ages of men (years) 
Veteran Athletes Sedentary 
50 ± 0.8 58 ± 0.7 21 ± 0.5 50 ± 0.8 60 ± 0.8 
Height (cm) 171.7 ± 2.3 172.8 ± 1.8 177.5 ± 2.5 175.9 ± 2.2 171.9 ± 1.4 
_ 
Body mass (kg) 73.2 ± 4.1 72.9 ± 2.6* 82.3 ± 3.3 85.0 ± 2.3 80.7 ± 2.3 
Body surface area (m) 1.8 ± 0.03 1.9 ± 0.04 2.0 ± 0.05 2.0 ± 0.03 1.9 ± 0.03 
Fat free mass (kg) 57.2 ± 2.5 57.4 ± 1.3 59.3 ± 1.8 59.7 ± 0.9 57.0± 1.4 
Fat mass (kg) 13.3 ± 1.8** 12.6 ± 1.8** 15.4 ± 1.1 22.5 ± 1.8++ 22.7: h 1.2++ 
Fat (%) 17.4 ± 1.5* , 16.8 ± 1.7** , 19.4 ± 1.0 25.9 d: 1.5+ 27.7 ± 1.1+ 
Table 3.10. Changes in maximal oxygen consumption and arterial-venous oxygen difference with 
age and fitness. 
Ages of men (years) 
Veteran Athletes Sedentary 
50 ± 0.8 58 ± 0.7 21 0.5 50 ± 0.8 60 0.8 
V02 
... (1/min) 3.5 ± 0.1** 3.3 ± 0.1** 3.6 0.1 2.8 ± 0.2++ 2.4 ± 0.1++ 
V02 
max 
(MI/Mill/kg) 48.9 1.8** 45.6 2.1 43.7 1.7 33.2 1.8++ 30.1 ± 1.0++ 
V02 
max(ml/niffiftl-15) 32.5 0.8** 28.7 1.4** 31.7 1.2 22.6 1.3++ 21.1 ± 0.8 ++ 
a-v 02 diff (ml/100rnl)ý 15.0 ± 0.4 15.6 ± 0.4 16.4 ± 0.4 . 
15.0: h 0.6 
. 
14-2: 1: 0.3 
Data are presented as means ± SEM, n= minimum of 9 per group (range =9- 14). Significant 
differences at *P<0.05 and **P<0.001 compared to age-matched controls, and +P<0.05 and 
'P<0.001 compared to sedentary 21 year-old men. 
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Table 3.11. Haemodynamic values at rest in relation to long-tenn endurance training 
and age. 
Ages of men (years) 
Veteran Athletes Sedentary 
50 ± 0.8 58 ± 0.7 21 ± 0.5 50 ± 0.8 60 ± 0.8 
HR ("m 51 ± 1.5** 53 ± 1.9** 70 ± 3.0 67 ± 3.3 66 ± 2.1 
SV (ml) 92.3 ± 7.5* 90.2 ± 3.4* 81.1 ± 4.8 67.5 ± 5.6 67.5 :h4.2 
SVi (ml/kg 0' 66 ) 6.4 ± 0.4** 6.2 ± 0.2* 5.1 ± 0.2 4.3 :L0.3 4.7 10.3 
4.6 ± 0.4 4.7 ± 0.2 5.5 ± 0.2 4.4 0.3+ 4.4 ± 0.2+ 
Ci (1/min/kg 
0.8) 0.2 ± 0.01 0.2 ± 0.01 0.2 ± 0.01 0.2 0.0 1 0.2 ± 0.0 1 
SBP (mm Hg) 121 ± 3.6 123 ± 5.6 116 ± 1.7 129.4±3.0 133.0±4.0+ 
DBP (mm Hg) 80 ± 2.0+ 76 ± 2.9 71 ± 2.0 86 ± 2.1++ 80.8 ± 1.8+ 
MAP (mm Hg) 97 =L 2.3+ 
1 
95 ± 3.1 
1 
87 ± 2.4 
i 
103 ± 2.6++ 102 ± 2.3++ 
Data are presented as means -1 SEM, for the same subjects used in Table 3.9. Significant 
differences *P<0.05 and **P<0.001 are compared to age-matched controls, and at 
+P<0.05 and ++P<0.001 compared to sedentary 21 year-old men. 
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to their sedentary controls, no significant differences were found (Figure 3.42A). 
Despite not being statistically different, training-related differences were evident in the 
components of COrest. For example, HR, ý, t was -22% lower (P<0.001), in the veteran 
athletes (Table 3.11), with this being compensated for by significantly (P<0.0 1) -35% 
greater SV,,, st in the veteran athletes (Table 3.11). Normalisation of the haemodynamic 
variables to FFMb did not alter these significant differences produced by endurance 
training (Table 3.11). 
Cardiac power output at maximal exercise 
It was only at maximal exercise that the benefits of long-term endurance training on 
cardiac function were revealed. This was illustrated by significantly (P<0.001) greater 
CPOn,. (18 to 27%) and CR (22 to 34%) values in the veteran athletes, compared to 
their age-related sedentary controls (Figure 3.41A). The greater CPO,,,,,, values were 
attributed to a significantly (P<0.001) 25% greater CO,,,.,, value in the veteran athletes, 
as no differences were found for MAPmax (Table 3.12). In turn, the larger SVn. 
contributed to the greater COrnax in both the 50 (32%) and 58 (21%) year-old veteran 
athletes, as HRm. were similar compared to sedentary controls (Table 3.12). Maximal 
SVR was significantly (P<0.001) -22% lower in the veteran athletes (Figure 3.42A) 
compared to age matched controls. 
The significant (P<0.01) differences arising from long-term endurance training were 
still evident (Figure 3.4113) even when scaled for FFMb, i. e. maximal CPi (16 to 34%), 
CRi (20 to 42%), Ci (24 to 31 %), and SVi (21 to 37%) were all greater in the veteran 
athletes (Table 3.12). In contrast, maximal SVRi was significantly lower (24%) in the 
veteran athletes (Figure 3.42B). 
Not only were the benefits of long-term endurance training apparent on measuring 
maximal cardiac function in relation to men of the same age, but interesting differences 
arose when comparing active older men to sedentary 21 year-old men. That is, Cpo.. 
and CR values were significantly (P<0.01) higher in the 50 year-old veteran athletes, by 
as much as 17% and 22%, respectively (Figure 3.41A). These findings indicate that 
maximal cardiac function had been more than fully preserved against the 
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Figure 3.42. The relationships between long-term endurance training, age and 
systemic vascular resistance. 
Systemic vascular resistance (A) and systemic vascular resistance index (B) are given 
for endurance trained (ET) and sedentary (Sed) men, with resting measures in blue 
(0) and maximal measures in the purple (M) bars. Data are presented as Mezins I 
SEM, n=9- 14. Significant differences at *P<0.05 and **P<0.001 are compared to 
age-matched controls, and at +P<0.05 and 
++P<0.001 compared to sedentary 21 year- 
old men. 
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process of ageing by endurance training. Even, the 58 year-old veteran athletes 
presented with similar CPOma,, and CR values compared to sedentary men 38 years 
younger. 
(E) Changes in cardiac structure due to long-term endurance training and age 
Long-term endurance training and ageing have been shown to affect certain structural 
features of the heart, which may account for the observed differences in maximal 
cardiac function. Therefore, echocardiographic data obtained on groups of sedentary 
men between 20 and 70 years were examined to show any age-and fitness-related 
changes in cardiac structures. Although not statistically significant, age-related 
decreases in posterior wall thickness (PWT), left ventricular internal diameter in 
diastole (LVIDd) and systole (LVIDs), left ventricular end diastolic volume (LVEDV), 
left ventricular volume (LVV) and left ventricular mass (LVM) were apparent over the 
50 year age span (Figure 3.43). These trends were either prevented or delayed by long- 
term endurance training. 
In summary, long-term endurance training appears to preserve cardiac structures and 
overall performance when viewed against healthy ageing and a sedentary lifestyle. 
125 
Results 
1-2 
-9, 
00.8 
0.4 
3: 
0,0 , 
50 58 
ET 
21 
I 
50 60 
- 
Sed 
C 
200 
EI ro ý 
do 
E 
120 
so 
40 
0 
50 58 21 50 60 70 
ET Sed 
50 
ET 
58 21 
'tEl 
60 70 
i 
50 58 21 50 60 70 
ET Sed 
Figure 3.43. The relationship between age, fitness and structural dimensions of the heart 
The structure variables measured are [A] septal wall (M) and posterior wall (0) thickness, III I lell 
ventricular internal diameter during diastole (M) and systole (0); [C] left ventricular volume (0) 
and left ventricular end diastolic volume (0); [D] left ventricular mass. Data are expressed as 
means ± SEM, n=9- 14. No significant differences were found. 
70 
B 
6 
5 
4 
EI U 
3] 
2 
I 
D 
250 
200 
150 
loo 
50 
o 
LI 50 Sed 
126 
Results 
3.4. The effects of creatine supplementation on measurements of 
cardiac power output in older sedentary and trained men. 
Dietary creatine supplementation has been shown to have positive ergogenic effects in 
improving skeletal muscle performance in both young and older men (Balsorn et A, 
1995; Vandenberghe et aL, 1997). Research examining the effects of creatine 
supplementation on the performance of the human heart is scare. Creatine 
concentrations have been shown to decline with age in the normal human heart 
(Nascimben et aL, 1996). Therefore, by restoring these creatine concentrations it may be 
possible to attenuate the age-related decrease in CPOma,, and CR, as identified in the 
previous sections. 
3.4.1. Cardiac power during creatine supplementation in sedentary older 
men. 
For this purpose ten healthy, inactive subjects were investigated. Their mean (± SEM) 
ages, heights and body mass' were 60 ± 1.4 years, 174 ± 1.9 cra and 82 ± 2.2 kg, 
respectively. 
Creatine supplementation has been shown to increase BM either by the retention of 
water or via increased protein synthesis (Vandenberghe et at., 1997). However, no 
significant differences in BM were measured, with values of 82.6 (± 2.2) and 82.5 
1.9) kg, for the placebo (maltodextrin) and creatine trials, respectively. 
Examination of resting cardiac function revealed no significant differences in CPO,,,, t, 
when comparing 5 days of either creatine or placebo supplementation (Table 3.12). 
Furthermore, no significant differences were measured in either of the component parts 
used to that determine CPO that is, MAP,, st and CO., m (Table 3.13). Other basal 
haemodynamic variables such as resting HR, SV, SBP, and DBP were also unchanged 
by creatine ingestion. 
Therefore, all of these measurements made at rest were very similar regardless of 
whether creatine or maltodextrin (drinks) was ingested. 
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Table 3.13. Resting and maximal measures of cardiac function in response to either 
placebo or creatine supplementation. 
Supplementation 
Placebo Creatine P-Value 
Heart Rate (b/m) 
At Rest 65 ± 2.2 67 0.43 
At Maximal Exercise 160 2.6 158 3.6 0.20 
Stroke Volume (ml) 
At Rest 65.4 3.9 64.5 2.6 
-- 
0.82 
At Maximal Exercise 115.5 5.5 114.4 ± 6.4 0.76 
Cardiac Output (1/min) 
At Rest 4.2 0.2 4.3 0.1 0.59 
At Maximal Exercise 18.4 0.7 17.9 0.6 0.37 
Systolic Pressure (mm Hg) 
At Rest 132 5.0 122 2.7 0.07 
At Maximal Exercise 206 5.5 201 4.3 0.25 
Diastolic Pressure (mm Hg) 
At Rest 81 ± 2.7 76 3.4 0.40 
At Maximal Exercise 82 ± 2.4 80 2.6 0.47 
Mean Arterial Pressure (mm Hg) 
At Rest 102 ± 3.4 96 3.0 0.06 
At Maximal Exercise 137 ± 2.8 133 3.7 0.43 
Cardiac Power Output (Watts) 
At Rest 1.0 ± 0.0 0.9 0.0 0.42 
At Maximal Exercise 5.6 ± 0.2 5.3 0.2 0.16 
Cardiac Reserve (Watts) 4.6 ± 0.3 4.3 0.2 0.26 
Data presented as mean ± SEM, n= 10. 
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A similar story was also observed at maximal exercise. No significant differences were 
measured in CPOm., CO or MAP, or in their component parts, i. e. HF, SV, SBP and 
DBP (Table 3.12). Inevitably, the lack of effect of creatine supplementation on either 
resting or maximal CPO values, resulted in no significant differences when CR was 
determined (Table 3.13). 
To confirm that the lack of disenable changes were not a result of averaging responses 
as mean values, each subject's individual responses were examined (Figures 3.44 to 
3.46). No consistent trends were seen with the ten individual subjects. 
Further supporting the lack of change in cardiac function, no significant differences 
were measured in the subjects' maximal aerobic capacity with creatine supplementation. 
Mean values of 30.2 ± 1.4 (range 23.7 to 38.2 ml/kg/min) and 27.5 ± 1.3 (range 22.2 to 
34.8) were recorded for the placebo and creatine trials, respectively. 
in summary, creatine supplementation at 20 grams/day over five days failed to exert any 
ergogenic effect on the hearts of older sedentary men. 
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Figure 3.44. Individual subject's values of cardiac power output. 
Resting (A) and maximal (B) cardiac power output, and (C) cardiac reserve were 
measured at the end of the placebo (0) or creatine (M) trial. 
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Figure 3.45. Individual subject's mean arterial pressure. 
Resting (A) and maximal (B) mean arterial pressure were measured after the 
placebo (0) or creatine (0) trial. 
131 
Results 
6 
25 
20 
15 
10 
5 
0 
A 
10 
5 
B 
fiLlilhil! 23456789 Subjects 
Figure 3.46. Cardiac output in individual subjects. 
10 
Resting (A) and maximal (B) cardiac output were measured after the placebo (0) or 
creatine (0) trial. 
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3.4.2. Creatine supplementation in active older men 
Past research has identified that exercise training improves the uptake of creatine into 
the skeletal muscles, with resultant improvements in muscle performance (Harris et al., 
1992; Robinson et al., 1999). 
The lack of effect of creatine supplementation on CPO, in sedentary older men, 
prompted an identical study in seven older trained men, who were actively training at 
the time of supplementation. Their mean (± SEM) ages, heights and body mass, were 56 
1.8 years, 172 ± 1.7 cm and 74 ± 2.1 kg, respectively. The active male runners 
consisted of six middle to long distance runners and one long distance cyclist. 
Once again, creatine supplementation did not significantly increase the subjects BM, i. e. 
73.2 (± 3.1) and 74.2 (± 3.2) kg, after the placebo and creatine trials, respectively. 
Creatine supplementation also failed to improve any of the resting or maximal aspects 
of cardiac function in these active older men (Table 3.14). Furthermore, no significant 
differences were measured in their maximal oxygen uptakes between the two trials. The 
mean ý102 max values were 42.2 ± 2.6 (range 36.3 to 51.6 ml/min/kg) and 43.2 ± 2.7 
(range 36.5 to 55.7 ml/min/kg) for the placebo and creatine trials, respectively. 
Further analysis of the responses within each individual also failed to demonstrate any 
consistent trends (Figures 3.47 to 3.49). 
In summary, creatine supplementation failed to improve cardiac function in either active 
or sedentary older men. 
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Table 3.14. Cardiac function after either placebo or creatine, supplementation in active older 
men. 
Supplementation 
Placebo Creatine P-Value 
Heart Rate (b/m) 
At Rest 50 1.6 51 1.6 0.51 
At Maximal Exercise 164 2.6 162 2.3 0.46 
Stroke Volume (ml) 
At Rest 90.8 3.4 93.1 ± 4.4 0.90 
At Maximal Exercise 133.6 ± 2.9 137.2 ± 6.5 0.83 
Cardiac Output (1/min) 
At Rest 4.6 0.2 4.7 ± 0.2 0.80 
At Maximal Exercise 21.7 0.6 22.2 ± 0.6 0.81 
SVstolic Pressure (mm H9) 
At Rest 128 7.2 116 ±3.5 0.24 
At Maximal Exercise 202 8.3 208 6.1 0.29 
Diastolic Pressure (mm Hg) 
At Rest 81 3.3 78 2.0 0.11 
At Maximal Exercise 72 4.2 72 ±4.0 0.87 
Mean Arterial Pressure (mm Hg) 
At Rest 100 4.0 95 ± 2.2 1 0.13 
At Maximal Exercise 125 4.7 128 ±4.1 0.08 
Cardiac Power Output (Watts) 
At Rest 1.0 0.1 1.0 ± 0.1 0.91 
At Maximal Exercise 6.2 0.2 6.3 ± 0.3 0.97 
ICardiac Reserve (Watts) 5.2 0.2 1 5.3 ± 0.3 1 0.97 
Data are expressed as mean ± SEM, n=7 
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Figure 3.47. Individual sub ect's values of cardiac power output j 
Resting (A) and maximal (B) cardiac power output, and (C) cardiac reserve 
were measured after either placebo (M) or creatine (M) supplementation at 
20 g/day for 5 days. 
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Figure 3.48. Mean arterial pressure for individual subjects data 
Measurements of mean arterial pressure were made at rest (A) and at maximal 
exercise (B), after either placebo (0) or creatine (0) supplementation. 
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Figure 3.49. Cardiac output for individual subjects data 
Measurements of' cardiac output were made at rest (A) and at maximal 
exercist (B). after either placetx) (W or creatine (W supplementation. 
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Discussion 
Four main findings emanate from this thesis. First, the way cardiac power output (CPO) 
was scaled was critical in the interpretation of the results. For example, in the sedentary 
women the age-related decline in CPOm. was lost when scaled for fat free mass 
(FFMb). In contrast in the sedentary men the decline in CPO.. was still evident. This 
significant age-related difference between men and women was the next novel aspect of 
this thesis. Third, it was evident that long-term endurance training, as shown in the 
veteran athletes, helped to ameliorate the loss in maximal cardiac function seen over 
approximately 40 years of ageing. Fourth, the increase in maximal mean arterial 
pressure (MAP) with age helped to ameliorate some of the loss in CPOn. with age. 
Therefore, if maximal cardiac output (CO) alone was used as the marker of cardiac 
function, as routinely used in past research, then the loss in overall cardiac function with 
age would have been overestimated. 
4.1. Limitations of the current research 
Before discussing these findings some of the limitations of these studies will be 
examined. When interpreting the results several limitations need to be taken into 
account. One limitation relates to the use of a cross-sectional designed study in 
measuring the age-and fitness-related changes in CPO. There are two major 
confounding factors associated with cross-sectional studies. First, the cohort 
(generational) effects, e. g. the lower CPOmax values attained in the older sedentary 
subjects compared to the sedentary 20 year olds, could be due to the less active lifestyle, 
rather than ageing per se. Second, the effects of selectivity. As one is carefully selecting 
subjects that are free of cardiovascular disease, the results obtained will relate to a small 
fraction of the older population. Furthermore, it is often the more active, middle-class 
older people who volunteer more readily to participate in the research, rather than 
inactive individuals. Therefore, the changes with age may appear to be attenuated 
through subject availability or selectivity. In the current studies, attempts were made to 
prevent such factors from occurring by ensuring the subjects were relatively sedentary, 
based on their answers to the physical activity questionnaire and their measured V02nux. 
The vast majority of investigations into the changes in cardiovascular function with age 
employ the cross-sectional study. This is not too surprising as the studies can be 
executed relatively quickly, and are relatively inexpensive. 
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Although longitudinal studies circumvent some of the problems described above they 
are costly both in terms of time and money. Also, they require a stable population of 
subjects, available over a long period of time with a stable reliable analytical 
methodology throughout the entire study. The latter includes the training and research 
skills of the investigators, as well as the confounding effects of repeatedly exposing the 
subjects to a measurement and possible leading to 'training' effects. Furthermore, 
environmental or lifestyle changes within the subject population over the course of the 
study can substantially influence the interpretation of the process of ageing. For 
example, changes in the quantity and quality of diet from decade to decade can affect 
cholesterol concentrations and be inappropriately interpreted as an effect of ageing. 
Other limitations include the measurements per se. For example, in the current studies 
the measurement of MAP using the manual auscultation method. At rest, the 
measurement of arterial BP using the auscultation method is relatively easy to perform 
and has been shown to closely reflect central aortic blood pressure (Lightfoot, 1991). 
The absolute value recorded is of course influenced by the amount of tissue in the arm 
that has to be compressed by the inflated cuff in order to occlude the brachial artery 
before establishing systolic pressure. The use of manual auscultation to measure BP 
during dynamic exercise is even more technically challenging (Lightfoot 1991) and 
requires extensive practice to overcome problems with treadmill vibrations and noise. 
Consequently, measurements made at maximal exercise have been shown to be less 
representative of the aortic pressures, compared to invasive techniques (Lightfoot, 
1991). In addition, ageing is associated with an increase in arterial stiffness (Lakatta, 
1993), which can therefore increase the amplification of the pulse wave. To date the 
only alternative method of measuring BP is the intra-arterial method. However, such a 
technique is potentially dangerous for the subject especially when exercise is involved. 
In addition, this invasive technique itself could physically limit the subjects' attainment 
of true maximal exercise etc. Therefore, until a more representative technique is 
developed, the manual auscultation method remains the best non-invasive technique 
available to measure MAP. 
Another possible limitation to the current data concerns the use of the C02 rebreathing 
technique to measure CO. This measurement of CO is dependent on the subjects' ability 
to breath adequately to facilitate the mixing of the gases in and across the lungs and 
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blood stream. This could conceivably be less accurate in individuals with pulmonary 
abnormalities. Such individuals were however not invited to participate in the study and 
therefore this, apart from poorer respiratory function in the elderly, was probably not a 
major problem. In addition, the C02 rebreathing technique is based on some 
assumptions, e. g. that the effects of differences in pH, venous oxygen saturation and 
temperature are negligible. To overcome these assumptions, past research has taken 
blood samples to account for the differences in haemoglobin concentrations (Coyle et 
aL, 1986; McHardy, 1967) and have oxygenated the mixed venous blood with high 
concentrations Of 02 (Coyle et aL, 1986; Rebuck et aL, 1983). However, this limits the 
non-invasive nature of the C02 rebreathing manoeuvre. Also the values of CO derived 
in this way are similar to those recorded after rebreathing acetylene (Spina et aL, 1993). 
Despite these limitations, most of the 'errors' are built in and will be consistent 
throughout as the same techniques etc were employed from the beginning to the end of 
these studies. In addition, by being aware of such limitations, every effort was made to 
minimise their impact on the studies and emphasis was placed on careful measurements 
being made and protocols followed faithfully. Many earlier studies in related areas have 
clearly been less rigorous. 
4.2 Blood pressure is a critical component in the measurement 
of CPO 
Despite recent advances, our understanding of the basic physiological mechanisms 
responsible for the changes in body structures and functions remains rudimental. Many 
of the publications concerning the age-related changes in cardiovascular function have 
neglected to control for the fundamental effects of disease and/or lifestyle. Such 
confounding factors have clouded the issue of ageing per se. It is therefore imperative 
that both disease and lifestyle variations are controlled for, so that the effects of healthy 
ageing on overall cardiac function are examined in relative isolation. Although, this may 
be difficult to achieve, as it is widely believed that ageing is synonymous with disease 
(Lakatta et al., 1987). Although examining the age-associated changes in a normal 
healthy population may be difficult if not impossible. In light of current theories, we 
attempted to perform such a task. In this thesis, the term 'Healthy ageing' was used to 
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represent the process of ageing in individuals in the absence of overt clinical diseases, 
and in particular cardiovascular abnormalities or diseases. Therefore, only subjects who 
met our criteria were selected. 
Another factor that has hindered interpretations in this important area of research, 
concerns the validity of the measurement variables used to describe the age-related 
changes in cardiac function. Cardiac power output, a measure of overall cardiac 
function was proposed as it takes into account both the pressure and flow generating 
capacities of the heart and can be measured at rest and at maximal exercise. From the 
values the reserve capacity of the heart (CR) can be calculated (CPOm" - CPO,,, t). 
Therefore, CPO has been shown to be a more representative and comprehensive 
indicator of overall cardiac function (Cooke et aL, 1998). 
The acceptance of CPO as the best measurement of overall cardiac function, will affect 
the way we interpret age-related functional changes. For example, by ignoring the 
pressure generating capacity of the heart and focusing solely on cardiac output (CO), as 
previously used in most of the literature, the changes in cardiac function are either 
under-or over-estimated depending on the health status of the subjects or patients 
examined (Figure 4.1). That is, in a healthy ageing population a greater decline in 
cardiac function would be reported if CO was solely used, thus overestimating by 5% to 
7% the changes compared to these reported for CPOmax (Figure UA). This is because 
unlike COna.,, MAPn, ýx increases with age. In contrast the detrimental effects of heart 
failure (1117) will be underestimated by 15% compared to age-matched healthy controls. 
These HF patients express an inability to increase both their flow and pressure 
generating capacities of the heart to the same extent as healthy controls at maximal 
exercise thereby showing an inability to maintain cardiac function (Figure 4.1 B). 
Furthermore, the importance of including the heart's pressure generating capacity in a 
measure of cardiac function was highlighted in a recent communication (Schlosshan et 
A, 2004). In a group of HF patients undergoing cardiac resynchronisation therapy, the 
authors identified an increase in CPO.,,.,, independent of any changes in maximal CO or 
SVR. It was therefore concluded that cardiac pressure-generating capacity must be a 
primary manifestation of improved cardiac function. Such data highlight the importance 
of incorporating pressure in the measurement of overall cardiac function. Ibis is an 
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Figure 4.1. Schematic diagram illustrating the potential errors associated in 
measurements of cardiac function when the pressure generating capacity is ignored. 
A) Data from sedentary 21 year-old men (Figure 3.41) have been used here to 
generate the baseline values (0%; x-axis) from which percentage differences in 
MAPm. (blue bar), COn,,., (grey bar) and CPO,,,,, (cream bar) have been calculated 
for 50,60 and 70 year-old sedentary men. Using CO,,, only overestimates the 
decline in cardiac function by 5-7%, compared to CPO,,,.. 
B) The percentage differences in MAP,,, a., (blue bar), CO,,,,, (grey 
bar) and ('110MM 
(cream bar) for 60 year-old heart failure (HF) patients (NYHA class 11-111) were 
calculated against data from 60 year-old healthy men (Figure 3.41) reduced to 0% 
baseline values (x-axis). Measuring CO a., alone, in this study would underestimate 
by 15.4% the decrease in cardiac function. These data for the IIF patients were 
obtained from Dr L-B Tan (personal communication). 
50 years 
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extremely important point as most current studies in a clinical or exercise pbysiology 
setting measure cardiac function based only on measures of flow. 
Prior to examining the main aim of the thesis, it was important to optimise the reliability 
and reproducibility of measurements of CPO. Optimising the experimental conditions 
becomes all the more crucial when documenting the critical changes that occur with 
age, which may eventually lead to a pathological state. The methodological advances of 
CPO from an initial invasive to a non-invasive protocol have provided opportunities to 
measure CPO in a non-clinical setting (Cooke et aL, 1998). As a natural progression of 
previous work, we conducted some further validation studies as a precursor to 
conducting the main investigations on the processes of ageing. 
4.3. The effects of time of day on the measurement of cardiac 
power output 
one possible consideration that needed to be addressed at the outset concerned the 
possibility that the measurements of CPO were influence by a circadian rhythm. 
Evidence to support this possibility is conflicting. Several studies have measured the 
component parts of CPO (i. e. CO and MAP) and have produced variable results which 
either support or refute the influence of circadian rhythms (Cohen and Muehl, 1977; 
Cugini et aL, 1991; De Scalzi et aL, 1984; Deschenes et aL, 1998; Wang el aL, 1992). 
Resting CPO is only a fraction of CPOnla,, and may therefore be sensitive to changes in 
body temperature or fluctuating hormonal concentrations. For example, research has 
tended to find rhythms in CO and MAP at rest (Atkinson et aL, 1994; Cugini et al., 
1991; De Scalzi et aL, 1984; Furlan et aL, 1990; Reilly et aL, 1984; Reilly and Brooks, 
1990; Wang et al., 1992). In contrast, at maximal exercise the whole body, and its 
regulatory pathways, will be maximally activated and probably no longer susceptible to 
stimuli associated with the time of day. Therefore, it has been suggested that circadian 
rhythms are not evident at maximal exercise (Davis and Sergeant, 1975; Deschenes et 
aL, 1998a). In addition, ýr02max, a measure of the maximal cardiovascular function and 
an indirect measure of cardiac function, has been reported to be stable and independent 
of the time of day (Reilly and Brooks, 1990). Indeed, in the current study, there was no 
suggestion of 1ý02nj. x being affected by the time of day at which it was measured. 
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Past research has reported that older individuals show a blunted circadian response 
compared to younger individuals (Otsuka et aL, 1989; Weizman et aL, 1982). It has 
been found that the amplitude of the circadian rhythms for rectal temperature (Atkinson 
et aL, 1994; Deschenes et aL, 2002) and resting pulse pressure (Atkinson el aL, 1994) 
were significantly reduced in older subjects. Also, no such differences have been 
reported for resting BP, HFet or the response of HR to exercise between 08: 00 and 
20: 00 hours (Deschenes et aL, 2002). Therefore, the lack of a circadian response for 
CPO identified in the young subjects, together with the reported blunted circadian 
response in older individuals, suggest that CPO will not be affected by a circadian 
rhythm in older subjects. 
In addition, it has been shown that circadian rhythms are highly influenced by other 
factors such as sleep, posture, ingestion of food and activity patterns (Pickering, 1988). 
Such influencing factors raise the question as to whether an endogenous component 
exists at all. 
Such discrepant results, and the lack of significant changes at maximal exercise, 
highlight the lack of precise knowledge of how circadian rhythms may affect 
cardiovascular function. As far as possible, the confounding effects of posture, food 
ingestion and digestion, and prior physical activity were controlled for in the current 
study to minimise such effects. It was therefore concluded that resting and maximal 
CPO were not affected by the time of day that they were measured (Table 3.1). Even 
when the subject data were treated separately and examined for individual trends, there 
was no suggestion of a circadian response to any of the resting or maximal 
haernodynamic data (Figures 3.1 to 3.3). It can therefore be concluded with reasonable 
confidence that the measurements of CPO were not affected by circadian variations and 
can be measured with reliability at any time point during the day. 'Ibis was reassuring, 
since if such a pattern had appeared the implications would have been very restrictive, 
limiting the number of subjects who could have been tested per day. Also, if the 
measurements of CPO had to be made according to an optimal time this would have 
impacted on cross-sectional studies and the pooling of such values. 
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4.4. Scaling of physiological variables 
It has been well documented that a number of physiological entities are influenced by 
body size (Batterham et at, 1999, de Simone et at, 1997; Nevill et at, 1994). Cardiac 
output, a vital component of CPO, has been shown to increase in accord with an 
increase in body mass (de Simone et at, 1997; Lakatta, 1993). It was therefore highly 
likely that CPO would be affected in a similar way to that reported for CO. Indeed, all 
variables of CPO were positively influenced by the various measures of body 
dimensions (Figures 3.5 to 3.7). In addition, the sex differences highlighted between 
men and women, and with age per se, also influence the measurement of CPO. 
Therefore, to obtain meaningful inter-or intra-group comparisons the effects of body 
size must be corrected for (Batterham et at, 1999). 
This is the first study that has examined the relationship between CPO and body 
dimensions. It was found that the allometric approach was the best scaling model to 
compare data from male and females, as the assumptions of this scaling model were 
satisfied. That is, the relationship between the variables of body dimensions and CPO, 
were similar for men and women, which allowed common b exponents to be calculated. 
The assumption of homoscedasticity was achieved and the allometric model completely 
corrected for the effects of body composition on the data for CPO (Table 3.6). 
However, it was also desirable to find the best scaling variable which would further 
improve the quality of such data. Often for convenience, body mass (BM) has been 
routinely used for the scaling of physiological function. In cardiology, body surface area 
(BSA) has been widely used as it incorporates some estimates of body composition. 
However, BSA is rarely measured and calculations of BSA introduce errors (Martin el 
aL, 1984). Although the use of BM or BSA reduces the differences between men and 
women, despite having similar physical fitness and health backgrounds, significant 
differences often remain. These differences can be partially attributed to the incorrect 
selection of the scaling model and due to the wrong choice of scaling variable. The 
current study identified that fat free mass scaled allometrically (FFM), was the best 
scaling variable for the independent removal of body dimensions on CPO values. 
Indeed, such an approach dramatically reduced the differences in CPO between men 
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and women (Table 3.8). Furthermore, no differences were found between men and 
women for CR. In contrast, large differences were still evident between men and 
women when BNP or BSAb was employed for the scaling of CPO. 
Although, the use of FFM as the scaling variable is an improvement on the conventional 
approach of scaling physiological functions to BM, it is not perfect. That is, FFM is 
composed of metabolically active constituents (i. e. skeletal and cardiac muscle etc) and 
low-metabolically active tissues or organs (i. e. tendons, ligaments, intestines, pancreas 
etc). Although at rest, the liver, kidneys and gastrointestinal tract are considered to be 
organs with high metabolic rates (Muller et aL, 2002), their energy expenditures 
represent a significantly smaller proportion during vigorous exercise. Therefore, an 
ideal scaling variable would be one that solely takes into account the most metabolically 
active tissues, i. e. skeletal and cardiac muscle. 
The selection of FFMb as the scaling variable was based on the statistical evidence and 
importantly its biological relevance. 'Mat is, statistically FFM presented with the 
strongest relationship of all body dimensions when correlated to CPO (Table 3.7). 
Further information was gained by examining the confidence intervals surrounding the 
b exponent. Body surface area produced wider confidence intervals than either FFM or 
BM for all variables of CPO (Table 3.7). This suggested that the exponents calculated 
for BSA were less stable, and hence potentially less applicable to other populations 
when compared to exponents of FFM or BM. In the absence of FFM, when used 
allometrically, BM may be the next best alternative in a similar population of subjects. 
That is, although both BM and BSA had similar Rý and root-mean-squares error values, 
the width of the confidence intervals for BM were tighter compared to BSA, which 
means the values are more generally acceptable to other populations. However, the fact 
that BM does not differentiate between the differences in body composition, e. g. a large 
proportion of metabolically active muscle versus metabolically inert adipose tissue, will 
therefore not fully correct for the changes in body composition. This was highlighted in 
Table 3.8, whereby highly significant sex-related differences remained once the 
differences in BM between groups were accounted for. 
The use of FFM as a scaling variable is not a new concept, a number of studies have 
shown its superiority compared to BM or BSA (Batterham and George, 1998; Bella et 
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aL, 1998; Collis et aL, 2001; Dbbeln, 1956; George et aL, 1999). The physiological 
basis for the selection of FFM as the scaling variable was that it allows the independent 
removal of body dimensions that are related to metabolically active tissues from CPO, 
e. g. muscle. 
On a cautionary note, the use of FFM is dependent on the accuracy by which it can be 
measured. For the current study, Dual Energy X-ray Absorptiometry (DEXA) was used 
to measure FFM, which has been recognised as a precise technique for the measurement 
of body composition (Kelly et aL, 1997; Khort, 1998; Makarn et aL, 1997). 
Unfortunately, in practice the use of FFM for the scaling of CPO may be limited by the 
availability of equipment and hence how accurately it can be measured. Although 
increasingly popular, DEXA machines and other reliable technique are not widely 
available. Although techniques to measure FFM, such as skinfold thickness and 
bioelectrical impedance, are more freely available they possess inherent errors. 
Additionally, these techniques measure fat and not FFM. Therefore under circumstances 
when FFM can not be measured accurately, other scaling variables may be warranted. 
Although scarce, aspects of cardiac function, i. e. CO and SV, have previously been 
examined. These may provide some insight into the results obtained for CPO. To my 
knowledge, the study of de Simone and colleagues (1997) is the only one that has 
correctly examined the relationship between body size and CO using the allometric 
model. Even then, this was only performed under resting conditions. In a similar 
population to the one used in the current study, de Simone et aL (1997) scaled CO and 
SV for BM to the power of 0.71. Their value of the b exponent was higher than that 
calculated for CPO., st when scaled to BM (b = 0.33) or FFM (b = 0.47). In addition, as 
illustrated in section 3.3.1, resting and maximal CO were scaled to FFM to the power of 
0.36 and 0.64 respectively (Figures 3.1213 and 3.18B), both of these b exponents are 
different to that reported by de Simone et aL (1997). Possible explanations for the 
differences between the exponents calculated in this study and those of de Simone et al. 
(1997) could relate to the different techniques used to measure CO and SV. de Simone 
et aL (1997) measured CO and SV using echocardiography, whereas the C02 
rebreathing technique was employed in the current study. Differences in results may 
also have been due to the health status of the subjects. We rigorously examined the 
subjects for any signs or symptoms of clinical diseases. Therefore as far as we can 
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ascertain, the population studied were disease-free. However, of the subjects used in the 
study by de Simone et aL (1997) only hypertension was ruled out by BP measurements. 
These factors could account for the differences between the two studies. 
Although the data for CPO was completely normalised for body size using the 
allometric model of scaling, ' a cautionary note still needs to be made. First, allometric 
scaling should be population specific, i. e. the allometric exponents should be calculated 
for each new data set to ensure that such data are completely normalised. Second, the 
allometric equations cannot be used for extrapolation beyond the range of the data at 
which they are based. Furthermore, as these results are novel further examination of the 
relationships between CPO and variables of body dimensions are warranted. This 
should help to establish the normal range of exponents for the allometrically scaling of 
CPO. 
By removing the confounding affects of body size on CPO, and scaling in the most 
appropriate way, valid inter-and intra-group comparisons could be made with greater 
confidence and age-related changes in CPO examined in both men and women. 
4.5. The effects of ageing 
Although the differences in cardiovascular function between young and old have been 
extensively documented, failure to acknowledge or control for the confounding 
influences of disease and lifestyle have clouded many issues. In fact some argue that 
ageing is intrinsically linked with disease. However, many achieve old age with little 
evidence of disease (Lakatta and Levy, 2003). Hence, it was necessary to study healthy 
subjects in well-defined groups separated according to sex, age, levels of physical 
fitness and training status. This was considered to be a very important aspect of these 
studies. 
At rest the heart, like other aspects of the cardiovascular system, operates at a fraction 
of its total capacity. Therefore changes at rest, unless the patients are in heart failure, are 
unlikely to have serious implications on the ability of the heart to cope with daily 
stresses. However, a deterioration in maximal cardiac function will have a substantial 
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affect on daily living. Maximal exercise is a commonly used experimental tool 
employed in studies in exercise physiology because it allows quantification of the limits 
of an individual's physiologic function. It is, therefore, perhaps more important to 
document the changes that occur at maximal exercise with increasing age. In so doing, 
one is defining the functional reserve capacity of the heart. , 
It has been reported that there is a progressive decline in the functional capacity of the 
cardiovascular system with ageing (Gerstenblith et al, 1976; Pimentel et aL, 2003). 
This deterioration has been demonstrated by a decrease in 902rnax (Astrand, 1960; Dehn 
and Bruce, 1972; Ogawa et aL, 1992). However, ý102max is a composite measure of 
many organ/bodily functions, whereas CPOm. measures just the overall function of a 
single organ (i. e. the heart). To date, the changes that occur in CPOmu and CR with age, 
and the differences between the sexes, have not been documented. 
Although, in absolute terms (i. e. data not normalised for FFMb)' men and women 
behaved similarly in terms of the age-related changes in maximal cardiac function, on 
an age for age basis, men presented with higher values Of Min., CF, CO, SV and a 
lower SVR .. a,, than women. Such sex-related differences in CO and SV are well known 
(Fleg et aL, 1990,1995; Lakatta, 1993). However this is the first study to find a sex- 
related difference in CPO . and CR in absolute terms. It is generally believed that men 
and women are distinctly different in terms of physiological function. However it is 
difficult to try and explain why healthy men and women, who have similar fitness 
levels, should be so vastly different apart from the obvious differences in body size. 
indeed, once the body compositional differences were accounted for, the differences in 
CPO.., CF, SVRi.. and SVm. were less evident and the differences in CO,. were 
substantially reduced (i. e. from 22% to 5%). These findings clearly show that the sex- 
related differences on maximal cardiac function and other heamodynamic variables 
could be mostly explained by differences in body composition in a sedentary 
population. 
The progressive age-related decline in CPO,,, a., identified in the current study for both 
sexes are therefore novel. It was also found that the rate of decline was greater in men 
than women (Figure 3.16A). Such change in maximal cardiac function impact on the 
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reserve capacity of the heart. Both men and women expressed a decline in CR with age. 
However, the 10% decline in CR for the sedentary women was not found to be 
statistically significant (Figure 3.17A). 
The age-related decline in maximal cardiac function in men was still evident after 
normalising CPO. a., for FFMb (Figure 3.16B). The age-related decline in CR in men is 
likely to result in a reduced exercise capacity and gradually an increased incidence of 
functional disability and an impaired quality of life. The age-related decline in CR 
would also mean that those older individuals engaging in physically demanding 
occupations may be working closer to their maximal capacity (CPO... ) and that could 
result in fatigue, acute cardiovascular events, etc (WHO, 1993). 
Interestingly, in women the decline in CPO. with age disappeared once normalised 
for FFNIý, leaving only a non-significant 8% decline in CPin.,, and M These changes 
or lack of them, in CPO,,,. and CR for the sedentary women has not previously been 
reported. It has been assumed that women behave in a similar fashion to men in terms of 
a loss in maximal functional capacity, as evidenced by a decline in ý102,, ", CO, stroke 
work index (Fleg et aL, 1994,1995; Ogawa et aL, 1992). However, such measures don't 
take into account the pressure generating capacity of the heart; a vital component in the 
measurement of overall cardiac function. 
Although CPi.. did not decline with age in the sedentary women, decreases in CO"" 
were reported, which were similar to those of sedentary men. However, unlike their 
male equivalents the decline in CPOm. disappeared when scaled appropriately. That is, 
in women, the increase in MAPn. was effective in preventing any loss in maximal 
cardiac function. Once again appropriate methods of scaling crucially influence data 
outcome and interpretations. 
In terms of the age-related changes in CPi.., why should women of similar fitness 
levels, behave differently to men? These functional differences are consistent with 
structural changes in the heart as reported previously. Between 20 and 95 years-of-age 
the total number of viable cardiomyocytes in the female heart, remains essentially 
constant (Figure 1.1). In contrast a 30-35% loss of the cardiomyocytes over the same 
age has been documented in men. Although the remaining viable cardiomyocytes 
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undergo hypertrophy in men, this adaptive response clearly does not fully compensate 
for the progressive decline in cardiomyocyte numbers (Olivetti et aL, 1995). This was 
clearly evident in the current study, as an age-related decrease in maximal cardiac 
function was still evident in the men. Currently there is no good explanation for this 
interesting sex difference. If women are able to maintain approximately the same 
number of contractile cells in the heart with increasing age, it may therefore not be too 
surprising that there is little or no change in their maximal cardiac function. 
The traditionally held belief that the heart has little or no regenerative capacity has 
recently been challenged. The recent detection of cardiac stem cells capable of giving 
rise to primitive myocytes, together with small myocytes still capable of dividing, 
suggest that a potential for cardiornyocyte regeneration does exist (Nadel-Ginard et aL, 
2003, Sussman and Anversa, 2003). Whether this regenerative capacity in the heart 
declines with age, and between men and women, will be important areas for future work 
(Sussman and Anversa, 2003). 
The current study was able to measure certain structural changes of the hear4 which 
may provide further insight into the changes in maximal cardiac function. 
Unfortunately, echocardiographic data were only available for sedentary men at the 
specific age groups of 20,50,60 and 70 years. Although not significantly different, 
these data suggested a gradual decline in LVM from 50 years-of-age onwards (Figure 
3.43). If this is true, the minor loss in LVM in the sedentary men may have accounted 
for some of the decline in CPOma,. On a cautionary note the measurement of LVM was 
performed using the technique of 2D M-mode echocardiography. This non-invasive 
technique samples only a single small area of the LV posterior wall or LV septum. 
These are then extrapolated to represent the global thickness of the LV; and inevitably 
carries with it a certain amount of variability. Left ventricular mass was then estimated, 
assuming a constant ventricular geometry at all ages. Furthermore, the use of 
echocardiography can not disclose important information concerning the compositional 
changes of the heart, such as the number of cardiomyocytes, the content and types of 
collagen etc. Such adaptations can occur without observable changes in LVM. 
Research examining the age-associated changes in LVM has been conflicting 
(Dannenberg et aL, 1989; Ensor et aL, 1983; Kitzman et aL, 1988; Potter et aL, 1982; 
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Smith et aL, 1991). By employ the technique of magnetic resonance imaging (MRI), a 
recent study by Hees et aL (2002) provided further insight into the age-associated 
changes in LVM. This 'gold standard' technique identified that ageing was associated 
with left ventricle remodelling in both men and women along the heart's long axis. 
However, in women a decrease in long axis length was countered by an increase in wall 
thickness, resulting in an altered shape of the heart but not in LVM. However, in men 
the decrease in long axis length was not accompanied by an increase in wall thickness. 
Thus, LVM decreased by about 10% between 20 to 80 years. Such data may help to 
explain the differences found in CPO.. between men and women, and with age. 
Further investigations need to be carried out in this area to provide more insight into the 
mechanisms governing the changes in cardiac function in women. Furthermore, it will 
be important to identify if the menstrual cycle affects cardiac function and what 
consequences, if any, the menopause and hormonal replacement therapy, has on CPO. 
Due to insufficient numbers and other priorities in the current study, it was not possible 
to examine the effects of the menstrual cycle or the menopause on CPO. Evidence from 
animal research suggests that oestrogen influences cardiovascular haemodynamics, both 
at rest and during exercise (Magness et al., 1989; Schaible et al., 1984; Scheuer et al., 
1987). However, studies in humans have been conflicting, with Green et al. (1997) 
suggesting that oestrogen supplementation may be associated with higher peak CO in 
exercise-trained, postmenopausal women due to alterations in the peripheral vascular 
and oxygen kinetic responses to maximal exercise. However, the differences between 
the oestrogen and non-oestrogen replacement therapy group only became significant 
once expressed relative to BSA (RES model). Furthermore, maximal CO was not 
measured. Rather it was calculated using the regression of CO on oxygen uptake at each 
stage of submaximal exercise and by extrapolating the CO to ý102peak. In addition, 
subjects were not matched for fitness levels or years of training. Therefore, the 
conclusion by Green et al. (1997) must be treated with some caution. A subsequent 
cross-sectional study highlighted that hormone replacement therapy (HRT) had no 
effect on CO.. in postmenopausal women (McCole et al., 1999). In addition, no 
differences were reported for maximal MAP, SBP, or DBP in postmenopausal women 
who were either on HRT or not. These findings were also independent of physical 
fitness, i. e. sedentary, physically active or master athletes (McCole et al., 1999). 
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Therefore, further investigations are warranted before a valid conclusion can be made 
concerning the effects of HRT on cardiovascular function. 
In the current study, men and women seemed to have similar mechanisms associated 
with the age-related changes in CO and MAP. At maximal exercise, CO is affected by 
multiple pathways, including HR and SV, which in turn are regulated by other 
determinants. For example, SV is dependent on preload, afterload, myocardial 
contractility and coronary blood flow, whilst HR is dependent on the autonomic nervous 
and endocrine systems etc. In turn these regulatory factors are themselves affected by 
determinants at multiple levels, such as the central nervous system, vascular and blood 
properties (for afterload). All of these are highly interrelated, thus highlighting the 
complexity of such a system, particularly when viewed from the perspective of ageing. 
Although the precise mechanisms underlying the observed age-related differences in 
central cardiac responses to maximal exercise could not be ascertained to any great 
extent in this study, the complex interactions between SVR, MAP and CO are likely to 
offer partial explanations. 
In addition, the control of BP during exercise involves complex interactions between the 
peripheral vasculature and the heart, which is carefully modulated through the central 
nervous system (Schrager et aL, 1983). 
Under normal circumstances, the cardiovascular system is designed so that MAP is 
relatively constant through a range of exercise intensities, although at maximal exercise 
an increase in arterial pressure occurs. Because the pressure gradient driving CO is 
relatively constant increases in blood flow to active muscle is achieved by reductions in 
SVR (Tanaka et al., 1996). The current study identified a decline in SVR from rest to 
maximal exercise. This reduction in SVR ...... was substantially less in the older men, 
compared to their younger controls. A corresponding increase in MAP ... . was also 
found with increasing age. Such changes may have lead to the reduction in CO""X. 
Systemic vascular resistance is commonly used as a surrogate of pump afterload 
(Milnor, 1975). Thus, the changes noted in the current study suggest that older 
sedentary individuals have an impaired ability to vasodilate their resistance vessels 
leading to a higher SVR at maximal exercise, i. e. a higher afterload. This increased 
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pump afterload is likely to reduce the maximal pumping performance of the heart in 
these subjects, via its affects on CO. Indeed, an inverse relationship was identified, 
whereby an increase in SVRm. was associated with a decline in CPO,. (Figure 3.38). 
The gradual increase in SVR.,, with increasing age, correlated with similar increases in 
MAP, SBP and DBP at maximal exercise (Figure 3.39). Therefore, based on Ohms law, 
it may be concluded that the primary manifestation of an increase in MAPm,, with 
increasing age would be due to an increase in SVP,.. Such changes may be adaptive in 
nature. That is, part of the heart's work directed to blood flow in the younger 
individuals may be replaced by work directed towards blood pressure in these older 
subjects. Support for the theory comes from Ogawa et al. (1992), who measured the 
changes in stroke work (i. e. the product of SV and MAP), and found that the maximal 
stroke work was either similar or greater in older, compared to young subjects. Ogawa 
et A (1992) indicated that the decline in SVn. with age was associated with a higher 
MAPn,,,. They concluded that less work was expended in SV and more in pressure 
generation in the older subjects. 
Several mechanisms may have accounted for the age-related increase in SVR,,,.. One 
possibility concerns structural changes to vessels walls, e. g. greater deposition of 
collagen, proteoglycans, and less elastin, making them less responsive to vaso-active 
agents (Challah et aL, 1997; Li et aL, 1999). Changes affecting the humoral and 
endothelial regulation of vascular smooth muscle tone can also affect the responsiveness 
of the vascular smooth muscle. That is, senescent vessels show an increased endothelial 
permeability and reduced nitric oxide-dependent vasodilatory response to acetylcholine 
(Taddei et aL, 1995). This has been consistently observed in different regional beds, 
including the coronary bed, of both animals and humans (Egashira et aL, 1993). Also, 
the vasodilator responses to P2-adrenoceptor agonists, are attenuated due to a reduced 
number and affinity of specific receptors. Also, but probably to a less extent, 
vasoconstrictor responses to ce-receptor stimulation have been found to be diminished in 
raged' arteries (Elliot et aL, 1982). 
The age-related changes identified in maximal CO were also associated with changes in 
maximal HR and SV. It has long been appreciated that, older subjects have a smaller 
increase in their HR during maximal exercise (Figure 3.19A). It has been postulated that 
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the decline in HR,,,.,, with age is due to an increase in elastic and collagenous tissue in 
all parts of the conductive system and fat accumulation around the SA node (Lakatta, 
1993). It has been identified that by the sixth decade there is a pronounced decrease in 
the number of pacemaker cells in the SA node, such that by age 75+, less than 10% of 
the original cell number found in the young adult remain (Fleg et at, 1988). This age- 
related decline in HR.. is one of the factors, contributing to the observed age-related 
decline in CO... Whether SVm. declines remains controversial (Fleg et al., 1990; 
Higginbotham et at, 1986; Julius et at, 1967; Kuikka and Lansimies, 1982). Such 
variability between studies can be attributed to the study design, measurement 
techniques, and the subject profiles used. There are at least two studies that have found 
an increased maximal SV index, which was sufficient to compensate for the decline in 
HR. a,,, thus maintaining maximal cardiac index with age (McGuire et al., 2001; 
Rodeheffer et at, 1984). In the current study maximal SV (or SVim. ) was maintained 
with increasing age, therefore the decline in COm. was solely attributable to the decline 
in HR.. 
Unfortunately we were unable to measure the left ventricular end diastolic (LVEDV) 
and systolic (LVESV) volumes at maximal exercise. Such data would have provided 
important information regarding the mechanisms by which SV ..... was maintained with 
age. However, it has been previously postulated that an augmentation of LVEDV during 
exercise may be an adaptation through which SVm. is maintained (Fleg et aL, 1990, 
1995; Lakatta, 1993). The maintenance of SVm. illustrates an important mechanism by 
which the ageing heart attempts to adapt to changes in function. In younger individuals 
there is a greater reliance on increasing HR and probably a reduction in LVESV to 
increase CO. However, with increasing age there is a greater reliance on the Frank- 
Starling mechanism, which is probably manifested by an increase in LVEDV and SV 
(Gerstenblith et aL, 1987). Because of such changes, it has been suggested that the heart 
of the older individual behaves like that of a younger one subjected to A-blockade 
(Lakatta and Yin, 1982). 
A possible mechanism that affects both the changes in maximal HR and SV concerns 
the age-associated diminution in the sympathetic modulation of the cardiovascular 
response to exercise. 'Mat is, the decline in HR .. n and inability of SV.,, to increase, 
and therefore compensate for this reduced rhythmicity, may be due to a down regulation 
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of 0-adrenergic receptors in response to the age-related increases in circulating 
concentrations of catecholamines (Pugh and Wei, 2001). 
For many years ý102,. has been used as a marker of cardiovascular function and 
therefore an indirect marker of cardiac function, providing that other organ systems (e. g. 
lungs, musculoskeletal system) are not limiting factors influencing exercise ability (Tan 
et aL, 1997). It is axiomatic to state that despite all other systems and organs 
functioning normally, if the heart is incapable of performing its normal function, Vo2, n,., 
will be compromised. Equally, V02max is influenced by the performance of the hear4 
particularly the flow generating capacity of the heart. Therefore, changes to CPOnx can 
be expected to be a major determinant of V02max- It was, therefore, not surprising to 
identify an age-related decline in Vo2.. in the current study. Several studies have also 
identified an age-related decline in V02m,, at approximately 10% per decade 
(Drinkwater et aL, 1975; Inbar et aL, 1994; Jackson et aL, 1995; Toth et aL, 1994). This 
figure was not too different from that reported in the current study. That is, 'Qo2max 
declined by 7.6% per decade in the sedentary men from 20 to 70 years of age. 
Interestingly, the age-related rate of decline in V02max was greater than that reported for 
CPOm., such that in advanced age the V02max of sedentary subjects reaches levels not to 
dissimilar to those with moderate heart failure. However, as mentioned earlier V02, n. is 
a composite measure of many organ/bodily functions, whereas CPOmax measures just 
the performance of a single organ. Therefore, age-related changes to the skeletal 
muscles, heart and liver will have a combined affect on the changes in V02.. with age. 
For example, there is evidence that the skeletal muscles in older subjects have a reduced 
aerobic capacity, which is independent of changes in lean body mass (Proctor and 
Joyner, 1997). Whether this reflects less oxygen delivery to the muscles, or an inability 
of muscle machinery e. g. decline in the number of mitochondria to utilise the oxygen, is 
at present unclear. In the current study the greater rate of decline in V02rnax could be 
attributed to a combined loss of central cardiac (CO) and peripheral (a-v 02 difference) 
factors (Figure 3.26). 
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In addition to the changes identified in maximal CPO, an age-related decrease in CPO,,, t 
was also measured in both male and female subjects (Figure 3.11 A). This reduction in 
CPO, ý, t has never been reported before. However, the reduction 
in CPO'ýst is unlikely to 
have an appreciable effect on either the performance of the heart or the individual 
concerned. 
The importance of accounting for differences in body composition has previously been 
addressed. If such data on body composition (i. e. FFM) were not available, one might 
reasonably conclude that resting CPO is reduced with age. However, a very different 
conclusion was obtained by scaling the data for the differences in FFMb . That is, no 
reduction in CPOet was found (Figure 3.11B). This highlights the importance of 
accounting for relevant body size and composition. Why should changes in body 
composition affect resting CPO? In adults, it has been shown that at rest, 70-80% of 
energy expenditure is derived from organs which comprise only -5% of BM, i. e. brain, 
heart, kidneys, liver etc. In contrast, the mass of all the skeletal muscles (approximately 
40% of body mass) roughly accounts for the remaining 20-30% (Muller et aL, 2002). 
The measurement of FFM will therefore take into account only the changes in the most 
metabolically active organs. Tzankoff and Horris (1977) actually found that the decline 
in basal metabolic rate, with age, was abolished when oxygen consumption was 
normalised (using RES model) for lean muscle mass. Therefore, the changes in resting 
CPO may relate to an age-related reduction in muscle mass and the functional 
requirements of less active skeletal muscles, with less mitochondria and hence oxidative 
capacity. 
Despite the lack of changes in CPO,,, t once scaled to FFMb ,a significant reduction in 
resting Ci,. t was still evident (Figures 3.1213). However, this rate of decline was 
reduced and consequently, was sufficient for the increase in MAP,. t to prevent an age- 
related decline in CPiet. 
The changes in peripheral blood flow are usually proportional to a tissue's metabolism 
(Lakatta, 1993). However, the decline in FFM did not fully account for this age-related 
decline in COr, ýq (Figure 3.12B). Therefore, other factors must have also contributed to 
the decline in CO (or Ci) with age, e. g. increases in resting MAP and SVR. When 
Ohm's law is applied to the circulation, increases in resistance and pressure would 
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result in a decrease in CO. This increased vascular loading on the heart may therefore 
contribute to the decline in resting CO (and Ci) in all populations, with advancing years. 
The mechanisms behind the gradual increase in resting arterial pressure with age are 
dependent on which aspect of pressure is analysed. Arterial pressure can be divided into 
steady (MAP) and pulsatile components (pulse pressure; PP) (Safar, 1989). Mean 
arterial pressure is determined by CO and SVR. The PP component, representing the 
variation in pressure around the mean, is influenced by left ventricular ejection, large 
artery stiffness, early pulse wave reflection and HR. Both increased resistance and wall 
stiffness elevate SBP. In contrast DBP rises with increased resistance but falls with 
increased stiffness; the relative contribution of each determining the net effect on DBP 
(Franklin and Weber, 1994; Franklin, 1995; Safar, 1989). 
It is believed that the changes in pressure are a result of alternations in the vasculature. 
That is, age-associated structural changes in compliance arteries (Gerstenblith et al., 
1977; O'Leary et aL, 1999) and impaired relaxation of smooth muscle tone following a. 
adrenergic stimulation lead to a reduction in arterial compliance with ageing (Lakatta, 
2002). Such changes are associated with an increase in SBP,, t within the clinical 
normal range (Pearson et aL, 1997). An increase in both SBP and DBP were identified 
in the current study and may well be due to an increase in arterial stiffness and 
resistance, respectively (Miyachi et aL, 2003; Tanaka et aL, 1998). Consequently, 
increasing age has been referred to as a muted form of hypertension (Lakatta, 1989). 
It has been well documented that SVR,,, t increases with age in patients with clinical 
hypertension, which elevates DBP and MAP (Kawamoto et aL, 1977; Lund-Johansen, 
199 1; Messerli et aL, 198 1; Messerli et al, 1984). However, the changes in SVR,, rt for 
normotensive subjects are inconsistent (Brandfonbrener et aL, 1955; Fleg et aL, 1990; 
Julius et aL, 1967). An increase SVR,,, t with age has only been reported to occur in 
healthy women and not men (Fleg et al., 1990,1995). However, an increase in SVR,, t 
with age in both sexes was clearly evident in the current study (Figure 3.15). 
The changes that are identified in resting cardiac function (CPO,. t) seem to be governed 
by a complex interplay between CO, MAP and SVR. In addition to the age-related 
differences in CPO.,, t significant sex-related differences were evident. It was also 
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interesting to note that, age for age, women had lower resting CPO, CO, SV and higher 
SVR values compared to men. These differences were solely related to the differences 
in body composition and once CPO and SV were normalised for FFMb , no sex-related 
differences were found. Therefore, the differences in FFM seem to be the principle 
reason for the apparent differences between sedentary men and women at rest. The lack 
of changes identified in resting CPO, (i. e. once normalised to FFM) between men and 
women of various ages and fitness levels, further demonstrates that such measurements 
at rest are unlikely to be of any real discriminatory value. The same is also true of 
patients with moderately to severe heart failure (Cotter et aL, 2003; Goldspink et aL, 
2003). 
4.6. The effects of endurance training 
A challenging question that has puzzled many physiologist, concerns whether the 
deterioration in physiological function is due to ageing per se or a less active lifestyle 
that accompanies ageing. It is well known that as individuals become older they 
gradually become less physically active. Consequently it can be difficult to separate this 
trend towards a more sedentary lifestyle from the intrinsic changes associated with 
ageing (Lakatta, 1993; Seals et aL, 2003). We attempted to examine this question by 
looking at a specific experimental model. For this purpose aerobically active men were 
examined in relation to age-matched sedentary controls. 
The findings of the current studies illustrated that maintaining an active lifestyle was not 
sufficient to prevent an age-related decline in maximal cardiac function or CR (Figures 
3.32 and 3.33). The mechanisms behind these age-related declines were similar to those 
identified in the sedentary men. 17hat is, the primary factor that contributed to the 
decline in CPO.. was a corresponding decline in CO.,,.. An increase in NW was also 
observed at maximal exercise in these active men, which helped to ameliorate the loss 
CPOm,, with age. 
Interestingly looking at the raw data, it would appear that the active men expressed the 
greatest rate of decline in CPO..., and CR, compared to their sedentary counterparts. 
Such data suggest that the benefits of aerobic training are lost with advancing age. 
159 
Discussion 
However, this may well be misleading. It was interesting to see that the older (60+ 
years) endurance trained men were physically smaller than their sedentary counterparts, 
i. e. on average they had lower BM and FFM values (Table 3.9). Such differences in 
body composition have been shown to affect CPO. It was therefore not surprising, that 
once these values were normalised for FFMb the rate of decline for both CPO.,,,, and CR 
were similar between the sedentary and active men (i. e. 14 to 18%, respectively). 
The heterogeneous sample of male fitness levels in section 3.3.2 has made it difficult to 
conclude whether the changes in cardiac function were attributed to ageing per se or due 
to other confounding factors. Therefore, two groups of long distance veteran athletes 
(50 and 58 years-of-age) were examined and compared to age-matched sedentary 
controls. However, these veteran athletes who had trained for an average of 18 years 
with a weekly running distance of -32 miles were unable to shed any further light on 
this question. That is, the age-related decline in CPO.,,, from 50 to 58 yeirs-of-age in 
these veteran athletes was similar (14 to 17%) to that found in the sedentary and active 
men (Figure 3.32A). This would suggest that irrespective of fitness levels, a decline in 
CPOma, is almost inevitable with increasing age in men. However, caution is warranted 
when comparing the age-related decline in CPO in these veteran athletes, because of the 
small sample size (n = 20) and the narrow age (46-64) range. 
It has been widely advocated that the age-associated decline in 'ý02rn. can be partially 
offset with aerobic exercise training (Ehsani et A, 1991; Seals et aL, 1984; Stratton el 
aL, 1994). However, others have shown that the age-related decline in V02max is greater 
in endurance trained individuals, compared to their sedentary counterparts (FitzGerald 
et aL, 1997; Pimentel et al., 2003; Wilson and Tanaka, 2000). However, in the current 
study, the rate of decline in ý102max (1/min) with age was similar for the sedentary and 
active men (Figure 3.25A). 
A possible explanation for the decline CPO.. identified in these veteran athletes could 
be due to changes in the exercise-training stimulus. 'Mat is, with increasing age the 
athletes are not able to perform the same intensity or volume of habitual aerobic 
exercise that they performed in their youth. Evidence for this comes from data obtained 
for the changes in 9o2,,,,. with increasing age. Pimentel et aL (2003) found that the 
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frequency of training decreases with increasing age and that correlated with the decline 
in ýIo2.. in the endurance trained men. Furthermore, longitudinal data have shown that 
values were preserved when the exercise training stimulus was maintained over 
periods of 10-20 years (Katzel et aL, 2001; Marti and Howald, 1990; Pollock et aL, 
1987). Data to either refute or confirm this explanation is difficult to obtain, especially 
in cross-sectional studies because precise documentation would be required of the 
subjects' volume and intensities of training. 
The current study obtained information regarding race times (i. e. 10k, half-and full. 
marathons) over the past year, training volume, intensity, and the number of years the 
subjects had been regularly participating in this form of training. However, details were 
not obtained concerning how their current training stimulus, compared to that over the 
past 10 years. It is therefore difficult to ascertain whether the subjects had reduced their 
training volume. Even if such data were available it would be difficult to elucidate 
whether the decrease in training stimulus with age caused a smaller decline in CPO,,.. 
Alternatively, with the age-related reductions in CPO.,,, the perception of exercise 
difficulty may be increased and the training stimulus consequently decreased. 
In addition, with increasing age, there is a likelihood of sub-clinical illnesses, which 
would confound the findings and may account for the changes in CPO. ax- Despite this 
possibility, we still observed significant perseveration of cardiac function with training 
in the older age-groups. 
It would therefore be interesting to establish how maximal cardiac function would vary 
with age if the training stimulus could be maintained. For this purpose, longitudinal 
studies that monitor the training stimulus would be required to provide further insight 
into this possible mechanism. Alternatively, cross-sectional studies that employ a wide 
age-range, large number of subjects, exclusion of any diseases, and a stringent training 
status criteria for subject selection of the may also provide some insight into the affects 
of training status on overall cardiac function. 
Despite all of these shortcomings the beneficial adaptations of long-term endurance 
training were clearly evident at maximal exercise. These veteran athletes who have 
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trained for -18 years had substantially greater CPO,,,. and CR values, than their age- 
matched controls (Figure 3.41). These beneficial differences were still evident when 
expressed relative to FFMb and cannot therefore be attributed to confounding affects of 
body composition. 
Although no differences were found for resting CPO, CO, or MAP between the veteran 
athletes and their sedentary controls, positive adaptations were present for resting SV 
and HFL These changes associated with long-term endurance training have been well 
documented (Blomqvist and Saltin, 1983; Saltin, 1969). The larger SVc, t (or SVi,,, t) 
found in the veteran athletes of the current study has previously been attributed to a 
larger resting LVEDV. In turn, such adaptations are thought to be directly related to 
expanded intravascular volumes, particularly plasma and total blood volumes (Hagberg 
et aL, 1998). The larger LVEDV is thought to evoke the Frank-Starling mechanism, 
thereby increasing SV. The limited echocardiography data we have suggested that those 
veteran athletes had greater LVEDV than their age-matched counterparts. Although not 
statistically significant (Figure 3.43), this observation was consistent with findings by 
others (Pluim et aL, 2000; Spirito et aL, 1994). Any myocardial hypertrophy could also 
result in increased force of contraction leading to a reduction in the LVESV, thereby 
increasing SV., t. However, the echocardiography data suggest no changes in cardiac 
structure in the veteran athletes, with left ventricular diameter and wall thickness no 
larger in the veteran athletes, compared to their sedentary age-matched controls. 
Changes in cardiac structure are common in endurance trained athletes and enable the 
heart to adapt to both pressure and volume overload (Pluim et aL, 2000; Spirito et aL, 
1994). It was therefore surprising not to establish differences between these two 
extreme populations. 
Resting bradycardia was also identified in the current study. This again is another 
common adaptation to training. It is thought that the bradycardia results from increased 
parasympathetic activity in the heart, while decreasing sympathetic activity (Dowell, 
1983; Saltin, 1969). Such antagonistic changes in SV and HR at rest means that the 
resting CO was not significantly different between the veteran athletes and their age- 
matched controls. 
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Past research has clearly identified that endurance training results in physiological 
stress, which induces adaptations to the heart. These are characterised by increased 
diastolic filling, left ventricular hypertrophy and SVn. (Astrand, 1960; Blomqvist and 
Saltin, 1983; Clausen, 1976; Levy et aL, 1993; Longhurst et aL, 1989; Saltin et aL, 
1968). Indeed, in the current study the active men had greater CO.. values which were 
solely attributed to a larger SV.., because HR. did not differ between the subjects 
(Table 3.12). No differences were found in MAP... Therefore, it is likely that CO plays 
a greater role in the adaptive increase in CPOm. in trained men. 
The increased SV.. in these endurance trained men could be due to a variety of 
beneficial adaptations. These could include an enhanced inotropic state which can result 
from enhanced sensitivity to catecholamines, a larger end diastolic volume (hence 
preload) thus evoking the Frank-Starling mechanism, left ventricular hypertrophy, or 
any combination of these variables (Ehsani et aL, 199 1; Fleg et aL, 1994; Lakatta, 1993; 
Ross, 1976). Milliken et al. (1988) demonstrated that LVM was greater in highly 
trained athletes and that this accounted for 40% of the variance in 1ý02m.. Although no 
statistical differences were found in our data for LVM (Figure 3.43D), the values tended 
to be greater in the veteran athletes, and may account for some of the greater SV,,,.., in 
these subjects. 
There are some suggestions that endurance trained individuals can obtain higher 
maximal BP values than untrained individuals (Ekblorn et aL, 1968; Stratton et al., 
1994; Tanaka et aL, 1996). However, others have found no such differences before and 
after endurance training (Svedenhag et aL, 1986), and between trained and untrained 
subjects (Steinhaus et A, 1988). It is thought that in trained athletes, the increase in 
maximal SBP is an adaptive response to maintain the perfusion pressure to widely 
dilated skeletal muscle and vital organs under conditions of low SVR (Rowell, 1991). 
However, the effect of endurance training in determining BP responses to dynamic 
exercise remains controversial. 'Me veteran athletes examined in the current study had 
similar maximal BP values, compared to their age-matched controls (Table 3.12). 
The evidence in the literature suggests that elevated SBP in response to maximal 
exercise may only be apparent in younger endurance trained individuals (Ekblom et aL, 
1968; Steinhaus et aL, 1988; Stratton et al., 1994; Svedenhag et aL, 1986; Tanaka et aL, 
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1996). Such evidence questions whether older endurance trained individuals have a 
similar response to their younger counterparts. We examined trained subjects who were 
into their fifth and sixth decade of life, which may have accounted for the lack of 
differences in MAP.... It may be that overtime this adaptive response is either lost or 
that older trained subjects adapt differently to the training stimulus. Another possible 
explanation concerns the inability to adequately differentiate between the veteran 
athletes and their age-matched controls. That is, the high SBP in the veteran athletes 
may be a result of an adaptive response to the training stimulus, whereas in the 
sedentary older men it may be due to a greater reduction in compliance of the large 
elastic arteries. This is one of the reasons why MAP, and not SBP, is used in the 
calculation of CPO. However, one cannot rule out the fact that the arteries of the vetcran 
athletes may also become stiffer with age, although past research has indicated that 
regular endurance training can attenuate the age-associated increase in arterial stiffness 
(Miyachi et aL, 2003; Tanaka et aL, 2000). Indeed, in the current study the veteran 
athletes had lower SVR,,, than their sedentary peers, which indicates greater maximal 
vascular dilatation, or less alterations in vascular structure (Clausen, 1977; Snell et aL, 
1987). Therefore, further evidence is required to clarify whether endurance training in 
older individuals enhances the pressure generating capacity of the heart. 
The greater CPO.,, values in these veteran athletes were associated with a lower 
SVP, ý,,. This is an important adaptation to endurance training as it highlights a lower 
vascular load on the heart, thereby allowing a greater volume of blood to be ejected 
from the ventricles. Such changes suggest improvements in peripheral function as well 
as positive central cardiac adaptations. 
The enhanced maximal cardiac function observed in these veteran athletes, comparcd to 
their age-matched controls has an important health-related outcome. Such individuals 
have a greater CR and should be able to cope better with the stresses of day-to-day life. 
More importantly, for the same size of myocardial infarction they should perhaps retain 
a greater cardiac functional reserve (CR) than a sedentary individual with a smallcr 
initial CFL It is therefore obvious that an active lifestyle is vitally important. 
How well the aged heart responds to aerobic exercise training is an important question 
that needs to be ascertained. Past research has demonstrated that older individuals do in 
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fact maintain the ability to adapt to endurance exercise training, as indicated by an 
increase in the ý102rnwx (Ehsani et aL, 1991; Hagberg et aL, 1989; Kohrt et aL, 1991; 
Meredith et aL, 1989; Stratton et aL, 1994). Initial responses suggest the CPOma,, and 
thus CR, can also be enhanced in older individuals by endurance training. A recent 
study by Ehsani et at, (2003) examined frail octogenarians (both men and women) who 
participated in a training programme of physical therapy for 6 months e. g. strength 
training, and walking followed by 3 months of more intense endurance exercise at 78% 
peak HP, These results contained pressure and flow changes both at rest and at maximal 
exercise. However like many studies, the two components were not combined to 
provide a marker of overall cardiac function. If CO and MAP been combined to 
calculate CPO, then the authors would have found that the trained group had increased 
their maximal cardiac function by 21%, compared to the insignificant 3% change 
identified in the control group. At present the only study to examine directly the 
changes in CPO was performed by Marshall et aL (2001). After performing 20 minutes 
of cycling at 75-80% of their 1ý02.. for 5 days a week for 8 weeks, 58 year-old men 
significantly improved their CPO.. and CR by 16 and 21%, respectively. 
Another interesting point would be to ascertain whether the total number of 
cardiomyocytes declines in individuals who maintain endurance training over many 
years. The reports of Olivetti et aL (1995; Figure 1.1) lead us to believe that ageing is 
associated with a loss of contractile cells, especially in men. Unfortunately, these 
investigators did not have any information relating to the lifestyle (e. g. sedentary of 
active) of these individuals prior to their death. Therefore, it may be that long-term 
endurance training attenuates or prevents such a loss of myocYtes by apoptosis and/or 
necrosis. It has been well documented that the cardiac muscle of endurance trained 
athletes undergoes considerable hypertrophy as a result of the training stimulus. 
Whereas the cardiomyocyte hypertrophy identified by Olivetti et aL (1995) presumably 
represents an attempt to compensate for the loss of heart cells, this hypertrophy clearly 
is not sufficient as CPOna., declines in the men, with age. If the age-related death and 
loss of myocytes occurs irrespective of fitness levels, it may be possible that the degree 
of hypertrophy in long-term endurance trained individuals may be sufficient to attenuate 
these losses and preserve overall cardiac function at least for some years, e. g. between 
20 and 60 years. 
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Several studies have shown that older endurance trained athletes have markedly higher 
ýrO2m. values than their sedentary peers (Hagberg et aL, 1985; Heath et aL, 1981; 
Pollock et aL, 1987; Seals et aL, 1994). Others have also shown that the V02max values 
of veteran athletes can be greater than younger sedentary individuals (Heath et al., 
1981; Ogawa et aL, 1992). The latter agrees with the current study (Table 3.10). Not 
only were the benefits of long-terin endurance training apparent on measuring maximal 
cardiac function in relation to men of the same age, but also in relation to sedentary 21 
year-old men (Figure 3.4 1). These positive findings indicate that endurance training can 
delay the loss in Votný, and cardiac functional reserve which normally occurs over 40 
years of ageing in inactive individuals. 
Compared to the sedentary 21 year-old men, these veteran athletes exhibited a training- 
induced preservation of cardiac function without a concomitant reduction in afterload, 
i. e. an improved CPOma,, but no differences in SVRma,, (Figure 3.42). These findings 
imply that the improvement attained in CPO. a,, in the veteran athletes were due 
preliminary to central adaptations (i. e. increased SV) rather than driven by peripheral 
factors such as oxygen demand and extraction or a reduction in afterload. 
It is well known that the vascular component of afterload greatly influences cardiac 
pump function. That is, at either extreme of the spectrum of vascular impedance, there 
would be no hydraulic energy output from the heart (Cotter et aL, 2003; Tan, 1986; Tan, 
1987; Williams et aL, 2001a). In the current study the increase in SVR with age could 
be associated with the decrease in CPO (Figure 3.38). These results provide further 
evidence to suggest an increase in SVRna., may have contributed to the decline in 
CPO, na,, with increasing age. 
By divorcing the effects of SVR from CPOm. we were able to identify an important 
relationship. It was found that the ability of the heart to perform external work was 
greater in the active men compared to their sedentary peers for a given vascular 
resistance. Hence, CPOznax was not totally dependent on SVR (Figure 3.38). A similar 
relationship was also identified in the ability of the heart to generate pressure (Figure 
3.39), that is the active men had a greater ability to generate pressure for a given SVR 
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compared to their sedentary controls. Therefore, the greater MAPnax in the active men 
was also not totally dependent on SVR. 
These novel findings are important as they illustrate that improvement in CPO,. in 
these active men was more likely to be a direct result of increased cardiac performance 
rather than a reduction in the pump afterload, which could also increase CPO. 
4.7. The effects of creatine supplementation on CPO 
Perhaps a simple and less energetic way of attenuating this age-related decline in 
maximal cardiac function is through creatine supplementation. Dietary creatine 
supplementation of 20g/day for 5 days has been shown to improve the performance of 
the skeletal muscles (Harris et aL, 1992). Furthermore, it has been shown that creatine 
concentrations decline in a normal human heart, with age (Nascimben et al., 1996). 
Additionally, creatine supplementation in the rat has been shown to increase myocardial 
ATP and phosphocreatine concentrations (Brzezinska et aL, 1998). Such evidence links 
the possibility that a decline in the heart's immediate energy system may affect its 
function. In these studies we examined whether it would be possible to 'rejuvenate' the 
ageing heart by "topping up" its creatine, and hence phosphocreatine (PCr) 
concentrations. This would have provided an easy, cheap and painless means of 
increasing cardiac functional reserve. However in the current study, there was no 
evidence to suggest that creatine supplementation had any beneficial effect in improving 
cardiac performance in 50-60 year-old inactive men. Subsequent to this investigation a 
group of 60 year-old active men were also examined, as creatine combined with 
exercise training has been shown to augment the uptake of creatine into skeletal muscles 
(Harris et aL, 1992; Robinson et aL, 1999). However, once again creatine 
supplementation failed to improve cardiac performance in these active older subjects. 
There may be a number of possible explanations for the lack of apparent improvement 
in cardiac performance. One such explanation is that the majority (95%) of the creatine 
stores are located in the skeletal muscles (Wyss and Kaddurah-Daiuk, 2000). This may 
explain why a number of studies have demonstrated significant increases in skeletal 
muscle creatine content and performance. However, of the remaining 5% in the body 
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the highest concentration is located in the heart (Wyss and Kaddurah-Daiuk, 2000). 
Whether, the cardiac store of creatine can be enhanced sufficiently to improve 
performance remains to be established. Also, Rawson et aL (2001) postulated that older 
individuals may have either a poorer ability to absorb creatine from the gut into the 
blood stream, or an inability of the muscle to take up creatine. Further to this, Neubauer 
et aL (1999) identified that the total creatine and number of creatine transporter proteins 
were significantly reduced in autopsied failing human hearts. It is currently unknown 
whether normal healthy ageing is associated with a decline in the number of creatine 
transporters in the heart. If this is the case then this could affect creatine uptake into the 
heart. 
Another possible explanation concerns the sensitivity of using CPO as the measurement 
tool. To measure CPO requires the subject to exercise to exhaustion (-9 minutes), 
before maximal limits are reached and CO and MAP measured. This process is then 
repeated for duplicate or triplicate measures. Walter et aL (1997) has indicated that 
creatine concentrations are reduced to less than 40% of the resting concentrations within 
10 seconds of maximal exercise, after which glycogenolysis becomes the prime energy 
supplier (Hultman and Sjoholm, 1983; Jacobs et aL, 1983). It is therefore conceivable 
that any beneficial improvements would have occurred at the very beginning of the high 
intense exercise when the PCr system is being utilised as a major source of ATP. At 
present the current CPO protocol cannot provide continuous measures of cardiac power, 
which is perhaps one of its limitations. Therefore it may not be sensitive enough to have 
identified any short-lived improvements. Furthermore, Teýung et al. (1999) indicated 
that marginal increases in performance due to creatine supplementation could be 
difficult to detect given the experimental variability of performance measurements in 
different individuals. This may well be true for the measurement of CPO. Any, such 
beneficial effects of creatine on CPO could conceivably be identified using the invasive 
CPO technique, which instantaneously measures flow and pressure generation from the 
heart. 
The negative results in the current study are similar to those found in an animal model 
where biological and environmental variables are more easily controlled. Data from 
Horn et aL (1998) demonstrated that increasing dietary creatine, and thus both extra-and 
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intra-extracellular creatine concentrations, did not affect cardiac performance or 
coronary blood flow in normal rats. Horn et aL (1998) concluded that in the normal 
heart the energy reserve provided by creatine kinase is not regulated by extracellular 
creatine concentrations. Furthermore, a study by Neubauer et aL (1999) examined the 
haemodynamic changes after 8 weeks of feeding 9-guanidinopropionate. This synthetic 
analogue depletes the PCr and total creatine pool by -80 and -70%, respectively 
(Neubauer et aL, 1999). Despite these dramatic losses in creatine concentrations no 
differences were found in peak haemodynamic variables such as left ventricular 
developed pressure, CO or SVR. Unknown to the authors, CPO could have been 
calculated ftom their data. Once determined, no differences were found in peak CPO. 
Such data suggest that the role between creatine and cardiac energy metabolism plays a 
relatively minor role in determining peak cardiac function in the rat. This may also be 
true in humans. It therefore appears that endurance exercise training remains the best 
approach to improve CR. 
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Conclusion 
The aim of this thesis was to determine if healthy ageing was associated with a decline 
in maximal cardiac function and functional reserve capacity. In the past many of the 
techniques used were invasive or measured only specific aspects of cardiac function. 
For example, CO alone has been commonly used in both exercise physiology and 
clinical medicine as an index of cardiac function. The pressure generating capacity of 
the heart is a vital element of cardiac function and must be incorporated when 
addressing overall cardiac function. These studies here highlight that by ignoring blood 
pressure and examining only blood flow the changes in cardiac function will be 
overestimated with healthy ageing. Furthermore, when examined in heart failure 
patients (NYM 11-III), the detrimental impact of the disease on cardiac function will be 
underestimated. It is therefore imperative to incorporate both the pressure and flow 
generating capacities of the heart when examining its overall function. Therefore, CPO, 
as a more representative and comprehensive indicator of cardiac function (Cooke et aL, 
1998; Nicholls and Reilly, 2001) was employed throughout to document the changes 
associated with ageing. Since this can be achieved non-invasively, it represents a 
powerful research tool. 
Prior to embarking on this large study, it was important to ascertain whether the 
measurement of CPO, like other physiological measures, was affected by a circadian 
rhythm. However, by measuring resting and maximal CPO at the extremes of 04: 30 and 
16: 30, it was established that there were no influences due to the time of day. In 
addition to its physiological importance this has huge practical benci"its concerning the 
number of subjects that were reliably tested each day, and for cross-sectional studies of 
this nature. 
Hence, the optimisation of the CPO protocol, i. e. time of day has significantly improvcd 
the precision and reproducibility of this non-invasive technique. 
Changes in body composition, particularly the amounts of metabolically active skeletal 
muscle mass, strongly influenced the interpretation of these results with respect to both 
age and gender. The physiological basis for this association is assumed to be a dircct 
relation between skeletal muscle mass and its capacity to consume oxygen (Fleg and 
Lakatta, 1988; Toth et al., 1994). The current results highlighted that both ý02m.., and 
variables of CPO were affected by differences in body composition in a way similar to 
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that reported for CO. Therefore, to permit meaningful comparisons of inter-or intra- 
groups of data the current studies identified that it was critical that CPO should be 
scaled to FFM, using the allometric model of scaling. 
Exactly how the process of ageing affects CPO is unknown. Past research has either 
tended to examine the age-related changes using incomplete measures of overall cardiac 
function, or the results have been difficult to interpret due to the confounding influences 
of disease, gender, fitness, or differences in body composition. Here, original 
observations on the effects of healthy ageing on overall cardiac function (CPO) have 
been reported. It is clear that healthy ageing is associated with a decline in both resting 
and maximal cardiac function, in both sedentary men and women. The primary 
mechanism for this decline in both resting and maximal cardiac function was a 
corresponding decrease in CO. Such a decline in resting and maximal CO has been 
reported in the past (Fleg et aL, 1990,1995; Rodelieffer el aL, 1984,1986). Although an 
age-related increase in resting MAP is well known, the increase in MAP at maximal 
exercise with age is seldom reported, which is a crucial component in measuring CPO. 
An age-associated decline in CPO,,, t has not been reported before. However, the decline 
in resting CPO, as experienced by both men and women, was entirely due to the age. 
associated changes in body composition. Hence, no differences remained when these 
data when normalised for FFMb. 
The age-related decline in maximal cardiac function was anticipated. flowcvcr, 
interestingly after the female CPO. data had been normalised for FFMb no significant 
decline was observed. In contrast a significant decline in maximal cardiac function was 
evident in the male data. At present it is not known why women behave differently to 
men. It may be a direct result of the female heart loosing substantially less 
cardiornyocytes with time, compared to men (Olivetti el aL, 1991). This could also be in 
agreement with the maintenance of LVM (Hees et al., 2002). Although, 89 women were 
studied between the ages of 19 to 76 these were not sufficient to determine with any 
accuracy whether the menopause and HRT exert any direct effects. It would be 
important therefore to repeat these findings in both cross-sectional and longitudinal 
studies to consolidate these findings of CPO. u in ageing for Postmenopausal women. 
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In an attempt to improve cardiac metabolic performance through oral creatine 
supplementation, this ergogenic aid was given to two groups of 60 year-old men. 
However, the dietary creatine supplementation had no effect on cardiac performance, in 
either sedentary or active men even though it has been reported that exercise training 
augments the uptake of creatine into the skeletal muscles (Harris et aL, 1992; Robinson 
et aL, 1999). 'Mese results suggest that creatine supplementation does not metabolically 
frejuvenate' the hearts of older men. 
This thesis also compared aerobically active and veteran endurance trained athletes to 
sedentary, age-matched men, to determine whether an active lifestyle could prevent or 
attenuate the changes associated with ageing. Although, the active men reported a 
similar decline in maximal cardiac function to their sedentary counterparts, important 
physiological adaptations were evident. Maximal CPO and CR were greater in the 
veteran athletes compared to their age-matched counterparts. Not only were these 
benefits of long-term endurance training apparent relative to men of the same age, but 
also when compared to sedentary 20 year-old men. These findings indicate that 
maximal cardiac function was more than fully preserved against the process of ageing 
by long-term endurance training. 
Animal experiments, involving sedentary versus long-term endurance trained animals, 
could be undertaken and the number of cardiomyocytes in their hearts counted to 
determine if cell loss is attenuated by exercise. If not, then all adaptations would appear 
to occur through different degree of myocyte hypertrophy. 
An unexpected outcome was the finding that for any given SVR the active men had 
greater CPO. and MAPmax values, compared to the sedentary men. Ilis indicated that 
maximal cardiac performance in these subjects was not totally dependent of SVF' 111is 
adaptive response suggests that the changes due to endurance training directly improve 
cardiac performance, rather than by reducing afterload. 
The results described in this thesis have progressed the understanding of the agc-and 
exercise training changes in overall cardiac function. In addition, improvements have 
been made towards the CPO protocol that should further improve the quality of the 
measurements of CPO, and hence CR. Also advances have been made towards how best 
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to normalise CPO measurements in relation to changes in body composition thereby 
improving the validity and interpretation of data for inter-and intra-group comparisons. 
Despite this, much still needs to be accomplished. 
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Appendix 1 
Section One 
Personal Information 
1. Name: 
2. DOB: Age: 
3. Height: Weight: 
4. Address 
5. Telephone number: 
Home: 
Mobile: 
6. Email: 
7. What is your ethnic group (please tick box) 
Caucasian Hispanic Black Asian Chinese Other 
00D Fý El Fý 
Section Two 
Personal Medical History Assessment (circle answer) 
8. Has your doctor ever said that you have had a heart condition? Yes No 
If yes, please give details, including dates 
9. Have you ever been instructed to perform physical activity only 
recommended by a doctor? Yes No 
If yes, please give details, including dates 
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10. Have you ever had a real, or suspected, heart attack? 
Yes No 
If yes, when did it occur 
11. Have you ever experienced rapid heart beating or palpitations? Yes No 
If so, please give details, including what you were doing at the time 
12. Have you ever had angina or a sharp heavy pain in your chest 
as the result of physical activity? Yes No 
If so, please circle level of activity: low moderate strenuous 
18. Do you lose your balance because of dizziness? Yes No 
19. Do you ever lose consciousness? Yes No 
20. Have you ever had a resting or exercise ECG taken? Yes No 
If yes, was the ECG normal? Yes No 
21. Have you ever been severely breathless as a result of 
low/moderate level exercise? Yes No 
22. Do you suffer from high or low blood pressure? Yes No 
If yes, which one? Low High 
23. Are you currently taking prescribed medication to control 
your blood pressure? Yes No 
If yes, give name and dosage 
24. Have you ever been told your blood cholesterol is too high? Yes No 
If yes, please state your cholesterol level (if known) 
25. Are you currently taking prescribed medication to control 
your cholesterol ? Yes No 
If yes, state name and dosage 
26. Do you suffer from any kidney problems now or in the past? Yes No 
If yes please specify condition and medication 
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27. Do you suffer from diabetes? 
If yes, how is it controlled (please tick) 
a) Dietary means b) Insulin injection 
c) Oral medication F-ý c) Uncontrolled 
F-I 
F1 
Yes No 
28. Do you suffer from asthma, or any respiratory disorders? Yes No 
Please give details of condition and any medication taken including inhaler 
Is the breathing condition made worse by exercise? Yes No 
If yes, what level of exercise (please circle) low moderate strenuous 
29. Do you have any musculo-skeletal problems that could be 
made worse by a change in physical activity? Yes No 
If so, please give details of condition 
What level of exercise can you do without making your condition worse? 
(please circle) low moderate strenuous 
30. Do you know of any other reason why you should not undertake 
physical activity? 
If yes, why 
3 1. Do you suffer from any of the following: - 
HIV/AIDS Yes No 
Hepatitis B or C Yes No 
Or any other disease transmitted by blood Yes No 
Haemophiliac Yes No 
Chron's disease Yes No 
Thyroid Problems Yes No 
Adrenal Problems Yes No 
Pituitary Problems Yes No 
32. Do you smoke? Yes No 
What do you smoke (please circle) cigarettes cigars pipe 
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If yes, 
How long have you smoked for? 
How many per day? 
Have you ever smoked? 
If yes, 
Yes No 
How long did you smoke for? 
How many per day? 
When did you stop? 
Section Three 
Physical Activity Assessment 
33. Considering a typical 7-day period (week), how many times do you do the 
following kinds of exercise for during your free time (write on each line the appropriate 
number). 
a) Strenuous Exercise 
(Heart beats rapidly) 
(e. g running, jogging, hockey, football, soccer, 
squash, basketball, cross country skiing, judo, 
roller skating, vigorous swimming, vigorous 
longer distance cycling) 
b) Moderate Exercise 
(Not Exhausting) 
(e. g. fast walking, baseball, tennis, easy cycling, 
volleyball, badminton, easy swimming, 
alpine skiing, popular and folk dancing) 
c) Mild Exercise 
(Minimal Effort) 
(e. g. yoga, archery, fishing from river bed, 
bowling, horseshoes, golf, easy walk) 
Times Per Duration 
Week (to the nearest 
5mins) 
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34. Considering a typical 7-day period (week), during your leisure time, how often to 
do you engage in regular activity long enough to work up a sweat with your heart 
beating rapidly? 
OFTEN SOMETIMES NEVER/RARELY 
F-I 
35. Are you currently engaged in moderate or intense training? Yes No 
If yes, please detail training schedule including, type of activity, intensity, number 
of sessions per week and duration of each session on the attached sheet at the end 
of the questionnaire. 
36. Have you ever previously engaged in moderate or intense training? Yes No 
If yes, please give details of your schedule: 
Intensity Number of times Duration of each session 
per week (to nearest 5mins) 
What year did you start training? 
How long ago did you stop training? 
Section four 
Diet Assessment 
(please circle) 
37. Are you a vegetarian Yes No 
38. During a typical day what do you eat/drink 
39. Do you take any food supplements Yes No 
If yes, please specify 
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40. Please detail any further information you would like to tell us 
Participant signature: 
Thank you for completing this questionnaire 
Question 35 continued. 
Please give details of current training schedule. 
Appendix 1 
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American College of Sports Medicine, percentile values for maximal aerobic 
capacity (ml/min/kg). 
I J. ý , 
-'06 Nears ,, !7k' 
Percentile 
Men 
90 
80 
70 
60 
50 
-: Fo 
30 
20 
10 
50-59 
41.0 
38.5 
36.7 
35.2 
33.8 
32.3 
30.2 
28.0 
60+ 
35.3 
33.6 
31.8 
30.2 
28.7 
26.5 
23.1 
Women I 
"I. o. 
I 
90 44.2 41.0 39.5 35.2 35.2 
80 41.0 38.6 36.3 32.3 31.2 
70 38.1 36.7 33.8 30.9 29.4 
60 36.7 24.6 '32.3 29.4 27.2 
50 35.2 33.8 30.9 28.2 25.8 
40 33.8 32.3 29.5 26.9 24.5 
30 32.3 30.5 28.3 25.5 23.8 
20 30.6 28.7 26.5 24.3 22.8 
10 28.4 26.5 25.1 22.3 20.8 
Data are presented by institute for Aeiobics Research, Dallas, IX (1994). Study 
population for the data sets were predominately white . and college educated. A modified 
Balke treadmill test was used with ý102 .. a,, estimated from the last grade/speed achieved. 
The following may be used as descript ors for the percentile rankings: well above 
average (90), above average (70), average (50), below average (30), and well below 
average (10). 
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20-29 - 
51.4 
48.2 
46.8 
44.2 
42.5. 
41.0 
39.5 
37.1 
34.5 
'30-39 
f '.! 
,ý 50.4 !, ' 
ý' 46.8! 
, 
42.4 
: ": 
32.5 
-4049 
45.3 42.5 
38.1 14 
ft, 
39 9 
3ý6.7 
'; '3.1 
30.9 
